<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6923730</article-id><article-id pub-id-type="pmcid-ver">PMC6923730.1</article-id><article-id pub-id-type="pmcaid">6923730</article-id><article-id pub-id-type="pmcaiid">6923730</article-id><article-id pub-id-type="pmid">31921136</article-id><article-id pub-id-type="doi">10.3389/fimmu.2019.02869</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Immunomodulation as a Novel Strategy for Prevention and Treatment of <italic toggle="yes">Bordetella</italic> spp. Infections</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gestal</surname><given-names initials="MC">Monica C.</given-names></name><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/519188/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Johnson</surname><given-names initials="HM">Hannah M.</given-names></name><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/808836/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Harvill</surname><given-names initials="ET">Eric T.</given-names></name><xref ref-type="corresp" rid="c002"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/401229/overview"/></contrib></contrib-group><aff><institution>Department of Infectious Diseases, College of Veterinary Sciences, University of Georgia</institution>, <addr-line>Athens, GA</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Roberta Antonia Diotti, Vita-Salute San Raffaele University, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Rene Raeven, Intravacc, Netherlands; Giorgio Fedele, Istituto Superiore di Sanit&#224; (ISS), Italy</p></fn><corresp id="c001">*Correspondence: Monica C. Gestal <email>mcarges@gmail.com</email></corresp><corresp id="c002">Eric T. Harvill <email>harvill@uga.edu</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>10</volume><issue-id pub-id-type="pmc-issue-id">328186</issue-id><elocation-id>2869</elocation-id><history><date date-type="received"><day>16</day><month>9</month><year>2019</year></date><date date-type="accepted"><day>22</day><month>11</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>09</day><month>01</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2020-01-12 04:56:27.930"><day>12</day><month>01</month><year>2020</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2019 Gestal, Johnson and Harvill.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Gestal, Johnson and Harvill</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fimmu-10-02869.pdf"/><abstract><p>Well-adapted pathogens have evolved to survive the many challenges of a robust immune response. Defending against all host antimicrobials simultaneously would be exceedingly difficult, if not impossible, so many co-evolved organisms utilize immunomodulatory tools to subvert, distract, and/or evade the host immune response. <italic toggle="yes">Bordetella</italic> spp. present many examples of the diversity of immunomodulators and an exceptional experimental system in which to study them. Recent advances in this experimental system suggest strategies for interventions that tweak immunity to disrupt bacterial immunomodulation, engaging more effective host immunity to better prevent and treat infections. Here we review advances in the understanding of respiratory pathogens, with special focus on <italic toggle="yes">Bordetella</italic> spp., and prospects for the use of immune-stimulatory interventions in the prevention and treatment of infection.</p></abstract><kwd-group><kwd>immunomodulation</kwd><kwd><italic toggle="yes">Bordetella</italic></kwd><kwd>Toll-receptors</kwd><kwd>adjuvants</kwd><kwd>pertussis</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source><award-id rid="cn001">R21AI140399</award-id><award-id rid="cn001">R21AI142678</award-id><award-id rid="cn001">RO1GM113681</award-id></award-group><award-group><funding-source id="cn002">American Lung Association<named-content content-type="fundref-id">10.13039/100002590</named-content></funding-source><award-id rid="cn002">FP00016431</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="0"/><equation-count count="0"/><ref-count count="316"/><page-count count="15"/><word-count count="14732"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><fig id="F1" position="float" orientation="portrait"><label>Graphical Abstract</label><caption><p>Areas of investigation focused on the use of immunomodulation in prevention and therapy of infectious diseases. Created with <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://biorender.com/">BioRender</ext-link>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-10-02869-g0001.jpg"/></fig><sec id="s1"><title>Introduction to the Strategy of Immunomodulation for Health</title><p>We are exposed to vast numbers of pathogens during our lifespan, but only a small number manage to cause disease. Invading bacteria face a hostile environment in hosts with arrays of antimicrobial compounds and components of immunity. To persist in such an environment, bacteria must find a way to survive this onslaught of antibacterials. The strategy of resisting them all may be exceedingly challenging or impossible; instead, most of the best-studied pathogens have mechanisms that allow them to evade the full effects of host defenses (<xref rid="B1" ref-type="bibr">1</xref>&#8211;<xref rid="B12" ref-type="bibr">12</xref>). In this review, we will consider examples of novel approaches in vaccine and therapeutic development that have been guided by the better understanding of bacterial immunomodulatory abilities. We will focus on findings with <italic toggle="yes">Bordetella</italic> spp., considering novel adjuvants that enhance host immune response and new immunostimulatory therapies that can augment the most effective aspects of the host immune response. The results highlighted in this review demonstrate that the manipulation and/or disruption of bacterial immunomodulatory properties are providing a highly promising approach that could replace antibiotics in a near future. Understanding the mechanisms that bacteria utilize to manipulate host immune response, as well as the immune signaling pathways that lead to greater protective immunity, can guide the development of targeted interventions that can enhance the host immune response to more effectively kill the bacterial hazard.</p></sec><sec id="s2"><title>The Bordetellae; Biology; and Experimental System</title><p>Pertussis disease is caused by <italic toggle="yes">B. pertussis</italic>, a highly transmissible human pathogen that causes a respiratory illness also known as the 100-day cough (<xref rid="B13" ref-type="bibr">13</xref>). Among the proposed reasons for its resurgence are waning immunity (<xref rid="B13" ref-type="bibr">13</xref>), the end of the &#8220;honeymoon period&#8221; (<xref rid="B14" ref-type="bibr">14</xref>), the past vaccination calendar (<xref rid="B15" ref-type="bibr">15</xref>), and the failure of the current acellular vaccine to confer sterilizing immunity and long-lasting herd immunity. The increase in the number of cases is associated with more advanced diagnostic tools than ever before, allowing for an increase in the number of identified cases (<xref rid="B16" ref-type="bibr">16</xref>&#8211;<xref rid="B31" ref-type="bibr">31</xref>), but also with increased morbidity and mortality that creates an unambiguous imperative for improved prevention methods.</p><p>Vaccination has greatly increased life expectancy by preventing several historically notorious infectious diseases (<xref rid="B32" ref-type="bibr">32</xref>&#8211;<xref rid="B36" ref-type="bibr">36</xref>). However, we are witnessing a rise in several preventable diseases previously thought to be controlled (<xref rid="B37" ref-type="bibr">37</xref>), such as pertussis (<xref rid="B38" ref-type="bibr">38</xref>). Around 1945, a whole-cell vaccine against <italic toggle="yes">B. pertussis</italic> was introduced, causing an unprecedented decrease in the number of reported pertussis cases. However, due to undesirable adverse effects such as fever, erythema, swelling, drowsiness and others, this was replaced in several industrialized countries by an acellular vaccine that contains between 3 to 5 bacterial proteins (<xref rid="B39" ref-type="bibr">39</xref>&#8211;<xref rid="B44" ref-type="bibr">44</xref>). Despite the fact that both types of vaccines generate antibodies that impede bacterial adhesion and have bactericidal action, these have not been sufficient to halt the increase in the number of cases. In response to this increase a boost was introduced to extend immunological memory, and new vaccination strategies targeted to pregnant women and close family have also been introduced as an attempt to protect highly susceptible newborns (<xref rid="B45" ref-type="bibr">45</xref>&#8211;<xref rid="B48" ref-type="bibr">48</xref>).</p><p>As the number of cases continues to increase, the scientific community is working to understand the causes that drive this reemergence (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B49" ref-type="bibr">49</xref>). Amongst the proposed causes of this increase are, limitation to the protection conferred by the current acellular vaccine. Not only does the acquired anamnestic response wane rapidly (<xref rid="B50" ref-type="bibr">50</xref>), but the acellular vaccine still allows for bacterial colonization of the nasal cavity and shedding. Combined, these factors illuminate the fact that the current vaccines used in most industrialized countries still permit transmission of pertussis from host to host (<xref rid="B51" ref-type="bibr">51</xref>&#8211;<xref rid="B54" ref-type="bibr">54</xref>), which has even more significant impacts when considered in tandem with the rise of anti-vaccination movements. Yet another cause for the increase is the differences detected in the immune response triggered by the whole cell vaccine (Th17) vs. the acellular vaccine (Th2) (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B55" ref-type="bibr">55</xref>&#8211;<xref rid="B57" ref-type="bibr">57</xref>). It is important to highlight that while neither whole-cell nor acellular vaccines confer long-lasting immunity, and the merits of both responses have been debated in recent years, the general consensus agrees on advantages to skewing T cell response toward Th1/Th17 immunity (<xref rid="B58" ref-type="bibr">58</xref>&#8211;<xref rid="B61" ref-type="bibr">61</xref>).</p><p>The &#8220;gold standard&#8221; of immunity to pertussis is considered to be the classical Th1/Th17 T cell response induced by convalescent immunity (<xref rid="B62" ref-type="bibr">62</xref>); however, there is significant cumulative evidence that infection-induced immunity is imperfect and shorter-lived than it could be (<xref rid="B50" ref-type="bibr">50</xref>). Current discoveries contribute to better understanding of the immune response to Bordetellae, and the important role that CD4 resident T cells play in a local memory response has been recently demonstrated (<xref rid="B63" ref-type="bibr">63</xref>). Another hypothesis is that Bordetellae are evolving, and due to the genome plasticity and adaptability of this pathogen, current isolates of <italic toggle="yes">B. pertussis</italic> have lost some of the antigens included in the acellular vaccine. This phenomenon is referred to as &#8220;vaccine driven evolution,&#8221; which helps justify why immunity is not as robust as it has previously been (<xref rid="B64" ref-type="bibr">64</xref>&#8211;<xref rid="B67" ref-type="bibr">67</xref>).</p><p>These are only some of the potential causes that are currently being considered, and it is most likely an uneven combination of all of them that is truly driving this pertussis resurgence. Although the whole-cell vaccine is still used, the trend is shifting toward a safer acellular vaccine, and efforts on improving their performance and the length of protective memory these generate will be discussed in this manuscript.</p><p>The current strategy for the development of vaccines is driven by the hypothesis that antibodies provide strong protection. As a consequence, most of the current acellular vaccines are highly safe and generate a rapid antibody response that is protective, albeit limited (<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B69" ref-type="bibr">69</xref>). Importantly, infection triggers a complex and well-orchestrated sequence of responses involving many interacting components of innate and adaptive immunity, directed by several signaling pathways that present numerable known, and probably many more unknown, opportunities to interfere in the succession of events that can skew the resulting immune response.</p><p>Bordetellae harbor multiple mechanisms that allow them to modulate the host immune response (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B71" ref-type="bibr">71</xref>). Some of the proteins that these organisms utilize to manipulate immune cells include adenylate cyclase toxin (ACT), a pore forming protein that leads to the deregulation of cAMP levels within target cells (<xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B73" ref-type="bibr">73</xref>); type 3 secretion system (T3SS), a needle-like structure that injects toxins within mammalian cells (<xref rid="B74" ref-type="bibr">74</xref>&#8211;<xref rid="B76" ref-type="bibr">76</xref>); a type 6 secretion system that uses a phage-like mechanism to inject molecules (<xref rid="B77" ref-type="bibr">77</xref>); pertussis toxin (PTX), which prevents G proteins from interacting with G protein-coupled receptors on the cell membrane and therefore interfering with intracellular communication (<xref rid="B78" ref-type="bibr">78</xref>&#8211;<xref rid="B80" ref-type="bibr">80</xref>); and filamentous hemagglutinin (FHA), which binds signaling receptors, enables adhesion to epithelial cells and interferes with cytokine production (<xref rid="B81" ref-type="bibr">81</xref>, <xref rid="B82" ref-type="bibr">82</xref>). Based on these studies of various immunomodulators we can now begin to adjust the way we design preventative and responsive medications to fight bacterial infections in more effective ways.</p><p>A good understanding of the sequential reactions of the immune response (and bacterial manipulation of them) is key to improving the induction and maintenance of robust long-lasting protective immunity. Some of the <italic toggle="yes">Bordetella</italic> spp. virulence factors are already being investigated for treatments, such as PTX for human immunodeficiency virus (HIV) treatment (<xref rid="B83" ref-type="bibr">83</xref>&#8211;<xref rid="B89" ref-type="bibr">89</xref>). Understanding how we can alter bacterial ability to sense and respond to the host to modulate its response can lead to treatments and therapies that focus on the enhancement of more appropriate and effective host immune responses.</p></sec><sec id="s3"><title>Immunotherapy in Prevention</title><sec><title>Adjuvants</title><p>The <italic toggle="yes">Bordetella pertussis</italic> acellular vaccine has not completely blocked the spread of pertussis because it allows for colonization of the nasal cavity (<xref rid="B48" ref-type="bibr">48</xref>) and provides only temporary protection (<xref rid="B13" ref-type="bibr">13</xref>). Adjuvants are well-documented for their potential to increase vaccine performance, and some adjuvants such as CpG oligodeoxynuceotides or alum are commonly found in vaccine formulations (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>). There are a plethora of adjuvants that can potentiate the performance of a vaccine and can be classified into two main groups: Toll-like receptors agonists (<xref rid="B92" ref-type="bibr">92</xref>&#8211;<xref rid="B94" ref-type="bibr">94</xref>) and mucosal adjuvants (<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B95" ref-type="bibr">95</xref>&#8211;<xref rid="B97" ref-type="bibr">97</xref>). These two distinct classes have been closely considered for their contributions to pertussis vaccines as well as therapeutics (<xref rid="B98" ref-type="bibr">98</xref>&#8211;<xref rid="B103" ref-type="bibr">103</xref>), yielding highly promising enhancing properties.</p></sec><sec><title>Toll-Like Receptors Agonists</title><p>Toll-Like Receptors (TLRs) are highly sophisticated sentinels that recognize specific pathogen-associated molecular patterns (PAMPs). The differential activation of TLRs is one of the main determinants for an efficient immune response against pathogens. Under this premise, researchers have been working on the addition of TLR agonists to vaccines with the expectation that activating different TLRs will command the type of T cell response produced (<xref rid="B104" ref-type="bibr">104</xref>) and will ultimately enhance host protective immunity (<xref rid="B105" ref-type="bibr">105</xref>).</p><p>One of the best studied Toll-Like Receptors is TLR2, which recognizes a broad spectrum of bacterial cell wall components, including lipopolypeptides, peptidoglycan, and lipochoic acids, that trigger different signals that shape the immune response against the bacterial threat (<xref rid="B106" ref-type="bibr">106</xref>). It has been demonstrated that the use of TLR2 agonists as adjuvants to already developed vaccines increases immunity, especially in neonates (<xref rid="B93" ref-type="bibr">93</xref>). This feature is highly relevant to the design of vaccines against diseases that primarily affect newborns and young infants (<xref rid="B93" ref-type="bibr">93</xref>). Moreover, TLR2 agonists in combination with the BCG vaccine can enhance protection against <italic toggle="yes">Mycobacterium tuberculosis</italic> (<xref rid="B107" ref-type="bibr">107</xref>), skewing the cellular response toward Th1 (<xref rid="B100" ref-type="bibr">100</xref>), and resulting in a more robust protective memory response, further promoting its use in vaccinology. TLR2 has been also correlated with an efficient response to <italic toggle="yes">B. pertussis</italic> infections (<xref rid="B108" ref-type="bibr">108</xref>), and some preliminary data has revealed that the use of these agonists enhances protection against infection by pertussis (<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B100" ref-type="bibr">100</xref>). Altogether, these data suggest that TLR2 agonists may be promising candidates to combine with current or new vaccines to enhance the protective response.</p><p>Similarly, TLR4 appears a good candidate for vaccine enhancement because it recognizes lipopolysaccharide (LPS) molecules, which are commonly present on the surface of most bacteria. Agonists of TLR4 enhance the performance of several vaccines including viral, bacterial, and even mycobacterial (<xref rid="B109" ref-type="bibr">109</xref>&#8211;<xref rid="B113" ref-type="bibr">113</xref>). One important aspect is its promotion of mucosal immunity (<xref rid="B114" ref-type="bibr">114</xref>&#8211;<xref rid="B116" ref-type="bibr">116</xref>), which is critical for the generation of protection against certain infections including gut and respiratory diseases like pertussis (<xref rid="B117" ref-type="bibr">117</xref>&#8211;<xref rid="B119" ref-type="bibr">119</xref>), although this increase is achieved via mucosal delivery of the vaccine rather than systemic (<xref rid="B120" ref-type="bibr">120</xref>). Molecular evidence has revealed that the addition of a TLR4 ligand to the acellular pertussis vaccine resulted in a shift from a Th2-dominant response to additional induction of Th17 (<xref rid="B121" ref-type="bibr">121</xref>, <xref rid="B122" ref-type="bibr">122</xref>). The abundant immunological evidence that highlights the role of TLR4 in the immune response to <italic toggle="yes">B. pertussis</italic> (<xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B123" ref-type="bibr">123</xref>&#8211;<xref rid="B130" ref-type="bibr">130</xref>) indicates that TLR4 agonists are promising candidate for the generation of more robust protective immunity.</p><p>TLR5 (<xref rid="B131" ref-type="bibr">131</xref>) is also a highly plausible candidate to augment vaccine performance since it recognizes flagella, which are present in a multitude of bacterial species. Previous literature has indicated that ectopic expression of flagella in <italic toggle="yes">Bordetella</italic> spp. leads to faster clearance of the infection (<xref rid="B132" ref-type="bibr">132</xref>), and it was later revealed that TLR5 activates antigen-presenting cells, increasing T cell response (<xref rid="B133" ref-type="bibr">133</xref>) (<italic toggle="yes">manuscript in preparation</italic>), and may ultimately contribute to the more rapid clearance previously reported. In several other microorganisms, the addition of TLR5 agonists have resulted in an increased performance of the vaccine (<xref rid="B134" ref-type="bibr">134</xref>&#8211;<xref rid="B141" ref-type="bibr">141</xref>). Altogether these data suggest that TLR5 agonists could significantly increase the performance of the current acellular pertussis vaccine.</p><p>TLR7 recognizes single-stranded RNA (<xref rid="B142" ref-type="bibr">142</xref>&#8211;<xref rid="B153" ref-type="bibr">153</xref>) and has been demonstrated to be a promising vaccine adjuvant for protection against several microorganisms (<xref rid="B154" ref-type="bibr">154</xref>, <xref rid="B155" ref-type="bibr">155</xref>). Similar to TLR2, the TLR7 agonist augments immunity in newborns, the most susceptible population (<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B143" ref-type="bibr">143</xref>, <xref rid="B156" ref-type="bibr">156</xref>, <xref rid="B157" ref-type="bibr">157</xref>). The addition of a TLR7 agonist to an alum-adjuvant of pertussis vaccine skewed the immune response toward Th1/Th17 and significantly decreased colonization (<xref rid="B98" ref-type="bibr">98</xref>), providing preliminary data to further pursue this agonist in other animal models.</p><p>Lastly, TLR9 recognizes unmethylated CpG oligodeoxynucleotides and promotes IL-6 secretion and consequent B cell activation (<xref rid="B158" ref-type="bibr">158</xref>&#8211;<xref rid="B168" ref-type="bibr">168</xref>). It has been demonstrated that enhancement of TLR9 receptors augment activity of antigen-presenting cells in neonates (<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B169" ref-type="bibr">169</xref>). Addition of a TLR9 agonist to the acellular pertussis vaccine resulted in greater stimulation of B and T cells and a shift to Th1, as well as higher antibody titers (<xref rid="B81" ref-type="bibr">81</xref>, <xref rid="B170" ref-type="bibr">170</xref>&#8211;<xref rid="B174" ref-type="bibr">174</xref>), suggesting that an agonist of TLR9 is also a candidate to add to the current pertussis vaccines. These have the potential to be widely used agonists, as most of the current vaccine's efficacy is measured as an increase in antibody titers.</p><p>Altogether, these results demonstrate that TLR agonists are great candidates to be used as vaccine adjuvants to increase protective immunity. Interestingly, some of the TLR agonists substantially augment vaccine performance in newborns and infants, which represent the most susceptible population (<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B169" ref-type="bibr">169</xref>) although there are substantial hurdles to applying this knowledge. Moreover, preliminary data obtained with TLR2, and TLR7 agonists demonstrate the improved performance of the current <italic toggle="yes">B. pertussis</italic> vaccine and indicates that the use of adjuvants can feasibly potentiate and augment the generation of protective immunity (<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B100" ref-type="bibr">100</xref>).</p></sec><sec><title>Mucosal Adjuvants</title><p>Adjuvants have been used to potentiate, enhance, or accelerate vaccine effects since the 1920s (<xref rid="B105" ref-type="bibr">105</xref>) and the field has greatly evolved since. Mucosal adjuvants include cholera toxin, heat-labile enterotoxin, and other compounds have been studied for their particular ability to increase protection on mucosal surfaces (<xref rid="B175" ref-type="bibr">175</xref>). These are of extreme importance, not only because of the aforementioned increase in vaccine performance, but also because the delivery method involving intranasal vaccination has a lot of potential for improving the delivery of the vaccine and increasing acceptance among needle-phobic population. In the following paragraphs we will detail the mechanisms of action and the data compiled for some of the most promising mucosal adjuvants.</p><p>Cholera toxin (CT) and heat-labile enterotoxin of <italic toggle="yes">Escherichia coli</italic> (LT) are highly antigenic; however, due to their toxicity, they are not ideal candidates for human therapies. Recently, safe forms of these toxins created via genetic manipulation have been utilized as adjuvants to enhance the function of mucosal vaccines (<xref rid="B103" ref-type="bibr">103</xref>, <xref rid="B176" ref-type="bibr">176</xref>&#8211;<xref rid="B181" ref-type="bibr">181</xref>). The mechanism behind this augmented immune response induced by CT is an increase in the permeability of the mucosal epithelium, enhanced antigen presentation, the consequent promotion of dendritic cell maturation, increased IgA response, and finally, the generation of complex stimulatory and inhibitory effects on T cell proliferation and cytokine production such as IL-4, IL-5, IL-6, and IL-10 that skew the response toward a Th2-type (<xref rid="B177" ref-type="bibr">177</xref>, <xref rid="B182" ref-type="bibr">182</xref>). CTA1 is the subunit responsible for the immunomodulatory activity in conjunction with ERdj5 in the endoplasmic reticulum, which is the target for CT. In the absence of ERdj5, mice failed to produce inflammatory cytokines, indicating that CT action requires ERdj5 (<xref rid="B183" ref-type="bibr">183</xref>). Similarly, the calcium-binding protein S100A4 is required for efficient antigen presentation and enhanced activity of CT, as it is necessary for the humoral and cellular response (<xref rid="B184" ref-type="bibr">184</xref>). CT has been tested as an adjuvant for pertussis vaccine and preliminary data suggests that it substantially improves mucosal protection by augmenting IgA levels (<xref rid="B183" ref-type="bibr">183</xref>, <xref rid="B185" ref-type="bibr">185</xref>), and it has even been suggested that this adjuvant may be safe for use in humans (<xref rid="B186" ref-type="bibr">186</xref>, <xref rid="B187" ref-type="bibr">187</xref>). Some studies have revealed that conjugation of CT with pertussis toxoid added to the current acellular vaccine (<xref rid="B188" ref-type="bibr">188</xref>) or Fimbriae (Fim2) (<xref rid="B189" ref-type="bibr">189</xref>) are highly promising candidates to improve the generation of protective immunity from these vaccines.</p><p>Similar to CT, the heat-labile enterotoxin from <italic toggle="yes">E. coli</italic> (LT) promotes an antigen-specific response inducing IgA antibodies, Th17 response, and the enhancement of long-lasting protective immunity (<xref rid="B190" ref-type="bibr">190</xref>) while also being safe for use in humans (<xref rid="B191" ref-type="bibr">191</xref>). LT promotes maturation of dendritic cells, antigen-specific IL-17 positive cells, and production of IL-1&#945;, IL-1&#946;, and IL-23 by dendritic cells. Trials in animals have revealed the efficacy of this adjuvant at enhancing mucosal response (<xref rid="B192" ref-type="bibr">192</xref>). LT promotes dendritic cell maturation enhancing IL-1&#946; production through activation of caspase-1 and the NLRP3 inflammasome complex. Simultaneously, LT enhances LPS-induced IL-1&#945; and IL-23 expression through activation of ERK MAPK in dendritic cells inducing the development of Th17 T cells (<xref rid="B193" ref-type="bibr">193</xref>). Interestingly, LT derivatives LTK63 (non-toxic mutant of LT) and LTR72 (which retains partial enzymatic activity) revealed two distinct phenotypes characterized by stimulation of IL-12 and TNF-&#945; production by macrophages, resulting in enhanced Th1 responses with the LTK63 adjuvants. In contrast, LTR72 suppresses LPS-induced IL-12 production, increases type 2 responses, inhibits Th1 response, and facilitates clearance of bacterial burden (<xref rid="B194" ref-type="bibr">194</xref>), demonstrating that both subunits of the toxin have particular activities that can be beneficial for the improvement of the current acellular pertussis vaccine.</p><p>Another mucosal adjuvant that is widely investigated is retinoic acid, a powerful immunomodulator that interferes with growth, differentiation, and other aspects of the cell life cycle. Importantly, retinoic acid is also essential in the generation of mucosal immunity, the promotion of tolerogenic effects, the generation of a robust innate and adaptive immune response, and moreover, it also acts as a negative regulator of IgE production (<xref rid="B195" ref-type="bibr">195</xref>&#8211;<xref rid="B197" ref-type="bibr">197</xref>). It has been hypothesized that retinoic acid plays a fundamental role in sustaining mucosal homeostasis by down-regulating IgE levels (<xref rid="B197" ref-type="bibr">197</xref>). Its performance as an adjuvant has been studied in several organisms and the plethora of results obtained have revealed that retinoic acid is a promising candidate to use as an adjuvant of mucosal vaccines by itself or encapsulated in nanoparticles (<xref rid="B198" ref-type="bibr">198</xref>&#8211;<xref rid="B203" ref-type="bibr">203</xref>). Unfortunately, its activity in conjunction with the pertussis vaccine has not yet been assessed.</p><p>The use of biopolymers in mucosally-administered vaccines has substantially improved the current vaccine formulations and has great potential for the future (<xref rid="B204" ref-type="bibr">204</xref>). Some of the presently investigated biopolymers include alginate (<xref rid="B205" ref-type="bibr">205</xref>&#8211;<xref rid="B212" ref-type="bibr">212</xref>) and gellan (<xref rid="B213" ref-type="bibr">213</xref>, <xref rid="B214" ref-type="bibr">214</xref>). Although these are still in early stages of study, other biopolymers, such as chitosan (<xref rid="B95" ref-type="bibr">95</xref>&#8211;<xref rid="B97" ref-type="bibr">97</xref>, <xref rid="B215" ref-type="bibr">215</xref>&#8211;<xref rid="B232" ref-type="bibr">232</xref>), starch (<xref rid="B233" ref-type="bibr">233</xref>), and &#946;-glucan (<xref rid="B234" ref-type="bibr">234</xref>&#8211;<xref rid="B241" ref-type="bibr">241</xref>), have already been tested in animal trials with encouraging success. While the use of biopolymers is still rising, this area of investigation is highly promising, especially for enhancement of mucosal protection. Mucosal delivery has been explored for pertussis immunization from different approaches that have resulted in hopeful results in which Th17 response was enhanced and the animals were more robustly protected against challenge (<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B170" ref-type="bibr">170</xref>, <xref rid="B242" ref-type="bibr">242</xref>, <xref rid="B243" ref-type="bibr">243</xref>).</p><p>To summarize, several mucosal adjuvants are being investigated, some of which are derived from toxins while still others are derived from biopolymers. Both act to enhance the performance of vaccines, particularly those that can be orally or intranasally delivered, usually in cases in which mucosal protection is a key component of immunity. However, these further demonstrate that different strategies and approaches can be used to improve the performance of the current vaccines to produce and enhance individual and herd immunity.</p></sec><sec><title>Novel Vaccination Strategies</title><p>The combination of BCG and acellular pertussis vaccination has been shown to reduce the mortality rate of pertussis (<xref rid="B244" ref-type="bibr">244</xref>&#8211;<xref rid="B247" ref-type="bibr">247</xref>). Immunological studies unraveling the underlying mechanism by which protection against pertussis is enhanced are necessary. Some groups have focused on the addition of antigens to the current vaccine in order to improve performance. After demonstrating via <italic toggle="yes">in vitro</italic> experiments that the autotransporter BrkA would be a good candidate to generate antibodies that kill <italic toggle="yes">Bordetella</italic> spp., BrkA has been tested as an adjuvant of the current acellular pertussis vaccine, the results of which revealed robust lung protection against infection with <italic toggle="yes">B. pertussis</italic> (<xref rid="B248" ref-type="bibr">248</xref>, <xref rid="B249" ref-type="bibr">249</xref>). Two other autotransporters, Vag8 (<xref rid="B250" ref-type="bibr">250</xref>, <xref rid="B251" ref-type="bibr">251</xref>) and SphB1, when added to the current pertussis vaccine resulted in improved protection against <italic toggle="yes">B. pertussis</italic> infection (<xref rid="B252" ref-type="bibr">252</xref>). Adenylate cyclase toxin (ACT), when added to a current vaccine formulation significantly decreased inflammation and increased the generation of protective immunity (<xref rid="B253" ref-type="bibr">253</xref>, <xref rid="B254" ref-type="bibr">254</xref>). BcfA (colonization factor A) has been used as adjuvant in the current vaccine, and the preliminary data obtained with the murine model reveals that the addition of this adjuvant shifts the T cell response toward Th1/Th17 (<xref rid="B255" ref-type="bibr">255</xref>).</p><p>Live vaccines have the potential to induce strong mucosal protection, but suffer from concern about their risk. An exciting new vaccine candidate against <italic toggle="yes">B. pertussis</italic> is the live attenuated vaccine, BPZE1, which has been shown to induce a robust local B and T cell response (<xref rid="B256" ref-type="bibr">256</xref>&#8211;<xref rid="B282" ref-type="bibr">282</xref>) despite genetically engineered mutations that render it relatively safe (<xref rid="B283" ref-type="bibr">283</xref>, <xref rid="B284" ref-type="bibr">284</xref>). Excitingly, phase I trials demonstrate that the intranasal formulation of the vaccine transiently colonizes the nasal cavity, leading to the generation of stronger immunity (<xref rid="B264" ref-type="bibr">264</xref>, <xref rid="B268" ref-type="bibr">268</xref>).</p><p>Several groups are currently working on the development of outer membrane vesicles and outer membrane proteins in protection against <italic toggle="yes">B. pertussis</italic> as well as cross-protection against several <italic toggle="yes">Bordetella</italic> spp. and characterizing the immune response as well as protective immunity (<xref rid="B285" ref-type="bibr">285</xref>&#8211;<xref rid="B295" ref-type="bibr">295</xref>). In animal studies, immunization with outer membrane vesicles led to not only better humoral and cellular (Th17) memory, but also to a significant increase in IgA titers, which is one of the major hurdles of current vaccination strategies against this pathogen (<xref rid="B296" ref-type="bibr">296</xref>&#8211;<xref rid="B298" ref-type="bibr">298</xref>). It is important to highlight that the increase in IgA responses upon immunization with outer membrane vesicles is only obtained when these are administrated mucosally (<xref rid="B299" ref-type="bibr">299</xref>). The classic delivery for OMV's, which is subcutaneous or intraperitoneal immunization, does not induce IgA responses and this novel delivery method provides a great advance, as it can be administered with more ease and induces an even better immunological response. The increase in mucosal protection has led to efforts toward improved nasal delivery approaches and a thermostable spray containing outer membrane vesicles has been developed. This spray significantly improves delivery and decreases the discomfort other intranasal formulations might cause. Importantly, this delivery method still maintains all the outstanding qualities of the classical delivery of these purified outer membrane vesicles (<xref rid="B300" ref-type="bibr">300</xref>).</p><p>Finally, another highly promising strategy is focused on the disruption of bacterial ability to manipulate the host immune response. Under the premise that bacteria harbor mechanisms that allow them to sense and respond to host immunity, disrupting these pathways would allow for the generation of more robust protective immunity. A live attenuated vaccine in which immunomodulatory mechanisms are disrupted might confer cross-protection against classical Bordetellae, which are known to share many antigens. Although this is only the first study for this method of vaccine design (<italic toggle="yes">manuscript in revision</italic>), this novel approach has great potential for the generation of new vaccine candidates and possibly therapeutics.</p></sec></sec><sec id="s4"><title>Immunotherapy in Treatment</title><sec><title>LOS-Derived Oligosaccharide Glycoconjugates</title><p>Pertussis toxin (PTX) in an inactivated form (PTd) functions as a major protective antigen, stimulating production of toxin-neutralizing antibodies which can protect against damage caused by the toxin, but do not target the bacteria itself (<xref rid="B301" ref-type="bibr">301</xref>, <xref rid="B302" ref-type="bibr">302</xref>); however, it also demonstrates possible partial reversion back to its toxic active form (<xref rid="B303" ref-type="bibr">303</xref>, <xref rid="B304" ref-type="bibr">304</xref>), which may be responsible for the reactogenicity seen in a small percentage of vaccine recipients. It is also a secretory protein, which is only loosely associated with the cell and is therefore not an ideal target for bactericidal antibodies. A more effective target is an abundant surface component such as the endotoxin lipooligosaccharide (LOS), an LPS analog with a complete absence of the O-specific polysaccharide chain that is produced by several varieties of Gram-negative bacteria (<xref rid="B305" ref-type="bibr">305</xref>). LOS provides significant adjuvant properties via induction of IL-12 and 1L-1&#946; that promote Th1 and Th17 responses, respectively (<xref rid="B306" ref-type="bibr">306</xref>, <xref rid="B307" ref-type="bibr">307</xref>). It also displays pyrogenic, mitogenic, and endotoxic activity that necessitate its conjugation or conversion to a less destructive form prior to its use in a vaccine.</p><p>LOS conjugated to protein carriers filamentous hemagglutinin, bovine serum albumin, and tetanus toxoid (TTd) successfully induce a strong bactericidal response specific to LOS presented on the surface of <italic toggle="yes">B. pertussis</italic>, leading to complement-mediated destruction of the cell (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B308" ref-type="bibr">308</xref>, <xref rid="B309" ref-type="bibr">309</xref>). These protein carriers are also surface components, like LOS, and the resulting surface-associated conjugate acts as a strong target for antibody action directed against <italic toggle="yes">B. pertussis</italic>.</p><p>Somewhat surprisingly, another conjugate iteration in which an LOS-derived oligosaccharide is covalently linked with the secretory protein PTX yields a uniquely non-toxic and immunogenic glycoconjugate that retains the antigenic properties of PTX while also inducing the production of bactericidal antibodies. The presumed linkage at the fetuin- and glycoprotein-binding sites of PTX inactivates the enzymatic activity of the protomer A and binding properties of oligomer B, demonstrated using <italic toggle="yes">in vitro</italic> assays (<xref rid="B310" ref-type="bibr">310</xref>). Although the use of LOS appears to be highly promising, <italic toggle="yes">in vivo</italic> studies still need to be done to assess pharmacological parameters of safety and biodistribution.</p></sec><sec><title>Cyclophilin Inhibitors</title><p>PTX is internalized in cells via endocytosis and then follows a retrograde transport system to the endoplasmic reticulum. The enzymatically active (A) subunit of PTX, PTS1, detaches from the rest of the toxin in the ER and unfolds due to its thermal instability. It is then transported into the cytosol with the help of cyclophilin (Cyps), an important protein folding helper enzyme that also is required to facilitate membrane translocation from early endosomes into the cytosol of various ADP-ribosylating toxins (<xref rid="B311" ref-type="bibr">311</xref>&#8211;<xref rid="B313" ref-type="bibr">313</xref>). Inhibiting Cyps activity has been shown to in turn inhibit membrane translocation and protect cells from intoxication with PTX and others (<xref rid="B311" ref-type="bibr">311</xref>).</p><p>Inhibition can be achieved via the approved immunosuppressive drug cyclosporine A (CsA), which specifically inhibits Cyps activity in mammalian cells by binding directly to Cyps and forming a ternary complex. It has been used as the primary agent in immunosuppressive regimens such as grafts and transplants since the 1980s. It is now suggested that CsA might interfere with the translocation of PTS1 from the ER into the cytosol; it may also play a role in reassembling the unfolded PTS1 subunit (<xref rid="B311" ref-type="bibr">311</xref>).</p><p><italic toggle="yes">In vitro</italic> intoxication assays performed on CHO-K1 cells demonstrated that CsA-treated cells were protected from PTX intoxication. Interestingly, up to 50% of CsA is retained intracellularly, even in the absence of extracellular inhibitor, after 18 h (<xref rid="B314" ref-type="bibr">314</xref>). Thus, presumably, intracellular Cyps stay inhibited over a longer period of time, explaining the toxin-resistant phenotype. This is also concomitant with the long retention of CsA in different tissues observed after CsA administration in human patients (<xref rid="B315" ref-type="bibr">315</xref>, <xref rid="B316" ref-type="bibr">316</xref>). This inhibitor was delivered orally during trials, but its use in a mucosal spray or as a directly injectable vaccine component has yet to be investigated.</p></sec></sec><sec id="s5"><title>Future Directions and Conclusion</title><p>Since the years of our notoriously premature celebration of victory over infectious disease, there has been seemingly inexorable retaliation. There is now justifiable concern, shifting toward fear, about the combined threats of increasing antibiotic resistance and the failures of current vaccines due to factors including incomplete vaccine uptake, vaccine-driven evolution and other threats. However, recent advances in our understanding of immunology and the tools to manipulate it present hope for more rational targeted interventions that are focused on enhancing the natural host response. Similarly, improved understanding of strategies and mechanisms by which bacteria modulate the immune response provides new targets for treatment and prevention. In the coming years, we will likely witness an expansion in the field of immunotherapy promoted by a better understanding of the finely tuned interactions of bacteria and host.</p></sec><sec id="s6"><title>Author Contributions</title><p>MG: original idea of the manuscript, writing, and editing. HJ: writing and editing. EH: editing and final approval.</p><sec><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>The authors would like to acknowledge the members of the EH Lab for helpful and fruitful discussions and brainstorming.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by the National Institutes of Health (NIH) (Grant Nos. R21 AI142678-01, R21AI140399, and RO1GM113681) and by the National Institute of Allergy and Infectious Diseases. This work has been also supported by the Catalyst Award (American Lung Association). The funders had no role in the study design, data collection, and interpretation, or the decision to submit the work for publication.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gestal</surname><given-names>MC</given-names></name><name name-style="western"><surname>Whitesides</surname><given-names>LT</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>Integrated signaling pathways mediate <italic toggle="yes">Bordetella</italic> immunomodulation, persistence, and transmission</article-title>. <source>Trends Microbiol.</source> (<year>2019</year>) <volume>27</volume>:<fpage>118</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2018.09.010</pub-id><pub-id pub-id-type="pmid">30661570</pub-id><pub-id pub-id-type="pmcid">PMC6342287</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hancock</surname><given-names>RE</given-names></name><name name-style="western"><surname>Nijnik</surname><given-names>A</given-names></name><name name-style="western"><surname>Philpott</surname><given-names>DJ</given-names></name></person-group>. <article-title>Modulating immunity as a therapy for bacterial infections</article-title>. <source>Nat Rev Microbiol.</source> (<year>2012</year>) <volume>10</volume>:<fpage>243</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2745</pub-id><pub-id pub-id-type="pmid">22421877</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Islam</surname><given-names>EA</given-names></name><name name-style="western"><surname>Jarvis</surname><given-names>GA</given-names></name><name name-style="western"><surname>Gray-Owen</surname><given-names>SD</given-names></name><name name-style="western"><surname>Russell</surname><given-names>MW</given-names></name></person-group>. <article-title>Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-&#946;-dependent mechanisms</article-title>. <source>Mucosal Immunol.</source> (<year>2012</year>) <volume>5</volume>:<fpage>320</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2012.12</pub-id><pub-id pub-id-type="pmid">22354319</pub-id><pub-id pub-id-type="pmcid">PMC3328619</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolfe</surname><given-names>DN</given-names></name><name name-style="western"><surname>Karanikas</surname><given-names>AT</given-names></name><name name-style="western"><surname>Hester</surname><given-names>SE</given-names></name><name name-style="western"><surname>Kennett</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>IL-10 induction by <italic toggle="yes">Bordetella parapertussis</italic> limits a protective IFN-gamma response</article-title>. <source>J Immunol.</source> (<year>2010</year>) <volume>184</volume>:<fpage>1392</fpage>&#8211;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0803045</pub-id><pub-id pub-id-type="pmid">20042578</pub-id><pub-id pub-id-type="pmcid">PMC5180427</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carbonetti</surname><given-names>NH</given-names></name></person-group>. <article-title>Immunomodulation in the pathogenesis of <italic toggle="yes">Bordetella pertussis</italic> infection and disease</article-title>. <source>Curr Opin Pharmacol.</source> (<year>2007</year>) <volume>7</volume>:<fpage>272</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2006.12.004</pub-id><pub-id pub-id-type="pmid">17418639</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tateda</surname><given-names>K</given-names></name><name name-style="western"><surname>Ishii</surname><given-names>Y</given-names></name><name name-style="western"><surname>Horikawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Matsumoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Miyairi</surname><given-names>S</given-names></name><name name-style="western"><surname>Pechere</surname><given-names>JC</given-names></name><etal/></person-group>. <article-title>The <italic toggle="yes">Pseudomonas aeruginosa</italic> autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils</article-title>. <source>Infect Immun.</source> (<year>2003</year>) <volume>71</volume>:<fpage>5785</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.71.10.5785-5793.2003</pub-id><pub-id pub-id-type="pmid">14500500</pub-id><pub-id pub-id-type="pmcid">PMC201082</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ritchie</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Yam</surname><given-names>AO</given-names></name><name name-style="western"><surname>Tanabe</surname><given-names>KM</given-names></name><name name-style="western"><surname>Rice</surname><given-names>SA</given-names></name><name name-style="western"><surname>Cooley</surname><given-names>MA</given-names></name></person-group>. <article-title>Modification of <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic> T- and B-cell-mediated immune responses by the <italic toggle="yes">Pseudomonas aeruginosa</italic> quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone</article-title>. <source>Infect Immun.</source> (<year>2003</year>) <volume>71</volume>:<fpage>4421</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.71.8.4421-4431.2003</pub-id><pub-id pub-id-type="pmid">12874321</pub-id><pub-id pub-id-type="pmcid">PMC165988</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sperandio</surname><given-names>V</given-names></name></person-group>. <article-title>Pathogens' adaptation to the human host</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2018</year>) <volume>115</volume>:<fpage>9342</fpage>&#8211;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1813379115</pub-id><pub-id pub-id-type="pmid">30190426</pub-id><pub-id pub-id-type="pmcid">PMC6156631</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lustri</surname><given-names>BC</given-names></name><name name-style="western"><surname>Sperandio</surname><given-names>V</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>CG</given-names></name></person-group>. <article-title>Bacterial chat: intestinal metabolites and signals in host-microbiota-pathogen interactions</article-title>. <source>Infect Immun.</source> (<year>2017</year>) <volume>85</volume>:<fpage>e00476</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00476-17</pub-id><pub-id pub-id-type="pmid">28947641</pub-id><pub-id pub-id-type="pmcid">PMC5695128</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#228;umler</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Sperandio</surname><given-names>V</given-names></name></person-group>. <article-title>Interactions between the microbiota and pathogenic bacteria in the gut</article-title>. <source>Nature</source>. (<year>2016</year>) <volume>535</volume>:<fpage>85</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/nature18849</pub-id><pub-id pub-id-type="pmid">27383983</pub-id><pub-id pub-id-type="pmcid">PMC5114849</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kendall</surname><given-names>MM</given-names></name><name name-style="western"><surname>Sperandio</surname><given-names>V</given-names></name></person-group>. <article-title>What a dinner party! mechanisms and functions of interkingdom signaling in host-pathogen associations</article-title>. <source>MBio.</source> (<year>2016</year>) <volume>7</volume>:<fpage>e01748</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.01748-15</pub-id><pub-id pub-id-type="pmid">26933054</pub-id><pub-id pub-id-type="pmcid">PMC4810492</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Curtis</surname><given-names>MM</given-names></name><name name-style="western"><surname>Sperandio</surname><given-names>V</given-names></name></person-group>. <article-title>A complex relationship: the interaction among symbiotic microbes, invading pathogens, and their mammalian host</article-title>. <source>Mucosal Immunol.</source> (<year>2011</year>) <volume>4</volume>:<fpage>133</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2010.89</pub-id><pub-id pub-id-type="pmid">21248724</pub-id><pub-id pub-id-type="pmcid">PMC3079440</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kilgore</surname><given-names>PE</given-names></name><name name-style="western"><surname>Salim</surname><given-names>AM</given-names></name><name name-style="western"><surname>Zervos</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>HJ</given-names></name></person-group>. <article-title>Pertussis: microbiology, disease, treatment, and prevention</article-title>. <source>Clin Microbiol Rev.</source> (<year>2016</year>) <volume>29</volume>, <fpage>449</fpage>&#8211;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00083-15</pub-id><pub-id pub-id-type="pmid">27029594</pub-id><pub-id pub-id-type="pmcid">PMC4861987</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Domenech de Cell&#232;s</surname><given-names>M</given-names></name><name name-style="western"><surname>Magpantay</surname><given-names>FM</given-names></name><name name-style="western"><surname>King</surname><given-names>AA</given-names></name><name name-style="western"><surname>Rohani</surname><given-names>P</given-names></name></person-group>. <article-title>The pertussis enigma: reconciling epidemiology, immunology and evolution</article-title>. <source>Proc Biol Sci.</source> (<year>2016</year>) <volume>283</volume>:<fpage>20152309</fpage>. <pub-id pub-id-type="doi">10.1098/rspb.2015.2309</pub-id><pub-id pub-id-type="pmid">26763701</pub-id><pub-id pub-id-type="pmcid">PMC4721090</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broutin</surname><given-names>H</given-names></name><name name-style="western"><surname>Viboud</surname><given-names>C</given-names></name><name name-style="western"><surname>Grenfell</surname><given-names>BT</given-names></name><name name-style="western"><surname>Miller</surname><given-names>MA</given-names></name><name name-style="western"><surname>Rohani</surname><given-names>P</given-names></name></person-group>. <article-title>Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries</article-title>. <source>Proc Biol Sci.</source> (<year>2010</year>) <volume>277</volume>:<fpage>3239</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1098/rspb.2010.0994</pub-id><pub-id pub-id-type="pmid">20534609</pub-id><pub-id pub-id-type="pmcid">PMC2981935</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyashita</surname><given-names>N</given-names></name><name name-style="western"><surname>Akaike</surname><given-names>H</given-names></name><name name-style="western"><surname>Teranishi</surname><given-names>H</given-names></name><name name-style="western"><surname>Kawai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ouchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Kato</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients</article-title>. <source>BMC Infect Dis.</source> (<year>2013</year>) <volume>13</volume>:<fpage>129</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-13-129</pub-id><pub-id pub-id-type="pmid">23496900</pub-id><pub-id pub-id-type="pmcid">PMC3600016</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Subissi</surname><given-names>L</given-names></name><name name-style="western"><surname>Rodeghiero</surname><given-names>C</given-names></name><name name-style="western"><surname>Martini</surname><given-names>H</given-names></name><name name-style="western"><surname>Litzroth</surname><given-names>A</given-names></name><name name-style="western"><surname>Huygen</surname><given-names>K</given-names></name><name name-style="western"><surname>Leroux-Roels</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve <italic toggle="yes">Bordetella pertussis</italic> serodiagnosis in recently vaccinated subjects</article-title>. <source>Clin Microbiol Infect.</source> (<year>2019</year>) . <pub-id pub-id-type="doi">10.1016/j.cmi.2019.10.001</pub-id><pub-id pub-id-type="pmid">31610300</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gil-Prieto</surname><given-names>R</given-names></name><name name-style="western"><surname>Walter</surname><given-names>S</given-names></name><name name-style="western"><surname>San-Rom&#225;n-Montero</surname><given-names>J</given-names></name><name name-style="western"><surname>Mar&#237;n-Garc&#237;a</surname><given-names>P</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Escalada</surname><given-names>A</given-names></name><name name-style="western"><surname>Gil-de-Miguel</surname><given-names>A</given-names></name></person-group>. <article-title>Paediatric hospitalizations due to whooping cough in Spain (1997-2017)</article-title>. <source>Vaccine.</source> (<year>2019</year>) <volume>37</volume>:<fpage>6342</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.09.017</pub-id><pub-id pub-id-type="pmid">31526619</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stefanelli</surname><given-names>P</given-names></name></person-group>. <article-title>Pertussis: identification, prevention and control</article-title>. <source>Adv Exp Med Biol.</source> (<year>2019</year>). <pub-id pub-id-type="doi">10.1007/5584_2019_408</pub-id><pub-id pub-id-type="pmid">31321754</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>DX</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yao</surname><given-names>KH</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Shi</surname><given-names>W</given-names></name><name name-style="western"><surname>Ke</surname><given-names>JW</given-names></name><etal/></person-group>. <article-title>Pertussis detection in children with cough of any duration</article-title>. <source>BMC Pediatr.</source> (<year>2019</year>) <volume>19</volume>:<fpage>236</fpage>. <pub-id pub-id-type="doi">10.1186/s12887-019-1615-3</pub-id><pub-id pub-id-type="pmid">31299934</pub-id><pub-id pub-id-type="pmcid">PMC6626350</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rabi</surname><given-names>A</given-names></name><name name-style="western"><surname>Rokni</surname><given-names>T</given-names></name><name name-style="western"><surname>Bennaoui</surname><given-names>F</given-names></name><name name-style="western"><surname>Rada</surname><given-names>N</given-names></name><name name-style="western"><surname>El Idrissi Slitine</surname><given-names>N</given-names></name><name name-style="western"><surname>Draiss</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Epidemiology of pertussis in Marrakech and contribution of molecular diagnosis</article-title>. <source>Infect Dis.</source> (<year>2019</year>) <volume>51</volume>:<fpage>703</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1080/23744235.2019.1637537</pub-id><pub-id pub-id-type="pmid">31274041</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fumimoto</surname><given-names>R</given-names></name><name name-style="western"><surname>Otsuka</surname><given-names>N</given-names></name><name name-style="western"><surname>Kamiya</surname><given-names>H</given-names></name><name name-style="western"><surname>Sunagawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Tanaka-Taya</surname><given-names>K</given-names></name><name name-style="western"><surname>Kamachi</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Seroprevalence of IgA and IgM antibodies to <italic toggle="yes">Bordetella pertussis</italic> in healthy Japanese donors: assessment for the serological diagnosis of pertussis</article-title>. <source>PLoS ONE.</source> (<year>2019</year>) <volume>14</volume>:<fpage>e0219255</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0219255</pub-id><pub-id pub-id-type="pmid">31260500</pub-id><pub-id pub-id-type="pmcid">PMC6602288</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dou</surname><given-names>M</given-names></name><name name-style="western"><surname>Macias</surname><given-names>N</given-names></name><name name-style="western"><surname>Shen</surname><given-names>F</given-names></name><name name-style="western"><surname>Bard</surname><given-names>JD</given-names></name><name name-style="western"><surname>Dom&#237;nguez</surname><given-names>DC</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name></person-group>. <article-title>Rapid and accurate diagnosis of the respiratory disease pertussis on a point-of-care biochip</article-title>. <source>EClinicalMedicine.</source> (<year>2019</year>) <volume>8</volume>:<fpage>72</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.eclinm.2019.02.008</pub-id><pub-id pub-id-type="pmid">31008450</pub-id><pub-id pub-id-type="pmcid">PMC6469871</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dou</surname><given-names>M</given-names></name><name name-style="western"><surname>Sanchez</surname><given-names>J</given-names></name><name name-style="western"><surname>Tavakoli</surname><given-names>H</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>JE</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Dien Bard</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>A low-cost microfluidic platform for rapid and instrument-free detection of whooping cough</article-title>. <source>Anal Chim Acta.</source> (<year>2019</year>) <volume>1065</volume>:<fpage>71</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.aca.2019.03.001</pub-id><pub-id pub-id-type="pmid">31005153</pub-id><pub-id pub-id-type="pmcid">PMC6481316</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Markey</surname><given-names>K</given-names></name><name name-style="western"><surname>Douglas-Bardsley</surname><given-names>A</given-names></name><name name-style="western"><surname>Asokanathan</surname><given-names>C</given-names></name><name name-style="western"><surname>Fry</surname><given-names>NK</given-names></name><name name-style="western"><surname>Barkoff</surname><given-names>AM</given-names></name><name name-style="western"><surname>Bacci</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Improvement in serological diagnosis of pertussis by external quality assessment</article-title>. <source>J Med Microbiol.</source> (<year>2019</year>) <volume>68</volume>:<fpage>741</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.000926</pub-id><pub-id pub-id-type="pmid">30990403</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Damouni Shalabi</surname><given-names>R</given-names></name><name name-style="western"><surname>Srugo</surname><given-names>I</given-names></name><name name-style="western"><surname>Golan-Shany</surname><given-names>O</given-names></name><name name-style="western"><surname>Kugelman</surname><given-names>A</given-names></name><name name-style="western"><surname>Bamberger</surname><given-names>E</given-names></name></person-group>. <article-title>Respiratory viruses frequently mimic pertussis in young infants</article-title>. <source>Pediatr Infect Dis J.</source> (<year>2019</year>) <volume>38</volume>:<fpage>e107</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/INF.0000000000002223</pub-id><pub-id pub-id-type="pmid">30986792</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moosa</surname><given-names>F</given-names></name><name name-style="western"><surname>du Plessis</surname><given-names>M</given-names></name><name name-style="western"><surname>Wolter</surname><given-names>N</given-names></name><name name-style="western"><surname>Carrim</surname><given-names>M</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>C</given-names></name><name name-style="western"><surname>von Mollendorf</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Challenges and clinical relevance of molecular detection of <italic toggle="yes">Bordetella pertussis</italic> in South Africa</article-title>. <source>BMC Infect Dis.</source> (<year>2019</year>) <volume>19</volume>:<fpage>276</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-019-3869-7</pub-id><pub-id pub-id-type="pmid">30898099</pub-id><pub-id pub-id-type="pmcid">PMC6429695</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tascini</surname><given-names>C</given-names></name><name name-style="western"><surname>Carannante</surname><given-names>N</given-names></name><name name-style="western"><surname>Sodano</surname><given-names>G</given-names></name><name name-style="western"><surname>Tiberio</surname><given-names>C</given-names></name><name name-style="western"><surname>Atripaldi</surname><given-names>L</given-names></name><name name-style="western"><surname>Di Caprio</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Neonatal pertussis diagnosis: low procalcitonin level and high lymphocyte count are able to discriminate pertussis from bacterial and viral infections</article-title>. <source>New Microbiol.</source> (<year>2019</year>) <volume>42</volume>:<fpage>49</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="pmid">30785208</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>GS</given-names></name><name name-style="western"><surname>Huh</surname><given-names>DH</given-names></name><name name-style="western"><surname>Han</surname><given-names>SB</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>DH</given-names></name><name name-style="western"><surname>Kang</surname><given-names>KR</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>Enzyme-linked immunosorbent assay for detecting anti-pertussis toxin antibody in mouse</article-title>. <source>Clin Exp Vaccine Res.</source> (<year>2019</year>) <volume>8</volume>:<fpage>64</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.7774/cevr.2019.8.1.64</pub-id><pub-id pub-id-type="pmid">30775352</pub-id><pub-id pub-id-type="pmcid">PMC6369130</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saiki-Macedo</surname><given-names>S</given-names></name><name name-style="western"><surname>Valverde-Ezeta</surname><given-names>J</given-names></name><name name-style="western"><surname>Cornejo-Tapia</surname><given-names>A</given-names></name><name name-style="western"><surname>Castillo</surname><given-names>ME</given-names></name><name name-style="western"><surname>Petrozzi-Helasvuo</surname><given-names>V.</given-names></name><name name-style="western"><surname>Aguilar-Luis</surname><given-names>MA</given-names></name><etal/></person-group>. <article-title>Identfication of viral and bacterial etiologic agents of the pertussis-like syndrome in children under 5 years old hospitalized</article-title>. <source>BMC Infect Dis.</source> (<year>2019</year>) <volume>19</volume>:<fpage>75</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-019-3671-6</pub-id><pub-id pub-id-type="pmid">30665366</pub-id><pub-id pub-id-type="pmcid">PMC6341522</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Matola</surname><given-names>T</given-names></name><name name-style="western"><surname>Miele</surname><given-names>C</given-names></name><name name-style="western"><surname>Coppola</surname><given-names>M</given-names></name><name name-style="western"><surname>Fumi</surname><given-names>M</given-names></name><name name-style="western"><surname>Pancione</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sale</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Utility of peripheral blood smear in rapid diagnosis of Pertussis</article-title>. <source>Int J Lab Hematol.</source> (<year>2019</year>) <volume>41</volume>:<fpage>e41</fpage>&#8211;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1111/ijlh.12947</pub-id><pub-id pub-id-type="pmid">30480363</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wadman</surname><given-names>M</given-names></name><name name-style="western"><surname>You</surname><given-names>J</given-names></name></person-group>. <article-title>The vaccine wars</article-title>. <source>Science</source>. (<year>2017</year>) <volume>356</volume>:<fpage>364</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1126/science.356.6336.364</pub-id><pub-id pub-id-type="pmid">28450592</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paff</surname><given-names>ML</given-names></name><name name-style="western"><surname>Nuismer</surname><given-names>SL</given-names></name><name name-style="western"><surname>Ellington</surname><given-names>A</given-names></name><name name-style="western"><surname>Molineux</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Bull</surname><given-names>JJ</given-names></name></person-group>. <article-title>Virus wars: using one virus to block the spread of another</article-title>. <source>PeerJ.</source> (<year>2016</year>) <volume>4</volume>:<fpage>e2166</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.2166</pub-id><pub-id pub-id-type="pmid">27413636</pub-id><pub-id pub-id-type="pmcid">PMC4933091</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Gregorio</surname><given-names>E</given-names></name><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name></person-group>. <article-title>Vaccines for the future: learning from human immunology</article-title>. <source>Microb Biotechnol.</source> (<year>2012</year>) <volume>5</volume>:<fpage>149</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1111/j.1751-7915.2011.00276.x</pub-id><pub-id pub-id-type="pmid">21880117</pub-id><pub-id pub-id-type="pmcid">PMC3815775</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frishman</surname><given-names>WH</given-names></name></person-group>. <article-title>Ten secrets to a long life</article-title>. <source>Am J Med.</source> (<year>2019</year>) <volume>132</volume>:<fpage>564</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjmed.2018.12.020</pub-id><pub-id pub-id-type="pmid">30639553</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roush</surname><given-names>SW</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>TV</given-names></name><collab>Vaccine-Preventable Disease Table Working Group</collab></person-group>. <article-title>Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States</article-title>. <source>JAMA.</source> (<year>2007</year>) <volume>298</volume>:<fpage>2155</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1001/jama.298.18.2155</pub-id><pub-id pub-id-type="pmid">18000199</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKee</surname><given-names>M</given-names></name><name name-style="western"><surname>Middleton</surname><given-names>J</given-names></name></person-group>. <article-title>Information wars: tackling the threat from disinformation on vaccines</article-title>. <source>BMJ.</source> (<year>2019</year>) <volume>365</volume>:<fpage>l2144</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.l2144</pub-id><pub-id pub-id-type="pmid">31085543</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rohani</surname><given-names>P</given-names></name><name name-style="western"><surname>Drake</surname><given-names>JM</given-names></name></person-group>. <article-title>The decline and resurgence of pertussis in the US</article-title>. <source>Epidemics.</source> (<year>2011</year>) <volume>3</volume>:<fpage>183</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.epidem.2011.10.001</pub-id><pub-id pub-id-type="pmid">22094341</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goezsy</surname><given-names>B</given-names></name><name name-style="western"><surname>Kato</surname><given-names>L</given-names></name></person-group>. <article-title>Sensitizing properties of <italic toggle="yes">B. pertussis</italic> in the mouse and rat</article-title>. <source>Rev Can Biol.</source> (<year>1964</year>) <volume>23</volume>:<fpage>427</fpage>&#8211;<lpage>37</lpage>. <pub-id pub-id-type="pmid">14237174</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morrone</surname><given-names>G</given-names></name><name name-style="western"><surname>Nunziata</surname><given-names>B</given-names></name><name name-style="western"><surname>Picciotto</surname><given-names>L</given-names></name></person-group>. <article-title>[Immunitary response of the infant vaccinated with quadruple DPT-polio vaccine]</article-title>. <source>Riv Ist Sieroter Ital.</source> (<year>1959</year>) <volume>34</volume>:<fpage>321</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="pmid">14424397</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>BL</given-names></name><name name-style="western"><surname>Chou</surname><given-names>CT</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CT</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YT</given-names></name><name name-style="western"><surname>Ko</surname><given-names>HH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>WC</given-names></name><etal/></person-group>. <article-title>Studies on diphtheria-pertussis-tetanus combined immunization in children. II. Immune responses after the primary vaccination</article-title>. <source>J Immunol.</source> (<year>1957</year>) <volume>79</volume>:<fpage>39</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="pmid">13475806</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ipsen</surname><given-names>J</given-names></name><name name-style="western"><surname>Bowen</surname><given-names>HE</given-names></name></person-group>. <article-title>Effects of routine immunization of children with triple vaccine (diphtheria-tetanus-pertussis)</article-title>. <source>Am J Public Health Nations Health.</source> (<year>1955</year>) <volume>45</volume>:<fpage>312</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.2105/AJPH.45.3.312</pub-id><pub-id pub-id-type="pmid">14350122</pub-id><pub-id pub-id-type="pmcid">PMC1623169</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albkrt</surname><given-names>A</given-names></name></person-group>. <article-title>Diphtheria-pertussis-tetanus immunizing of infants</article-title>. <source>J Maine Med Assoc.</source> (<year>1954</year>) <volume>45</volume>:<fpage>126</fpage>. <pub-id pub-id-type="pmid">13163603</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Combined immunization against diphtheria tetanus pertussis</collab></person-group><source>Squibb Memo</source>. (<year>1947</year>) <volume>26</volume>:<fpage>4</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="pmid">20265420</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cabor&#233;</surname><given-names>RN</given-names></name><name name-style="western"><surname>Maertens</surname><given-names>K</given-names></name><name name-style="western"><surname>Dobly</surname><given-names>A</given-names></name><name name-style="western"><surname>Leuridan</surname><given-names>E</given-names></name><name name-style="western"><surname>Van Damme</surname><given-names>P</given-names></name><name name-style="western"><surname>Huygen</surname><given-names>K</given-names></name></person-group>. <article-title>Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium</article-title>. <source>Virulence.</source> (<year>2017</year>) <volume>8</volume>: <fpage>1245</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1080/21505594.2017.1296998</pub-id><pub-id pub-id-type="pmid">28277900</pub-id><pub-id pub-id-type="pmcid">PMC5711396</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaillard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Bottero</surname><given-names>D</given-names></name><name name-style="western"><surname>Zurita</surname><given-names>ME</given-names></name><name name-style="western"><surname>Carriquiriborde</surname><given-names>F</given-names></name><name name-style="western"><surname>Martin Aispuro</surname><given-names>P</given-names></name><name name-style="western"><surname>Bartel</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Pertussis maternal immunization: narrowing the knowledge gaps on the duration of transferred protective immunity and on vaccination frequency</article-title>. <source>Front Immunol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>1099</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01099</pub-id><pub-id pub-id-type="pmid">28932228</pub-id><pub-id pub-id-type="pmcid">PMC5592197</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gkentzi</surname><given-names>D</given-names></name><name name-style="western"><surname>Katsakiori</surname><given-names>P</given-names></name><name name-style="western"><surname>Marangos</surname><given-names>M</given-names></name><name name-style="western"><surname>Hsia</surname><given-names>Y</given-names></name><name name-style="western"><surname>Amirthalingam</surname><given-names>G</given-names></name><name name-style="western"><surname>Heath</surname><given-names>PT</given-names></name><etal/></person-group>. <article-title>Maternal vaccination against pertussis: a systematic review of the recent literature</article-title>. <source>Arch Dis Child Fetal Neonatal Ed.</source> (<year>2017</year>) <volume>102</volume>:<fpage>F456</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2016-312341</pub-id><pub-id pub-id-type="pmid">28468899</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warfel</surname><given-names>JM</given-names></name><name name-style="western"><surname>Papin</surname><given-names>JF</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>RF</given-names></name><name name-style="western"><surname>Zimmerman</surname><given-names>LI</given-names></name><name name-style="western"><surname>Merkel</surname><given-names>TJ</given-names></name></person-group>. <article-title>Maternal and neonatal vaccination protects newborn baboons from pertussis infection</article-title>. <source>J Infect Dis.</source> (<year>2014</year>) <volume>210</volume>:<fpage>604</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiu090</pub-id><pub-id pub-id-type="pmid">24526741</pub-id><pub-id pub-id-type="pmcid">PMC4133576</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Black</surname><given-names>RE</given-names></name><name name-style="western"><surname>Cousens</surname><given-names>S</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>HL</given-names></name><name name-style="western"><surname>Lawn</surname><given-names>JE</given-names></name><name name-style="western"><surname>Rudan</surname><given-names>I</given-names></name><name name-style="western"><surname>Bassani</surname><given-names>DG</given-names></name><etal/></person-group>. <article-title>Global, regional, and national causes of child mortality in 2008: a systematic analysis</article-title>. <source>Lancet</source>. (<year>2010</year>) <volume>375</volume>:<fpage>1969</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(10)60549-1</pub-id><pub-id pub-id-type="pmid">20466419</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wendelboe</surname><given-names>AM</given-names></name><name name-style="western"><surname>Van Rie</surname><given-names>A</given-names></name><name name-style="western"><surname>Salmaso</surname><given-names>S</given-names></name><name name-style="western"><surname>Englund</surname><given-names>JA</given-names></name></person-group><article-title>Duration of immunity against pertussis after natural infection or vaccination</article-title>. <source>Pediatr Infect Dis J.</source> (<year>2005</year>) <volume>24</volume>:<fpage>S58</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1097/01.inf.0000160914.59160.41</pub-id><pub-id pub-id-type="pmid">15876927</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warfel</surname><given-names>JM</given-names></name><name name-style="western"><surname>Zimmerman</surname><given-names>LI</given-names></name><name name-style="western"><surname>Merkel</surname><given-names>TJ</given-names></name></person-group>. <article-title>Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2014</year>) <volume>111</volume>:<fpage>787</fpage>&#8211;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1314688110</pub-id><pub-id pub-id-type="pmid">24277828</pub-id><pub-id pub-id-type="pmcid">PMC3896208</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Weyrich</surname><given-names>LS</given-names></name><name name-style="western"><surname>Lavine</surname><given-names>JS</given-names></name><name name-style="western"><surname>Karanikas</surname><given-names>AT</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>Lack of cross-protection against <italic toggle="yes">Bordetella holmesii</italic> after pertussis vaccination</article-title>. <source>Emerg Infect Dis.</source> (<year>2012</year>) <volume>18</volume>:<fpage>1771</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3201/eid1811.111544</pub-id><pub-id pub-id-type="pmid">23092514</pub-id><pub-id pub-id-type="pmcid">PMC3559177</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavine</surname><given-names>J</given-names></name><name name-style="western"><surname>Broutin</surname><given-names>H</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name><name name-style="western"><surname>Bj&#248;rnstad</surname><given-names>ON</given-names></name></person-group>. <article-title>Imperfect vaccine-induced immunity and whooping cough transmission to infants</article-title>. <source>Vaccine.</source> (<year>2010</year>) <volume>29</volume>:<fpage>11</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2010.10.029</pub-id><pub-id pub-id-type="pmid">21034823</pub-id><pub-id pub-id-type="pmcid">PMC2997163</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>GH</given-names></name><name name-style="western"><surname>Karanikas</surname><given-names>AT</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name><name name-style="western"><surname>Read</surname><given-names>AF</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>PJ</given-names></name></person-group>. <article-title>Acellular pertussis vaccination facilitates <italic toggle="yes">Bordetella parapertussis</italic> infection in a rodent model of bordetellosis</article-title>. <source>Proc Biol Sci.</source> (<year>2010</year>) <volume>277</volume>:<fpage>2017</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1098/rspb.2010.0010</pub-id><pub-id pub-id-type="pmid">20200027</pub-id><pub-id pub-id-type="pmcid">PMC2880100</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diavatopoulos</surname><given-names>DA</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>KM</given-names></name></person-group>. <article-title>What is wrong with pertussis vaccine immunity?</article-title> why immunological memory to pertussis is failing. <source>Cold Spring Harb Perspect Biol</source>. (<year>2017</year>) <volume>9</volume>:<fpage>a029553</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a029553</pub-id><pub-id pub-id-type="pmid">28289059</pub-id><pub-id pub-id-type="pmcid">PMC5710107</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burdin</surname><given-names>N</given-names></name><name name-style="western"><surname>Handy</surname><given-names>LK</given-names></name><name name-style="western"><surname>Plotkin</surname><given-names>SA</given-names></name></person-group>. <article-title>What is wrong with pertussis vaccine immunity?</article-title> the problem of waning effectiveness of pertussis vaccines. <source>Cold Spring Harb Perspect Biol</source>. (<year>2017</year>) <volume>9</volume>:<fpage>a029454</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a029454</pub-id><pub-id pub-id-type="pmid">28289064</pub-id><pub-id pub-id-type="pmcid">PMC5710106</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bancroft</surname><given-names>T</given-names></name><name name-style="western"><surname>Dillon</surname><given-names>MB</given-names></name><name name-style="western"><surname>da Silva Antunes</surname><given-names>R</given-names></name><name name-style="western"><surname>Paul</surname><given-names>S</given-names></name><name name-style="western"><surname>Peters</surname><given-names>B</given-names></name><name name-style="western"><surname>Crotty</surname><given-names>S</given-names></name><etal/></person-group><article-title>Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood</article-title>. <source>Cell Immunol.</source> (<year>2016</year>) <volume>304&#8211;5</volume>:<fpage>35</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellimm.2016.05.002</pub-id><pub-id pub-id-type="pmcid">PMC4899275</pub-id><pub-id pub-id-type="pmid">27212461</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allen</surname><given-names>AC</given-names></name><name name-style="western"><surname>Wilk</surname><given-names>MM</given-names></name><name name-style="western"><surname>Misiak</surname><given-names>A</given-names></name><name name-style="western"><surname>Borkner</surname><given-names>L</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>D</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KHG</given-names></name></person-group>. <article-title>Sustained protective immunity against <italic toggle="yes">Bordetella pertussis</italic> nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T<sub>RM</sub> cells</article-title>. <source>Mucosal Immunol.</source> (<year>2018</year>) <volume>11</volume>:<fpage>1763</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1038/s41385-018-0080-x</pub-id><pub-id pub-id-type="pmid">30127384</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kapil</surname><given-names>P</given-names></name><name name-style="western"><surname>Merkel</surname><given-names>TJ</given-names></name></person-group>. <article-title>Pertussis vaccines and protective immunity</article-title>. <source>Curr Opin Immunol.</source> (<year>2019</year>) <volume>59</volume>:<fpage>72</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2019.03.006</pub-id><pub-id pub-id-type="pmid">31078081</pub-id><pub-id pub-id-type="pmcid">PMC6774807</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambert</surname><given-names>EE</given-names></name><name name-style="western"><surname>Buisman</surname><given-names>AM</given-names></name><name name-style="western"><surname>van Els</surname><given-names>CACM</given-names></name></person-group>. <article-title>Superior <italic toggle="yes">B. pertussis</italic> specific CD4+ T-cell immunity imprinted by natural infection</article-title>. <source>Adv Exp Med Biol</source>. (<year>2019</year>). <pub-id pub-id-type="doi">10.1007/5584_2019_405</pub-id><pub-id pub-id-type="pmid">31321753</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilk</surname><given-names>MM</given-names></name><name name-style="western"><surname>Borkner</surname><given-names>L</given-names></name><name name-style="western"><surname>Misiak</surname><given-names>A</given-names></name><name name-style="western"><surname>Curham</surname><given-names>L</given-names></name><name name-style="western"><surname>Allen</surname><given-names>AC</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KHG</given-names></name></person-group><article-title>Immunization with whole cell but not acellular pertussis vaccines primes CD4 T<sub>RM</sub> cells that sustain protective immunity against nasal colonization with <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>Emerg Microbes Infect.</source> (<year>2019</year>) <volume>8</volume>:<fpage>169</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1080/22221751.2018.1564630</pub-id><pub-id pub-id-type="pmid">30866771</pub-id><pub-id pub-id-type="pmcid">PMC6455184</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raeven</surname><given-names>RH</given-names></name><name name-style="western"><surname>Brummelman</surname><given-names>J</given-names></name><name name-style="western"><surname>Pennings</surname><given-names>JL</given-names></name><name name-style="western"><surname>Nijst</surname><given-names>OE</given-names></name><name name-style="western"><surname>Kuipers</surname><given-names>B</given-names></name><name name-style="western"><surname>Blok</surname><given-names>LE</given-names></name><etal/></person-group>. <article-title>Molecular signatures of the evolving immune response in mice following a <italic toggle="yes">Bordetella pertussis</italic> infection</article-title>. <source>PLoS ONE.</source> (<year>2014</year>) <volume>9</volume>:<fpage>e104548</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0104548</pub-id><pub-id pub-id-type="pmid">25137043</pub-id><pub-id pub-id-type="pmcid">PMC4138111</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilk</surname><given-names>MM</given-names></name><name name-style="western"><surname>Misiak</surname><given-names>A</given-names></name><name name-style="western"><surname>McManus</surname><given-names>RM</given-names></name><name name-style="western"><surname>Allen</surname><given-names>AC</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>MA</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KHG</given-names></name></person-group>. <article-title>Lung CD4 Tissue-resident memory t cells mediate adaptive immunity induced by previous infection of mice with <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>J Immunol.</source> (<year>2017</year>) <volume>199</volume>:<fpage>233</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1602051</pub-id><pub-id pub-id-type="pmid">28533445</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouchez</surname><given-names>V</given-names></name><name name-style="western"><surname>Hegerle</surname><given-names>N</given-names></name><name name-style="western"><surname>Strati</surname><given-names>F</given-names></name><name name-style="western"><surname>Njamkepo</surname><given-names>E</given-names></name><name name-style="western"><surname>Guiso</surname><given-names>N</given-names></name></person-group>. <article-title>New data on vaccine antigen deficient <italic toggle="yes">Bordetella pertussis</italic> isolates</article-title>. <source>Vaccines.</source> (<year>2015</year>) <volume>3</volume>:<fpage>751</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.3390/vaccines3030751</pub-id><pub-id pub-id-type="pmid">26389958</pub-id><pub-id pub-id-type="pmcid">PMC4586476</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azarian</surname><given-names>T</given-names></name><name name-style="western"><surname>Ali</surname><given-names>A</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>JA</given-names></name><name name-style="western"><surname>Mohr</surname><given-names>D</given-names></name><name name-style="western"><surname>Prosperi</surname><given-names>M</given-names></name><name name-style="western"><surname>Veras</surname><given-names>NM</given-names></name><etal/></person-group>. <article-title>Phylodynamic analysis of clinical and environmental <italic toggle="yes">Vibrio cholerae</italic> isolates from Haiti reveals diversification driven by positive selection</article-title>. <source>MBio.</source> (<year>2014</year>) <volume>5</volume>:<fpage>e01824</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.01824-14</pub-id><pub-id pub-id-type="pmid">25538191</pub-id><pub-id pub-id-type="pmcid">PMC4278535</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hegerle</surname><given-names>N</given-names></name><name name-style="western"><surname>Guiso</surname><given-names>N</given-names></name></person-group>. <article-title>Antibody-mediated inhibition of <italic toggle="yes">Bordetella pertussis</italic> adenylate cyclase-haemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population</article-title>. <source>Microbiology.</source> (<year>2014</year>) <volume>160</volume>(<issue>Pt 5</issue>):<fpage>962</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.074690-0</pub-id><pub-id pub-id-type="pmid">24554758</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Octavia</surname><given-names>S</given-names></name><name name-style="western"><surname>Maharjan</surname><given-names>RP</given-names></name><name name-style="western"><surname>Sintchenko</surname><given-names>V</given-names></name><name name-style="western"><surname>Stevenson</surname><given-names>G</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>PR</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>GL</given-names></name><etal/></person-group>. <article-title>Insight into evolution of <italic toggle="yes">Bordetella pertussis</italic> from comparative genomic analysis: evidence of vaccine-driven selection</article-title>. <source>Mol Biol Evol.</source> (<year>2011</year>) <volume>28</volume>:<fpage>707</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msq245</pub-id><pub-id pub-id-type="pmid">20833694</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirimanjeswara</surname><given-names>GS</given-names></name><name name-style="western"><surname>Mann</surname><given-names>PB</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>Role of antibodies in immunity to <italic toggle="yes">Bordetella</italic> infections</article-title>. <source>Infect Immun.</source> (<year>2003</year>) <volume>71</volume>:<fpage>1719</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.71.4.1719-1724.2003</pub-id><pub-id pub-id-type="pmid">12654784</pub-id><pub-id pub-id-type="pmcid">PMC152104</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolfe</surname><given-names>DN</given-names></name><name name-style="western"><surname>Goebel</surname><given-names>EM</given-names></name><name name-style="western"><surname>Bjornstad</surname><given-names>ON</given-names></name><name name-style="western"><surname>Restif</surname><given-names>O</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>The O antigen enables <italic toggle="yes">Bordetella parapertussis</italic> to avoid <italic toggle="yes">Bordetella pertussis</italic>-induced immunity</article-title>. <source>Infect Immun.</source> (<year>2007</year>) <volume>75</volume>:<fpage>4972</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00763-07</pub-id><pub-id pub-id-type="pmid">17698566</pub-id><pub-id pub-id-type="pmcid">PMC2044517</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Melvin</surname><given-names>JA</given-names></name><name name-style="western"><surname>Scheller</surname><given-names>EV</given-names></name><name name-style="western"><surname>Miller</surname><given-names>JF</given-names></name><name name-style="western"><surname>Cotter</surname><given-names>PA</given-names></name></person-group>. <article-title><italic toggle="yes">Bordetella pertussis</italic> pathogenesis: current and future challenges</article-title>. <source>Nat Rev Microbiol.</source> (<year>2014</year>) <volume>12</volume>:<fpage>274</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3235</pub-id><pub-id pub-id-type="pmid">24608338</pub-id><pub-id pub-id-type="pmcid">PMC4205565</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fedele</surname><given-names>G</given-names></name><name name-style="western"><surname>Bianco</surname><given-names>M</given-names></name><name name-style="western"><surname>Ausiello</surname><given-names>CM</given-names></name></person-group>. <article-title>The virulence factors of <italic toggle="yes">Bordetella pertussis</italic>: talented modulators of host immune response</article-title>. <source>Arch Immunol Ther Exp.</source> (<year>2013</year>) <volume>61</volume>:<fpage>445</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1007/s00005-013-0242-1</pub-id><pub-id pub-id-type="pmid">23955529</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorgojo</surname><given-names>J</given-names></name><name name-style="western"><surname>Scharrig</surname><given-names>E</given-names></name><name name-style="western"><surname>G&#243;mez</surname><given-names>RM</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name><name name-style="western"><surname>Rodr&#237;guez</surname><given-names>ME</given-names></name></person-group>. <article-title><italic toggle="yes">Bordetella parapertussis</italic> circumvents neutrophil extracellular bactericidal mechanisms</article-title>. <source>PLoS ONE.</source> (<year>2017</year>) <volume>12</volume>:<fpage>e0169936</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0169936</pub-id><pub-id pub-id-type="pmid">28095485</pub-id><pub-id pub-id-type="pmcid">PMC5240980</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fedele</surname><given-names>G</given-names></name><name name-style="western"><surname>Schiavoni</surname><given-names>I</given-names></name><name name-style="western"><surname>Adkins</surname><given-names>I</given-names></name><name name-style="western"><surname>Klimova</surname><given-names>N</given-names></name><name name-style="western"><surname>Sebo</surname><given-names>P</given-names></name></person-group>. <article-title>Invasion of dendritic cells, macrophages and neutrophils by the <italic toggle="yes">Bordetella</italic> adenylate cyclase toxin: a subversive move to fool host immunity</article-title>. <source>Toxins.</source> (<year>2017</year>) <volume>9</volume>:<fpage>E293</fpage>. <pub-id pub-id-type="doi">10.3390/toxins9100293</pub-id><pub-id pub-id-type="pmid">28934122</pub-id><pub-id pub-id-type="pmcid">PMC5666340</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nicholson</surname><given-names>TL</given-names></name><name name-style="western"><surname>Brockmeier</surname><given-names>SL</given-names></name><name name-style="western"><surname>Loving</surname><given-names>CL</given-names></name><name name-style="western"><surname>Register</surname><given-names>KB</given-names></name><name name-style="western"><surname>Kehrli</surname><given-names>ME</given-names></name><name name-style="western"><surname>Shore</surname><given-names>SM</given-names></name></person-group><article-title>The <italic toggle="yes">Bordetella bronchiseptica</italic> type III secretion system is required for persistence and disease severity but not transmission in swine</article-title>. <source>Infect Immun.</source> (<year>2014</year>) <volume>82</volume>:<fpage>1092</fpage>&#8211;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01115-13</pub-id><pub-id pub-id-type="pmid">24366249</pub-id><pub-id pub-id-type="pmcid">PMC3957984</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fennelly</surname><given-names>NK</given-names></name><name name-style="western"><surname>Sisti</surname><given-names>F</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>SC</given-names></name><name name-style="western"><surname>Ross</surname><given-names>PJ</given-names></name><name name-style="western"><surname>van der Heide</surname><given-names>H</given-names></name><name name-style="western"><surname>Mooi</surname><given-names>FR</given-names></name><etal/></person-group>. <article-title><italic toggle="yes">Bordetella pertussis</italic> expresses a functional type III secretion system that subverts protective innate and adaptive immune responses</article-title>. <source>Infect Immun.</source> (<year>2008</year>) <volume>76</volume>:<fpage>1257</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00836-07</pub-id><pub-id pub-id-type="pmid">18195025</pub-id><pub-id pub-id-type="pmcid">PMC2258832</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skinner</surname><given-names>JA</given-names></name><name name-style="western"><surname>Pilione</surname><given-names>MR</given-names></name><name name-style="western"><surname>Shen</surname><given-names>H</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name><name name-style="western"><surname>Yuk</surname><given-names>MH</given-names></name></person-group>. <article-title><italic toggle="yes">Bordetella</italic> type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence</article-title>. <source>J Immunol.</source> (<year>2005</year>) <volume>175</volume>:<fpage>4647</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.7.4647</pub-id><pub-id pub-id-type="pmid">16177111</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coulthurst</surname><given-names>S</given-names></name></person-group>. <article-title>The Type VI secretion system: a versatile bacterial weapon</article-title>. <source>Microbiology.</source> (<year>2019</year>) <volume>165</volume>:<fpage>503</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.000789</pub-id><pub-id pub-id-type="pmid">30893029</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Starost</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Karassek</surname><given-names>S</given-names></name><name name-style="western"><surname>Sano</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kanda</surname><given-names>T</given-names></name><name name-style="western"><surname>Kim</surname><given-names>KS</given-names></name><name name-style="western"><surname>Dobrindt</surname><given-names>U</given-names></name><etal/></person-group>. <article-title>Pertussis Toxin Exploits host cell signaling pathways induced by meningitis-causing <italic toggle="yes">E. coli</italic> K1-RS218 and enhances adherence of monocytic THP-1 cells to human cerebral endothelial cells</article-title>. <source>Toxins.</source> (<year>2016</year>) <volume>8</volume>:<fpage>E291</fpage>. <pub-id pub-id-type="doi">10.3390/toxins8100291</pub-id><pub-id pub-id-type="pmid">27754355</pub-id><pub-id pub-id-type="pmcid">PMC5086651</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suh</surname><given-names>HW</given-names></name><name name-style="western"><surname>Sim</surname><given-names>YB</given-names></name><name name-style="western"><surname>Park</surname><given-names>SH</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>N</given-names></name><name name-style="western"><surname>Im</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Hong</surname><given-names>JS</given-names></name></person-group>. <article-title>Effect of pertussis toxin pretreated centrally on blood glucose level induced by stress</article-title>. <source>Korean J Physiol Pharmacol.</source> (<year>2016</year>) <volume>20</volume>:<fpage>467</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.4196/kjpp.2016.20.5.467</pub-id><pub-id pub-id-type="pmid">27610033</pub-id><pub-id pub-id-type="pmcid">PMC5014993</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirimanjeswara</surname><given-names>GS</given-names></name><name name-style="western"><surname>Agosto</surname><given-names>LM</given-names></name><name name-style="western"><surname>Kennett</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Bjornstad</surname><given-names>ON</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>J Clin Invest.</source> (<year>2005</year>) <volume>115</volume>:<fpage>3594</fpage>&#8211;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1172/JCI24609</pub-id><pub-id pub-id-type="pmid">16294220</pub-id><pub-id pub-id-type="pmcid">PMC1283938</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bakhshaei</surname><given-names>P</given-names></name><name name-style="western"><surname>Kazemi</surname><given-names>MH</given-names></name><name name-style="western"><surname>Golara</surname><given-names>M</given-names></name><name name-style="western"><surname>Abdolmaleki</surname><given-names>S</given-names></name><name name-style="western"><surname>Khosravi-Eghbal</surname><given-names>R</given-names></name><name name-style="western"><surname>Khoshnoodi</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Investigation of the cellular immune response to recombinant fragments of filamentous hemagglutinin and pertactin of <italic toggle="yes">Bordetella pertussis</italic> in BALB/c mice</article-title>. <source>J Interferon Cytokine Res.</source> (<year>2018</year>) <volume>38</volume>:<fpage>161</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1089/jir.2017.0060</pub-id><pub-id pub-id-type="pmid">29638208</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villarino Romero</surname><given-names>R</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>S</given-names></name><name name-style="western"><surname>Fa&#233;</surname><given-names>K</given-names></name><name name-style="western"><surname>Holubova</surname><given-names>J</given-names></name><name name-style="western"><surname>Geurtsen</surname><given-names>J</given-names></name><name name-style="western"><surname>Schwarzer</surname><given-names>M</given-names></name><etal/></person-group><article-title><italic toggle="yes">Bordetella pertussis</italic> filamentous hemagglutinin itself does not trigger anti-inflammatory interleukin-10 production by human dendritic cells</article-title>. <source>Int J Med Microbiol.</source> (<year>2016</year>) <volume>306</volume>:<fpage>38</fpage>&#8211;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2015.11.003</pub-id><pub-id pub-id-type="pmid">26699834</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rizzi</surname><given-names>C</given-names></name><name name-style="western"><surname>Crippa</surname><given-names>MP</given-names></name><name name-style="western"><surname>Jeeninga</surname><given-names>RE</given-names></name><name name-style="western"><surname>Berkhout</surname><given-names>B</given-names></name><name name-style="western"><surname>Blasi</surname><given-names>F</given-names></name><name name-style="western"><surname>Poli</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1</article-title>. <source>J Immunol.</source> (<year>2006</year>) <volume>176</volume>:<fpage>999</fpage>&#8211;<lpage>1006</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.176.2.999</pub-id><pub-id pub-id-type="pmid">16393986</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alfano</surname><given-names>M</given-names></name><name name-style="western"><surname>Grivel</surname><given-names>JC</given-names></name><name name-style="western"><surname>Ghezzi</surname><given-names>S</given-names></name><name name-style="western"><surname>Corti</surname><given-names>D</given-names></name><name name-style="western"><surname>Trimarchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Poli</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Pertussis toxin B-oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissue</article-title>. <source>AIDS.</source> (<year>2005</year>) <volume>19</volume>:<fpage>1007</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1097/01.aids.0000174446.40379.3b</pub-id><pub-id pub-id-type="pmid">15958831</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alfano</surname><given-names>M</given-names></name><name name-style="western"><surname>Rizzi</surname><given-names>C</given-names></name><name name-style="western"><surname>Corti</surname><given-names>D</given-names></name><name name-style="western"><surname>Adduce</surname><given-names>L</given-names></name><name name-style="western"><surname>Poli</surname><given-names>G</given-names></name></person-group>. <article-title>Bacterial toxins: potential weapons against HIV infection</article-title>. <source>Curr Pharm Des.</source> (<year>2005</year>) <volume>11</volume>:<fpage>2909</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.2174/1381612054546725</pub-id><pub-id pub-id-type="pmid">16101445</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lapenta</surname><given-names>C</given-names></name><name name-style="western"><surname>Spada</surname><given-names>M</given-names></name><name name-style="western"><surname>Santini</surname><given-names>SM</given-names></name><name name-style="western"><surname>Racca</surname><given-names>S</given-names></name><name name-style="western"><surname>Dorigatti</surname><given-names>F</given-names></name><name name-style="western"><surname>Poli</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice</article-title>. <source>Int Immunol.</source> (<year>2005</year>) <volume>17</volume>:<fpage>469</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/dxh226</pub-id><pub-id pub-id-type="pmid">15746245</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alfano</surname><given-names>M</given-names></name><name name-style="western"><surname>Vallanti</surname><given-names>G</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>P</given-names></name><name name-style="western"><surname>Bovolenta</surname><given-names>C</given-names></name><name name-style="western"><surname>Vicenzi</surname><given-names>E</given-names></name><name name-style="western"><surname>Mantelli</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells</article-title>. <source>J Immunol.</source> (<year>2001</year>) <volume>166</volume>:<fpage>1863</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.166.3.1863</pub-id><pub-id pub-id-type="pmid">11160233</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alfano</surname><given-names>M</given-names></name><name name-style="western"><surname>Pushkarsky</surname><given-names>T</given-names></name><name name-style="western"><surname>Poli</surname><given-names>G</given-names></name><name name-style="western"><surname>Bukrinsky</surname><given-names>M</given-names></name></person-group>. <article-title>The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages</article-title>. <source>J Virol.</source> (<year>2000</year>) <volume>74</volume>:<fpage>8767</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.74.18.8767-8770.2000</pub-id><pub-id pub-id-type="pmid">10954581</pub-id><pub-id pub-id-type="pmcid">PMC116391</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alfano</surname><given-names>M</given-names></name><name name-style="western"><surname>Schmidtmayerova</surname><given-names>H</given-names></name><name name-style="western"><surname>Amella</surname><given-names>CA</given-names></name><name name-style="western"><surname>Pushkarsky</surname><given-names>T</given-names></name><name name-style="western"><surname>Bukrinsky</surname><given-names>M</given-names></name></person-group>. <article-title>The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains</article-title>. <source>J Exp Med.</source> (<year>1999</year>) <volume>190</volume>:<fpage>597</fpage>&#8211;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1084/jem.190.5.597</pub-id><pub-id pub-id-type="pmid">10477545</pub-id><pub-id pub-id-type="pmcid">PMC2195621</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robbins</surname><given-names>JB</given-names></name><name name-style="western"><surname>Schneerson</surname><given-names>R</given-names></name><name name-style="western"><surname>Kubler-Kielb</surname><given-names>J</given-names></name><name name-style="western"><surname>Keith</surname><given-names>JM</given-names></name><name name-style="western"><surname>Trollfors</surname><given-names>B</given-names></name><name name-style="western"><surname>Vinogradov</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Toward a new vaccine for pertussis</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2014</year>) <volume>111</volume>:<fpage>3213</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1324149111</pub-id><pub-id pub-id-type="pmid">24556987</pub-id><pub-id pub-id-type="pmcid">PMC3948267</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coffman</surname><given-names>RL</given-names></name><name name-style="western"><surname>Sher</surname><given-names>A</given-names></name><name name-style="western"><surname>Seder</surname><given-names>RA</given-names></name></person-group>. <article-title>Vaccine adjuvants: putting innate immunity to work</article-title>. <source>Immunity.</source> (<year>2010</year>) <volume>33</volume>:<fpage>492</fpage>&#8211;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2010.10.002</pub-id><pub-id pub-id-type="pmid">21029960</pub-id><pub-id pub-id-type="pmcid">PMC3420356</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Sunagar</surname><given-names>R</given-names></name><name name-style="western"><surname>Gosselin</surname><given-names>E</given-names></name></person-group>. <article-title>Bacterial protein toll-like-receptor agonists: a novel perspective on vaccine adjuvants</article-title>. <source>Front Immunol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>1144</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.01144</pub-id><pub-id pub-id-type="pmid">31191528</pub-id><pub-id pub-id-type="pmcid">PMC6549121</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Surendran</surname><given-names>N</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>A</given-names></name><name name-style="western"><surname>Pichichero</surname><given-names>ME</given-names></name></person-group>. <article-title>TLR agonist combinations that stimulate Th type I polarizing responses from human neonates</article-title>. <source>Innate Immun.</source> (<year>2018</year>) <volume>24</volume>:<fpage>240</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1177/1753425918771178</pub-id><pub-id pub-id-type="pmid">29673285</pub-id><pub-id pub-id-type="pmcid">PMC6830928</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ignacio</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Albin</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Esser-Kahn</surname><given-names>AP</given-names></name><name name-style="western"><surname>Verdoes</surname><given-names>M</given-names></name></person-group>. <article-title>Toll-like receptor agonist conjugation: a chemical perspective</article-title>. <source>Bioconjug Chem.</source> (<year>2018</year>) <volume>29</volume>:<fpage>587</fpage>&#8211;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1021/acs.bioconjchem.7b00808</pub-id><pub-id pub-id-type="pmid">29378134</pub-id><pub-id pub-id-type="pmcid">PMC10642707</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinani</surname><given-names>G</given-names></name><name name-style="western"><surname>Sessevmez</surname><given-names>M</given-names></name><name name-style="western"><surname>G&#246;k</surname><given-names>MK</given-names></name><name name-style="western"><surname>&#214;zg&#252;m&#252;&#351;</surname><given-names>S</given-names></name><name name-style="western"><surname>Oya Alpar</surname><given-names>H</given-names></name><name name-style="western"><surname>Cevher</surname><given-names>E</given-names></name></person-group>. <article-title>Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination</article-title>. <source>Int J Pharm.</source> (<year>2019</year>) <volume>569</volume>:<fpage>118592</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2019.118592</pub-id><pub-id pub-id-type="pmid">31386881</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehrabi</surname><given-names>M</given-names></name><name name-style="western"><surname>Montazeri</surname><given-names>H</given-names></name><name name-style="western"><surname>Mohamadpour Dounighi</surname><given-names>N</given-names></name><name name-style="western"><surname>Rashti</surname><given-names>A</given-names></name><name name-style="western"><surname>Vakili-Ghartavol</surname><given-names>R</given-names></name></person-group>. <article-title>Chitosan-based nanoparticles in mucosal vaccine delivery</article-title>. <source>Arch Razi Inst.</source> (<year>2018</year>) <volume>73</volume>:<fpage>165</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.22092/ari.2017.109235.1101</pub-id><pub-id pub-id-type="pmid">30280836</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moran</surname><given-names>HBT</given-names></name><name name-style="western"><surname>Turley</surname><given-names>JL</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>M</given-names></name><name name-style="western"><surname>Lavelle</surname><given-names>EC</given-names></name></person-group>. <article-title>Immunomodulatory properties of chitosan polymers</article-title>. <source>Biomaterials.</source> (<year>2018</year>) <volume>184</volume>:<fpage>1</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.08.054</pub-id><pub-id pub-id-type="pmid">30195140</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misiak</surname><given-names>A</given-names></name><name name-style="western"><surname>Leuzzi</surname><given-names>R</given-names></name><name name-style="western"><surname>Allen</surname><given-names>AC</given-names></name><name name-style="western"><surname>Galletti</surname><given-names>B</given-names></name><name name-style="western"><surname>Baudner</surname><given-names>BC</given-names></name><name name-style="western"><surname>D'Oro</surname><given-names>U</given-names></name><etal/></person-group>. <article-title>Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model</article-title>. <source>Vaccine.</source> (<year>2017</year>) <volume>35</volume>:<fpage>5256</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2017.08.009</pub-id><pub-id pub-id-type="pmid">28823618</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brummelman</surname><given-names>J</given-names></name><name name-style="western"><surname>Wilk</surname><given-names>MM</given-names></name><name name-style="western"><surname>Han</surname><given-names>WG</given-names></name><name name-style="western"><surname>van Els</surname><given-names>CA</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title>Roads to the development of improved pertussis vaccines paved by immunology</article-title>. <source>Pathog Dis.</source> (<year>2015</year>) <volume>73</volume>:<fpage>ftv067</fpage>. <pub-id pub-id-type="doi">10.1093/femspd/ftv067</pub-id><pub-id pub-id-type="pmid">26347400</pub-id><pub-id pub-id-type="pmcid">PMC4626578</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunne</surname><given-names>A</given-names></name><name name-style="western"><surname>Mielke</surname><given-names>LA</given-names></name><name name-style="western"><surname>Allen</surname><given-names>AC</given-names></name><name name-style="western"><surname>Sutton</surname><given-names>CE</given-names></name><name name-style="western"><surname>Higgs</surname><given-names>R</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>CC</given-names></name><etal/></person-group>. <article-title>A novel TLR2 agonist from <italic toggle="yes">Bordetella pertussis</italic> is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine</article-title>. <source>Mucosal Immunol.</source> (<year>2015</year>) <volume>8</volume>:<fpage>607</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2014.93</pub-id><pub-id pub-id-type="pmid">25315966</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunne</surname><given-names>A</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>NA</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title>TLR based therapeutics</article-title>. <source>Curr Opin Pharmacol.</source> (<year>2011</year>) <volume>11</volume>:<fpage>404</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2011.03.004</pub-id><pub-id pub-id-type="pmid">21501972</pub-id></mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higgins</surname><given-names>SC</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title>TLR, NLR Agonists, and other immune modulators as infectious disease vaccine adjuvants</article-title>. <source>Curr Infect Dis Rep.</source> (<year>2010</year>) <volume>12</volume>:<fpage>4</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1007/s11908-009-0080-9</pub-id><pub-id pub-id-type="pmid">21308494</pub-id></mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pizza</surname><given-names>M</given-names></name><name name-style="western"><surname>Giuliani</surname><given-names>MM</given-names></name><name name-style="western"><surname>Fontana</surname><given-names>MR</given-names></name><name name-style="western"><surname>Monaci</surname><given-names>E</given-names></name><name name-style="western"><surname>Douce</surname><given-names>G</given-names></name><name name-style="western"><surname>Dougan</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants</article-title>. <source>Vaccine.</source> (<year>2001</year>) <volume>19</volume>:<fpage>2534</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/S0264-410X(00)00553-3</pub-id><pub-id pub-id-type="pmid">11257389</pub-id></mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>KP</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title>Dendritic cells and other innate determinants of T helper cell polarisation</article-title>. <source>Trends Immunol.</source> (<year>2013</year>) <volume>34</volume>:<fpage>521</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2013.07.006</pub-id><pub-id pub-id-type="pmid">23973621</pub-id></mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Pasquale</surname><given-names>A</given-names></name><name name-style="western"><surname>Preiss</surname><given-names>SF</given-names></name><name name-style="western"><surname>Tavares Da</surname><given-names>Silva</given-names></name><name name-style="western"><surname>Gar&#231;on</surname><given-names>N</given-names></name></person-group>. <article-title>Vaccine adjuvants: from 1920 to 2015 and Beyond</article-title>. <source>Vaccines.</source> (<year>2015</year>) <volume>3</volume>:<fpage>320</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.3390/vaccines3020320</pub-id><pub-id pub-id-type="pmid">26343190</pub-id><pub-id pub-id-type="pmcid">PMC4494348</pub-id></mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>N</given-names></name><name name-style="western"><surname>Shang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>The novel toll-like receptor 2 agonist SUP3 enhances antigen presentation and T cell activation by dendritic cells</article-title>. <source>Front Immunol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>158</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.00158</pub-id><pub-id pub-id-type="pmid">28270814</pub-id><pub-id pub-id-type="pmcid">PMC5318439</pub-id></mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name><name name-style="western"><surname>Ni</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N</given-names></name><name name-style="western"><surname>Jie</surname><given-names>J</given-names></name><name name-style="western"><surname>Xie</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>The combination of MBP and BCG-induced dendritic cell maturation through TLR2/TLR4 promotes Th1 activation <italic toggle="yes">in vitro</italic> and <italic toggle="yes">vivo</italic></article-title>. <source>Mediators Inflamm.</source> (<year>2017</year>) <volume>2017</volume>:<fpage>1953680</fpage>. <pub-id pub-id-type="doi">10.1155/2017/1953680</pub-id><pub-id pub-id-type="pmid">28293065</pub-id><pub-id pub-id-type="pmcid">PMC5331320</pub-id></mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asgarian-Omran</surname><given-names>H</given-names></name><name name-style="western"><surname>Amirzargar</surname><given-names>AA</given-names></name><name name-style="western"><surname>Zeerleder</surname><given-names>S</given-names></name><name name-style="western"><surname>Mahdavi</surname><given-names>M</given-names></name><name name-style="western"><surname>van Mierlo</surname><given-names>G</given-names></name><name name-style="western"><surname>Solati</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Interaction of <italic toggle="yes">Bordetella pertussis</italic> filamentous hemagglutinin with human TLR2: identification of the TLR2-binding domain</article-title>. <source>APMIS.</source> (<year>2015</year>) <volume>123</volume>:<fpage>156</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1111/apm.12332</pub-id><pub-id pub-id-type="pmid">25353353</pub-id></mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rostamian</surname><given-names>M</given-names></name><name name-style="western"><surname>Bahrami</surname><given-names>F</given-names></name><name name-style="western"><surname>Niknam</surname><given-names>HM</given-names></name></person-group>. <article-title>Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice</article-title>. <source>PLoS ONE.</source> (<year>2018</year>) <volume>13</volume>:<fpage>e0204491</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0204491</pub-id><pub-id pub-id-type="pmid">30248142</pub-id><pub-id pub-id-type="pmcid">PMC6152959</pub-id></mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rostamian</surname><given-names>M</given-names></name><name name-style="western"><surname>Niknam</surname><given-names>HM</given-names></name></person-group>. <article-title>Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice</article-title>. <source>Mol Immunol.</source> (<year>2017</year>) <volume>91</volume>:<fpage>202</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2017.09.010</pub-id><pub-id pub-id-type="pmid">28963929</pub-id></mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lebedeva</surname><given-names>E</given-names></name><name name-style="western"><surname>Bagaev</surname><given-names>A</given-names></name><name name-style="western"><surname>Pichugin</surname><given-names>A</given-names></name><name name-style="western"><surname>Chulkina</surname><given-names>M</given-names></name><name name-style="western"><surname>Lysenko</surname><given-names>A</given-names></name><name name-style="western"><surname>Tutykhina</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector</article-title>. <source>BMC Immunol.</source> (<year>2018</year>) <volume>19</volume>:<fpage>26</fpage>. <pub-id pub-id-type="doi">10.1186/s12865-018-0264-x</pub-id><pub-id pub-id-type="pmid">30055563</pub-id><pub-id pub-id-type="pmcid">PMC6064145</pub-id></mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goff</surname><given-names>PH</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>T</given-names></name><name name-style="western"><surname>He</surname><given-names>W</given-names></name><name name-style="western"><surname>Yao</surname><given-names>S</given-names></name><name name-style="western"><surname>Cottam</surname><given-names>HB</given-names></name><name name-style="western"><surname>Tan</surname><given-names>GS</given-names></name><etal/></person-group>. <article-title>Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands work additively via myd88 to induce protective antiviral immunity in mice</article-title>. <source>J Virol.</source> (<year>2017</year>) <volume>91</volume>:<fpage>e01050</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01050-17</pub-id><pub-id pub-id-type="pmid">28724768</pub-id><pub-id pub-id-type="pmcid">PMC5599744</pub-id></mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Subcutaneous immunization with fusion protein DnaJ-&#916;A146Ply without additional adjuvants induces both humoral and cellular immunity against Pneumococcal infection partially depending on TLR4</article-title>. <source>Front Immunol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>686</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.00686</pub-id><pub-id pub-id-type="pmid">28659923</pub-id><pub-id pub-id-type="pmcid">PMC5466963</pub-id></mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shibata</surname><given-names>N</given-names></name><name name-style="western"><surname>Kunisawa</surname><given-names>J</given-names></name><name name-style="western"><surname>Hosomi</surname><given-names>K</given-names></name><name name-style="western"><surname>Fujimoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mizote</surname><given-names>K</given-names></name><name name-style="western"><surname>Kitayama</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Lymphoid tissue-resident Alcaligenes LPS induces IgA production without excessive inflammatory responses via weak TLR4 agonist activity</article-title>. <source>Mucosal Immunol.</source> (<year>2018</year>) <volume>11</volume>:<fpage>693</fpage>&#8211;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2017.103</pub-id><pub-id pub-id-type="pmid">29411777</pub-id></mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reed</surname><given-names>SG</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>FC</given-names></name><name name-style="western"><surname>Carter</surname><given-names>D</given-names></name><name name-style="western"><surname>Orr</surname><given-names>MT</given-names></name></person-group>. <article-title>The science of vaccine adjuvants: advances in TLR4 ligand adjuvants</article-title>. <source>Curr Opin Immunol.</source> (<year>2016</year>) <volume>41</volume>:<fpage>85</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2016.06.007</pub-id><pub-id pub-id-type="pmid">27392183</pub-id></mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaffaroni</surname><given-names>L</given-names></name><name name-style="western"><surname>Peri</surname><given-names>F</given-names></name></person-group>. <article-title>Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives</article-title>. <source>Future Med Chem.</source> (<year>2018</year>) <volume>10</volume>:<fpage>461</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.4155/fmc-2017-0172</pub-id><pub-id pub-id-type="pmid">29380635</pub-id></mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rolin</surname><given-names>O</given-names></name><name name-style="western"><surname>Smallridge</surname><given-names>W</given-names></name><name name-style="western"><surname>Henry</surname><given-names>M</given-names></name><name name-style="western"><surname>Goodfield</surname><given-names>L</given-names></name><name name-style="western"><surname>Place</surname><given-names>D</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>Toll-like receptor 4 limits transmission of <italic toggle="yes">Bordetella bronchiseptica</italic></article-title>. <source>PLoS ONE.</source> (<year>2014</year>) <volume>9</volume>:<fpage>e85229</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0085229</pub-id><pub-id pub-id-type="pmid">24497924</pub-id><pub-id pub-id-type="pmcid">PMC3907416</pub-id></mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dadaglio</surname><given-names>G</given-names></name><name name-style="western"><surname>Fayolle</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Ryffel</surname><given-names>B</given-names></name><name name-style="western"><surname>Oberkampf</surname><given-names>M</given-names></name><name name-style="western"><surname>Felix</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses</article-title>. <source>J Immunol.</source> (<year>2014</year>) <volume>193</volume>:<fpage>1787</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1302974</pub-id><pub-id pub-id-type="pmid">25024388</pub-id></mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fedele</surname><given-names>G</given-names></name><name name-style="western"><surname>Spensieri</surname><given-names>F</given-names></name><name name-style="western"><surname>Palazzo</surname><given-names>R</given-names></name><name name-style="western"><surname>Nasso</surname><given-names>M</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>GY</given-names></name><name name-style="western"><surname>Coote</surname><given-names>JG</given-names></name><etal/></person-group>. <article-title><italic toggle="yes">Bordetella pertussis</italic> commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways</article-title>. <source>PLoS ONE.</source> (<year>2010</year>) <volume>5</volume>:<fpage>e8734</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0008734</pub-id><pub-id pub-id-type="pmid">20090944</pub-id><pub-id pub-id-type="pmcid">PMC2806909</pub-id></mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boehm</surname><given-names>DT</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>MA</given-names></name><name name-style="western"><surname>Hall</surname><given-names>JM</given-names></name><name name-style="western"><surname>Wong</surname><given-names>TY</given-names></name><name name-style="western"><surname>Sen-Kilic</surname><given-names>E</given-names></name><name name-style="western"><surname>Basinger</surname><given-names>HD</given-names></name><etal/></person-group>. <article-title>Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from</article-title>. <source>NPJ Vaccines.</source> (<year>2019</year>) <volume>4</volume>:<fpage>40</fpage>. <pub-id pub-id-type="doi">10.1038/s41541-019-0136-2</pub-id><pub-id pub-id-type="pmid">31602318</pub-id><pub-id pub-id-type="pmcid">PMC6776550</pub-id></mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brummelman</surname><given-names>J</given-names></name><name name-style="western"><surname>Raeven</surname><given-names>RH</given-names></name><name name-style="western"><surname>Helm</surname><given-names>K</given-names></name><name name-style="western"><surname>Pennings</surname><given-names>JL</given-names></name><name name-style="western"><surname>Metz</surname><given-names>B</given-names></name><name name-style="western"><surname>van Eden</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Transcriptome signature for dampened Th2 dominance in acellular pertussis vaccine-induced CD4(+) T cell responses through TLR4 ligation</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>25064</fpage>. <pub-id pub-id-type="doi">10.1038/srep25064</pub-id><pub-id pub-id-type="pmid">27118638</pub-id><pub-id pub-id-type="pmcid">PMC4846868</pub-id></mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brummelman</surname><given-names>J</given-names></name><name name-style="western"><surname>Helm</surname><given-names>K</given-names></name><name name-style="western"><surname>Hamstra</surname><given-names>HJ</given-names></name><name name-style="western"><surname>van der Ley</surname><given-names>P</given-names></name><name name-style="western"><surname>Boog</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Han</surname><given-names>WG</given-names></name><etal/></person-group>. <article-title>Modulation of the CD4(+) T cell response after acellular pertussis vaccination in the presence of TLR4 ligation</article-title>. <source>Vaccine.</source> (<year>2015</year>) <volume>33</volume>:<fpage>1483</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.01.063</pub-id><pub-id pub-id-type="pmid">25659267</pub-id></mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolfe</surname><given-names>DN</given-names></name><name name-style="western"><surname>Buboltz</surname><given-names>AM</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>Inefficient Toll-like receptor-4 stimulation enables <italic toggle="yes">Bordetella parapertussis</italic> to avoid host immunity</article-title>. <source>PLoS ONE.</source> (<year>2009</year>) <volume>4</volume>:<fpage>e4280</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0004280</pub-id><pub-id pub-id-type="pmid">19169359</pub-id><pub-id pub-id-type="pmcid">PMC2627931</pub-id></mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fedele</surname><given-names>G</given-names></name><name name-style="western"><surname>Nasso</surname><given-names>M</given-names></name><name name-style="western"><surname>Spensieri</surname><given-names>F</given-names></name><name name-style="western"><surname>Palazzo</surname><given-names>R</given-names></name><name name-style="western"><surname>Frasca</surname><given-names>L</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Lipopolysaccharides from <italic toggle="yes">Bordetella pertussis</italic> and <italic toggle="yes">Bordetella parapertussis</italic> differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses</article-title>. <source>J Immunol.</source> (<year>2008</year>) <volume>181</volume>:<fpage>208</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.181.1.208</pub-id><pub-id pub-id-type="pmid">18566386</pub-id></mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>MacArthur</surname><given-names>I</given-names></name><name name-style="western"><surname>Mann</surname><given-names>PB</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name><name name-style="western"><surname>Preston</surname><given-names>A</given-names></name></person-group>. <article-title>IEIIS Meeting minireview: <italic toggle="yes">Bordetella</italic> evolution: lipid A and Toll-like receptor 4</article-title>. <source>J Endotoxin Res.</source> (<year>2007</year>) <volume>13</volume>:<fpage>243</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1177/0968051907082609</pub-id><pub-id pub-id-type="pmid">17956943</pub-id></mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirimanjeswara</surname><given-names>GS</given-names></name><name name-style="western"><surname>Mann</surname><given-names>PB</given-names></name><name name-style="western"><surname>Pilione</surname><given-names>M</given-names></name><name name-style="western"><surname>Kennett</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>The complex mechanism of antibody-mediated clearance of <italic toggle="yes">Bordetella</italic> from the lungs requires TLR4</article-title>. <source>J Immunol.</source> (<year>2005</year>) <volume>175</volume>:<fpage>7504</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.11.7504</pub-id><pub-id pub-id-type="pmid">16301658</pub-id></mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mann</surname><given-names>PB</given-names></name><name name-style="western"><surname>Wolfe</surname><given-names>D</given-names></name><name name-style="western"><surname>Latz</surname><given-names>E</given-names></name><name name-style="western"><surname>Golenbock</surname><given-names>D</given-names></name><name name-style="western"><surname>Preston</surname><given-names>A</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>Comparative toll-like receptor 4-mediated innate host defense to <italic toggle="yes">Bordetella</italic> infection</article-title>. <source>Infect Immun.</source> (<year>2005</year>) <volume>73</volume>:<fpage>8144</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.73.12.8144-8152.2005</pub-id><pub-id pub-id-type="pmid">16299309</pub-id><pub-id pub-id-type="pmcid">PMC1307046</pub-id></mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mann</surname><given-names>PB</given-names></name><name name-style="western"><surname>Elder</surname><given-names>KD</given-names></name><name name-style="western"><surname>Kennett</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against <italic toggle="yes">Bordetella bronchiseptica</italic></article-title>. <source>Infect Immun.</source> (<year>2004</year>) <volume>72</volume>:<fpage>6650</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.72.11.6650-6658.2004</pub-id><pub-id pub-id-type="pmid">15501798</pub-id><pub-id pub-id-type="pmcid">PMC523027</pub-id></mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKay</surname><given-names>PF</given-names></name><name name-style="western"><surname>King</surname><given-names>DF</given-names></name><name name-style="western"><surname>Mann</surname><given-names>JF</given-names></name><name name-style="western"><surname>Barinaga</surname><given-names>G</given-names></name><name name-style="western"><surname>Carter</surname><given-names>D</given-names></name><name name-style="western"><surname>Shattock</surname><given-names>RJ</given-names></name></person-group><article-title>TLR4 and TLR7/8 adjuvant combinations generate different vaccine antigen-specific immune outcomes in minipigs when administered via the ID or IN routes</article-title>. <source>PLoS ONE.</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0148984</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0148984</pub-id><pub-id pub-id-type="pmid">26862758</pub-id><pub-id pub-id-type="pmcid">PMC4749393</pub-id></mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mann</surname><given-names>PB</given-names></name><name name-style="western"><surname>Kennett</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Harvill</surname><given-names>ET</given-names></name></person-group>. <article-title>Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis</article-title>. <source>J Infect Dis.</source> (<year>2004</year>) <volume>189</volume>:<fpage>833</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1086/381898</pub-id><pub-id pub-id-type="pmid">14976600</pub-id></mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mizel</surname><given-names>SB</given-names></name><name name-style="western"><surname>West</surname><given-names>AP</given-names></name><name name-style="western"><surname>Hantgan</surname><given-names>RR</given-names></name></person-group>. <article-title>Identification of a sequence in human toll-like receptor 5 required for the binding of Gram-negative flagellin</article-title>. <source>J Biol Chem.</source> (<year>2003</year>) <volume>278</volume>:<fpage>23624</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M303481200</pub-id><pub-id pub-id-type="pmid">12711596</pub-id></mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akerley</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Cotter</surname><given-names>PA</given-names></name><name name-style="western"><surname>Miller</surname><given-names>JF</given-names></name></person-group>. <article-title>Ectopic expression of the flagellar regulon alters development of the <italic toggle="yes">Bordetella</italic>-host interaction</article-title>. <source>Cell.</source> (<year>1995</year>) <volume>80</volume>:<fpage>611</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(95)90515-4</pub-id><pub-id pub-id-type="pmid">7867068</pub-id></mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tremblay</surname><given-names>MM</given-names></name><name name-style="western"><surname>Bilal</surname><given-names>MY</given-names></name><name name-style="western"><surname>Houtman</surname><given-names>JC</given-names></name></person-group>. <article-title>Prior TLR5 induction in human T cells results in a transient potentiation of subsequent TCR-induced cytokine production</article-title>. <source>Mol Immunol.</source> (<year>2014</year>) <volume>57</volume>:<fpage>161</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2013.09.002</pub-id><pub-id pub-id-type="pmid">24128895</pub-id><pub-id pub-id-type="pmcid">PMC3845368</pub-id></mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bargieri</surname><given-names>DY</given-names></name><name name-style="western"><surname>Rosa</surname><given-names>DS</given-names></name><name name-style="western"><surname>Braga</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>BO</given-names></name><name name-style="western"><surname>Costa</surname><given-names>FT</given-names></name><name name-style="western"><surname>Esp&#237;ndola</surname><given-names>NM</given-names></name><etal/></person-group>. <article-title>New malaria vaccine candidates based on the <italic toggle="yes">Plasmodium vivax</italic> merozoite surface protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin</article-title>. <source>Vaccine.</source> (<year>2008</year>) <volume>26</volume>:<fpage>6132</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2008.08.070</pub-id><pub-id pub-id-type="pmid">18804504</pub-id></mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Honko</surname><given-names>AN</given-names></name><name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name><name name-style="western"><surname>Lees</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Mizel</surname><given-names>SB</given-names></name></person-group>. <article-title>Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with <italic toggle="yes">Yersinia pestis</italic></article-title>. <source>Infect Immun.</source> (<year>2006</year>) <volume>74</volume>:<fpage>1113</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.74.2.1113-1120.2006</pub-id><pub-id pub-id-type="pmid">16428759</pub-id><pub-id pub-id-type="pmcid">PMC1360354</pub-id></mixed-citation></ref><ref id="B136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Letran</surname><given-names>SE</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Atif</surname><given-names>SM</given-names></name><name name-style="western"><surname>Uematsu</surname><given-names>S</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S</given-names></name><name name-style="western"><surname>McSorley</surname><given-names>SJ</given-names></name></person-group>. <article-title>TLR5 functions as an endocytic receptor to enhance flagellin-specific adaptive immunity</article-title>. <source>Eur J Immunol.</source> (<year>2011</year>) <volume>41</volume>:<fpage>29</fpage>&#8211;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201040717</pub-id><pub-id pub-id-type="pmid">21182074</pub-id><pub-id pub-id-type="pmcid">PMC3652676</pub-id></mixed-citation></ref><ref id="B137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>DN</given-names></name><name name-style="western"><surname>Treanor</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Strout</surname><given-names>C</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>C</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>T</given-names></name><name name-style="western"><surname>Kavita</surname><given-names>U</given-names></name><etal/></person-group>. <article-title>Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)</article-title>. <source>Vaccine.</source> (<year>2011</year>) <volume>29</volume>:<fpage>4897</fpage>&#8211;<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.05.001</pub-id><pub-id pub-id-type="pmid">21596084</pub-id></mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kinnebrew</surname><given-names>MA</given-names></name><name name-style="western"><surname>Ubeda</surname><given-names>C</given-names></name><name name-style="western"><surname>Zenewicz</surname><given-names>LA</given-names></name><name name-style="western"><surname>Smith</surname><given-names>N</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name><name name-style="western"><surname>Pamer</surname><given-names>EG</given-names></name></person-group>. <article-title>Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection</article-title>. <source>J Infect Dis.</source> (<year>2010</year>) <volume>201</volume>:<fpage>534</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1086/650203</pub-id><pub-id pub-id-type="pmid">20064069</pub-id><pub-id pub-id-type="pmcid">PMC2811237</pub-id></mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JR</given-names></name><name name-style="western"><surname>Holbrook</surname><given-names>BC</given-names></name><name name-style="western"><surname>Hayward</surname><given-names>SL</given-names></name><name name-style="western"><surname>Blevins</surname><given-names>LK</given-names></name><name name-style="western"><surname>Jorgensen</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kock</surname><given-names>ND</given-names></name><etal/></person-group>. <article-title>Inclusion of flagellin during vaccination against influenza enhances recall responses in nonhuman primate neonates</article-title>. <source>J Virol.</source> (<year>2015</year>) <volume>89</volume>:<fpage>7291</fpage>&#8211;<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00549-15</pub-id><pub-id pub-id-type="pmid">25948746</pub-id><pub-id pub-id-type="pmcid">PMC4473543</pub-id></mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>H</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhai</surname><given-names>X</given-names></name><name name-style="western"><surname>Liang</surname><given-names>G</given-names></name></person-group>. <article-title>A porcine reproductive and respiratory syndrome virus vaccine candidate based on PRRSV glycoprotein 5 and the Toll-like receptor 5 agonist Salmonella typhimurium flagellin</article-title>. <source>J Mol Microbiol Biotechnol.</source> (<year>2015</year>) <volume>25</volume>:<fpage>56</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1159/000375496</pub-id><pub-id pub-id-type="pmid">25766593</pub-id></mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cunningham</surname><given-names>AL</given-names></name><name name-style="western"><surname>Dang</surname><given-names>KM</given-names></name><name name-style="western"><surname>Yu</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Guentzel</surname><given-names>MN</given-names></name><name name-style="western"><surname>Heidner</surname><given-names>HW</given-names></name><name name-style="western"><surname>Klose</surname><given-names>KE</given-names></name><etal/></person-group>. <article-title>Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated <italic toggle="yes">Francisella tularensis</italic> subsp. novicida strain U112&#916;iglB::fljB</article-title>. <source>Vaccine.</source> (<year>2014</year>) <volume>32</volume>:<fpage>5234</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.07.038</pub-id><pub-id pub-id-type="pmid">25050972</pub-id><pub-id pub-id-type="pmcid">PMC4140432</pub-id></mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowling</surname><given-names>DJ</given-names></name></person-group>. <article-title>Recent advances in the discovery and delivery of TLR7/8 agonists as vaccine adjuvants</article-title>. <source>Immunohorizons.</source> (<year>2018</year>) <volume>2</volume>:<fpage>185</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.4049/immunohorizons.1700063</pub-id><pub-id pub-id-type="pmid">31022686</pub-id></mixed-citation></ref><ref id="B143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dowling</surname><given-names>DJ</given-names></name><name name-style="western"><surname>van Haren</surname><given-names>SD</given-names></name><name name-style="western"><surname>Scheid</surname><given-names>A</given-names></name><name name-style="western"><surname>Bergelson</surname><given-names>I</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D</given-names></name><name name-style="western"><surname>Mancuso</surname><given-names>CJ</given-names></name><etal/></person-group>. <article-title>TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth</article-title>. <source>JCI Insight.</source> (<year>2017</year>) <volume>2</volume>:<fpage>e91020</fpage>. <pub-id pub-id-type="doi">10.1172/jci.insight.91020</pub-id><pub-id pub-id-type="pmid">28352660</pub-id><pub-id pub-id-type="pmcid">PMC5360187</pub-id></mixed-citation></ref><ref id="B144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Haren</surname><given-names>SD</given-names></name><name name-style="western"><surname>Dowling</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Foppen</surname><given-names>W</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>D</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>P</given-names></name><name name-style="western"><surname>Reed</surname><given-names>SG</given-names></name><etal/></person-group>. <article-title>Age-specific adjuvant synergy: dual TLR7/8 and mincle activation of human newborn dendritic cells enables Th1 polarization</article-title>. <source>J Immunol.</source> (<year>2016</year>) <volume>197</volume>:<fpage>4413</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1600282</pub-id><pub-id pub-id-type="pmid">27793997</pub-id><pub-id pub-id-type="pmcid">PMC7386828</pub-id></mixed-citation></ref><ref id="B145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Haren</surname><given-names>SD</given-names></name><name name-style="western"><surname>Ganapathi</surname><given-names>L</given-names></name><name name-style="western"><surname>Bergelson</surname><given-names>I</given-names></name><name name-style="western"><surname>Dowling</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Banks</surname><given-names>M</given-names></name><name name-style="western"><surname>Samuels</surname><given-names>RC</given-names></name><etal/></person-group>. <article-title><italic toggle="yes">in vitro</italic> cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant</article-title>. <source>Cytokine.</source> (<year>2016</year>) <volume>83</volume>:<fpage>99</fpage>&#8211;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2016.04.001</pub-id><pub-id pub-id-type="pmid">27081760</pub-id><pub-id pub-id-type="pmcid">PMC4906944</pub-id></mixed-citation></ref><ref id="B146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganapathi</surname><given-names>L</given-names></name><name name-style="western"><surname>Van Haren</surname><given-names>S</given-names></name><name name-style="western"><surname>Dowling</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Bergelson</surname><given-names>I</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>NM</given-names></name><name name-style="western"><surname>Malladi</surname><given-names>SS</given-names></name><etal/></person-group>. <article-title>The imidazoquinoline toll-like receptor-7/8 agonist hybrid-2 potently induces cytokine production by human newborn and adult leukocytes</article-title>. <source>PLoS ONE.</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0134640</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0134640</pub-id><pub-id pub-id-type="pmid">26274907</pub-id><pub-id pub-id-type="pmcid">PMC4537157</pub-id></mixed-citation></ref><ref id="B147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilkinson</surname><given-names>A</given-names></name><name name-style="western"><surname>Lattmann</surname><given-names>E</given-names></name><name name-style="western"><surname>Roces</surname><given-names>CB</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>GK</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>D</given-names></name><name name-style="western"><surname>Perrie</surname><given-names>Y</given-names></name></person-group><article-title>Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01</article-title>. <source>J Control Release.</source> (<year>2018</year>) <volume>291</volume>:<fpage>1</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2018.10.002</pub-id><pub-id pub-id-type="pmid">30291987</pub-id></mixed-citation></ref><ref id="B148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collier</surname><given-names>MA</given-names></name><name name-style="western"><surname>Junkins</surname><given-names>RD</given-names></name><name name-style="western"><surname>Gallovic</surname><given-names>MD</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>BM</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>MM</given-names></name><name name-style="western"><surname>Macintyre</surname><given-names>AN</given-names></name><etal/></person-group>. <article-title>Acetalated dextran microparticles for codelivery of STING and TLR7/8 agonists</article-title>. <source>Mol Pharm.</source> (<year>2018</year>) <volume>15</volume>:<fpage>4933</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.8b00579</pub-id><pub-id pub-id-type="pmid">30281314</pub-id><pub-id pub-id-type="pmcid">PMC6261357</pub-id></mixed-citation></ref><ref id="B149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGowan</surname><given-names>DC</given-names></name><name name-style="western"><surname>Herschke</surname><given-names>F</given-names></name><name name-style="western"><surname>Khamlichi</surname><given-names>MD</given-names></name><name name-style="western"><surname>Rosauro</surname><given-names>ML</given-names></name><name name-style="western"><surname>Benedicto</surname><given-names>SMP</given-names></name><name name-style="western"><surname>Pauwels</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Design and synthesis of tetrahydropyridopyrimidine based toll-like receptor (TLR) 7/8 dual agonists</article-title>. <source>Bioorg Med Chem Lett.</source> (<year>2018</year>) <volume>28</volume>:<fpage>3216</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2018.08.015</pub-id><pub-id pub-id-type="pmid">30143425</pub-id></mixed-citation></ref><ref id="B150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gadd</surname><given-names>AJR</given-names></name><name name-style="western"><surname>Castelletto</surname><given-names>V</given-names></name><name name-style="western"><surname>Kabova</surname><given-names>E</given-names></name><name name-style="western"><surname>Shankland</surname><given-names>K</given-names></name><name name-style="western"><surname>Perrie</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hamley</surname><given-names>I</given-names></name><etal/></person-group><article-title>High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation</article-title>. <source>Eur J Pharm Sci.</source> (<year>2018</year>) <volume>123</volume>:<fpage>268</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejps.2018.07.048</pub-id><pub-id pub-id-type="pmid">30048801</pub-id><pub-id pub-id-type="pmcid">PMC6137072</pub-id></mixed-citation></ref><ref id="B151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vo</surname><given-names>HTM</given-names></name><name name-style="western"><surname>Baudner</surname><given-names>BC</given-names></name><name name-style="western"><surname>Sammicheli</surname><given-names>S</given-names></name><name name-style="western"><surname>Iannacone</surname><given-names>M</given-names></name><name name-style="western"><surname>D'Oro</surname><given-names>U</given-names></name><name name-style="western"><surname>Piccioli</surname><given-names>D</given-names></name></person-group>. <article-title>Alum/toll-like receptor 7 adjuvant enhances the expansion of memory B cell compartment within the draining lymph node</article-title>. <source>Front Immunol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>641</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00641</pub-id><pub-id pub-id-type="pmid">29686670</pub-id><pub-id pub-id-type="pmcid">PMC5900039</pub-id></mixed-citation></ref><ref id="B152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carignan</surname><given-names>D</given-names></name><name name-style="western"><surname>Herblot</surname><given-names>S</given-names></name><name name-style="western"><surname>Lalibert&#233;-Gagn&#233;</surname><given-names>M</given-names></name><name name-style="western"><surname>Bolduc</surname><given-names>M</given-names></name><name name-style="western"><surname>Duval</surname><given-names>M</given-names></name><name name-style="western"><surname>Savard</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist</article-title>. <source>Nanomedicine.</source> (<year>2018</year>) <volume>14</volume>:<fpage>2317</fpage>&#8211;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.nano.2017.10.015</pub-id><pub-id pub-id-type="pmid">29128662</pub-id></mixed-citation></ref><ref id="B153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Hoeven</surname><given-names>N</given-names></name><name name-style="western"><surname>Fox</surname><given-names>CB</given-names></name><name name-style="western"><surname>Granger</surname><given-names>B</given-names></name><name name-style="western"><surname>Evers</surname><given-names>T</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>SW</given-names></name><name name-style="western"><surname>Nana</surname><given-names>GI</given-names></name><etal/></person-group>. <article-title>A formulated TLR7/8 agonist is a flexible, highly potent and effective adjuvant for pandemic influenza vaccines</article-title>. <source>Sci Rep.</source> (<year>2017</year>) <volume>7</volume>:<fpage>46426</fpage>. <pub-id pub-id-type="doi">10.1038/srep46426</pub-id><pub-id pub-id-type="pmid">28429728</pub-id><pub-id pub-id-type="pmcid">PMC5399443</pub-id></mixed-citation></ref><ref id="B154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rubtsova</surname><given-names>K</given-names></name><name name-style="western"><surname>Rubtsov</surname><given-names>AV</given-names></name><name name-style="western"><surname>Halemano</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>SX</given-names></name><name name-style="western"><surname>Kappler</surname><given-names>JW</given-names></name><name name-style="western"><surname>Santiago</surname><given-names>ML</given-names></name><etal/></person-group>. <article-title>T cell production of IFN&#947; in response to TLR7/IL-12 stimulates optimal B cell responses to viruses</article-title>. <source>PLoS ONE.</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0166322</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0166322</pub-id><pub-id pub-id-type="pmid">27880772</pub-id><pub-id pub-id-type="pmcid">PMC5120817</pub-id></mixed-citation></ref><ref id="B155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cong</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Qi</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-&#954;B signaling pathway</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>23977</fpage>. <pub-id pub-id-type="doi">10.1038/srep23977</pub-id><pub-id pub-id-type="pmid">27046485</pub-id><pub-id pub-id-type="pmcid">PMC4820752</pub-id></mixed-citation></ref><ref id="B156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aguado-Mart&#237;nez</surname><given-names>A</given-names></name><name name-style="western"><surname>Basto</surname><given-names>AP</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Ryser</surname><given-names>LT</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>TP</given-names></name><name name-style="western"><surname>Ortega-Mora</surname><given-names>LM</given-names></name><etal/></person-group>. <article-title>Immunization with a cocktail of antigens fused with OprI reduces Neospora caninum vertical transmission and postnatal mortality in mice</article-title>. <source>Vaccine.</source> (<year>2019</year>) <volume>37</volume>:<fpage>473</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.11.060</pub-id><pub-id pub-id-type="pmid">30497830</pub-id></mixed-citation></ref><ref id="B157"><label>157.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buonsanti</surname><given-names>C</given-names></name><name name-style="western"><surname>Balocchi</surname><given-names>C</given-names></name><name name-style="western"><surname>Harfouche</surname><given-names>C</given-names></name><name name-style="western"><surname>Corrente</surname><given-names>F</given-names></name><name name-style="western"><surname>Galli Stampino</surname><given-names>L</given-names></name><name name-style="western"><surname>Mancini</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>29063</fpage>. <pub-id pub-id-type="doi">10.1038/srep29063</pub-id><pub-id pub-id-type="pmid">27439378</pub-id><pub-id pub-id-type="pmcid">PMC4954951</pub-id></mixed-citation></ref><ref id="B158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>F</given-names></name><name name-style="western"><surname>Mosley</surname><given-names>YC</given-names></name><name name-style="western"><surname>Carmichael</surname><given-names>B</given-names></name><name name-style="western"><surname>Brown</surname><given-names>DD</given-names></name><name name-style="western"><surname>HogenEsch</surname><given-names>H</given-names></name></person-group>. <article-title>Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and CpG enhances the magnitude and avidity of the humoral immune response</article-title>. <source>Vaccine.</source> (<year>2019</year>) <volume>37</volume>:<fpage>1945</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.02.033</pub-id><pub-id pub-id-type="pmid">30803844</pub-id></mixed-citation></ref><ref id="B159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs</article-title>. <source>Hum Vaccin Immunother.</source> (<year>2019</year>) <volume>15</volume>:<fpage>2684</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1080/21645515.2019.1596710</pub-id><pub-id pub-id-type="pmid">31021703</pub-id><pub-id pub-id-type="pmcid">PMC6930060</pub-id></mixed-citation></ref><ref id="B160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>JW</given-names></name><name name-style="western"><surname>Tang</surname><given-names>SQ</given-names></name><name name-style="western"><surname>Rong</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>MQ</given-names></name></person-group>. <article-title>Synergistic effect of dual targeting vaccine adjuvant with aminated &#946;-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses</article-title>. <source>Acta Biomater.</source> (<year>2018</year>) <volume>78</volume>:<fpage>211</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2018.08.002</pub-id><pub-id pub-id-type="pmid">30098441</pub-id></mixed-citation></ref><ref id="B161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>P</given-names></name><name name-style="western"><surname>Tian</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase</article-title>. <source>Biomaterials.</source> (<year>2018</year>) <volume>171</volume>:<fpage>198</fpage>&#8211;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.04.039</pub-id><pub-id pub-id-type="pmid">29698869</pub-id></mixed-citation></ref><ref id="B162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alkie</surname><given-names>TN</given-names></name><name name-style="western"><surname>Taha-Abdelaziz</surname><given-names>K</given-names></name><name name-style="western"><surname>Barjesteh</surname><given-names>N</given-names></name><name name-style="western"><surname>Bavananthasivam</surname><given-names>J</given-names></name><name name-style="western"><surname>Hodgins</surname><given-names>DC</given-names></name><name name-style="western"><surname>Sharif</surname><given-names>S</given-names></name></person-group>. <article-title>Characterization of innate responses induced by PLGA encapsulated- and soluble TLR ligands <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> in chickens</article-title>. <source>PLoS ONE.</source> (<year>2017</year>) <volume>12</volume>:<fpage>e0169154</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0169154</pub-id><pub-id pub-id-type="pmid">28045984</pub-id><pub-id pub-id-type="pmcid">PMC5207720</pub-id></mixed-citation></ref><ref id="B163"><label>163.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hawksworth</surname><given-names>D</given-names></name></person-group>. <article-title>Advancing Freund's and addaVax adjuvant regimens using CpG oligodeoxynucleotides</article-title>. <source>Monoclon Antib Immunodiagn Immunother.</source> (<year>2018</year>) <volume>37</volume>:<fpage>195</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1089/mab.2018.0022</pub-id><pub-id pub-id-type="pmid">30281392</pub-id></mixed-citation></ref><ref id="B164"><label>164.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>CY</given-names></name><name name-style="western"><surname>Yu</surname><given-names>GY</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>R</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>TH</given-names></name></person-group>. <article-title>Immunostimulatory activities of CpG-oligodeoxynucleotides in teleosts: toll-like receptors 9 and 21</article-title>. <source>Front Immunol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>179</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00179</pub-id><pub-id pub-id-type="pmid">30800129</pub-id><pub-id pub-id-type="pmcid">PMC6375897</pub-id></mixed-citation></ref><ref id="B165"><label>165.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akkaya</surname><given-names>M</given-names></name><name name-style="western"><surname>Akkaya</surname><given-names>B</given-names></name><name name-style="western"><surname>Miozzo</surname><given-names>P</given-names></name><name name-style="western"><surname>Rawat</surname><given-names>M</given-names></name><name name-style="western"><surname>Pena</surname><given-names>M</given-names></name><name name-style="western"><surname>Sheehan</surname><given-names>PW</given-names></name><etal/></person-group>. <article-title>B cells produce type 1 IFNs in response to the TLR9 agonist CpG-A conjugated to cationic lipids</article-title>. <source>J Immunol.</source> (<year>2017</year>) <volume>199</volume>:<fpage>931</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1700348</pub-id><pub-id pub-id-type="pmid">28652397</pub-id><pub-id pub-id-type="pmcid">PMC5531204</pub-id></mixed-citation></ref><ref id="B166"><label>166.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>L</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Doycheva</surname><given-names>D</given-names></name><name name-style="western"><surname>Malaguit</surname><given-names>J</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>B</given-names></name><name name-style="western"><surname>Xu</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>CpG-ODN exerts a neuroprotective effect via the TLR9/pAMPK signaling pathway by activation of autophagy in a neonatal HIE rat model</article-title>. <source>Exp Neurol.</source> (<year>2018</year>) <volume>301</volume>(<issue>Pt A</issue>):<fpage>70</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2017.12.008</pub-id><pub-id pub-id-type="pmid">29274721</pub-id></mixed-citation></ref><ref id="B167"><label>167.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yan</surname><given-names>T</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Feng</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D</given-names></name><name name-style="western"><surname>Fujita</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Graphene oxide-chitosan nanocomposites for intracellular delivery of immunostimulatory CpG oligodeoxynucleotides</article-title>. <source>Mater Sci Eng C Mater Biol Appl.</source> (<year>2017</year>) <volume>73</volume>:<fpage>144</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2016.12.072</pub-id><pub-id pub-id-type="pmid">28183591</pub-id></mixed-citation></ref><ref id="B168"><label>168.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Dong</surname><given-names>S</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>CpG-oligodeoxynucleotides improved irradiation-induced injuries by G-CSF and IL-6 up-regulation</article-title>. <source>Cell Physiol Biochem.</source> (<year>2017</year>) <volume>44</volume>:<fpage>2368</fpage>&#8211;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1159/000486153</pub-id><pub-id pub-id-type="pmid">29262401</pub-id></mixed-citation></ref><ref id="B169"><label>169.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramirez</surname><given-names>A</given-names></name><name name-style="western"><surname>Co</surname><given-names>M</given-names></name><name name-style="western"><surname>Mathew</surname><given-names>A</given-names></name></person-group><article-title>CpG improves influenza vaccine efficacy in young adult but not aged mice</article-title>. <source>PLoS ONE.</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0150425</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0150425</pub-id><pub-id pub-id-type="pmid">26934728</pub-id><pub-id pub-id-type="pmcid">PMC4774967</pub-id></mixed-citation></ref><ref id="B170"><label>170.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asokanathan</surname><given-names>C</given-names></name><name name-style="western"><surname>Corbel</surname><given-names>M</given-names></name><name name-style="western"><surname>Xing</surname><given-names>D</given-names></name></person-group>. <article-title>A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>Hum Vaccin Immunother.</source> (<year>2013</year>) <volume>9</volume>:<fpage>325</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.4161/hv.22755</pub-id><pub-id pub-id-type="pmid">23291942</pub-id><pub-id pub-id-type="pmcid">PMC3859755</pub-id></mixed-citation></ref><ref id="B171"><label>171.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knight</surname><given-names>JB</given-names></name><name name-style="western"><surname>Huang</surname><given-names>YY</given-names></name><name name-style="western"><surname>Halperin</surname><given-names>SA</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>R</given-names></name><name name-style="western"><surname>Morris</surname><given-names>A</given-names></name><name name-style="western"><surname>Macmillan</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>Clin Exp Immunol.</source> (<year>2006</year>) <volume>144</volume>:<fpage>543</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03097.x</pub-id><pub-id pub-id-type="pmid">16734625</pub-id><pub-id pub-id-type="pmcid">PMC1941966</pub-id></mixed-citation></ref><ref id="B172"><label>172.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyd</surname><given-names>AP</given-names></name><name name-style="western"><surname>Ross</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Conroy</surname><given-names>H</given-names></name><name name-style="western"><surname>Mahon</surname><given-names>N</given-names></name><name name-style="western"><surname>Lavelle</surname><given-names>EC</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title><italic toggle="yes">Bordetella pertussis</italic> adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death</article-title>. <source>J Immunol.</source> (<year>2005</year>) <volume>175</volume>:<fpage>730</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.2.730</pub-id><pub-id pub-id-type="pmid">16002668</pub-id></mixed-citation></ref><ref id="B173"><label>173.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maletto</surname><given-names>B</given-names></name><name name-style="western"><surname>R&#243;polo</surname><given-names>A</given-names></name><name name-style="western"><surname>Mor&#243;n</surname><given-names>V</given-names></name><name name-style="western"><surname>Pistoresi-Palencia</surname><given-names>MC</given-names></name></person-group>. <article-title>CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice</article-title>. <source>J Leukoc Biol.</source> (<year>2002</year>) <volume>72</volume>:<fpage>447</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="pmid">12223511</pub-id></mixed-citation></ref><ref id="B174"><label>174.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gracia</surname><given-names>A</given-names></name><name name-style="western"><surname>Polewicz</surname><given-names>M</given-names></name><name name-style="western"><surname>Halperin</surname><given-names>SA</given-names></name><name name-style="western"><surname>Hancock</surname><given-names>RE</given-names></name><name name-style="western"><surname>Potter</surname><given-names>AA</given-names></name><name name-style="western"><surname>Babiuk</surname><given-names>LA</given-names></name><etal/></person-group>. <article-title>Antibody responses in adult and neonatal BALB/c mice to immunization with novel <italic toggle="yes">Bordetella pertussis</italic> vaccine formulations</article-title>. <source>Vaccine.</source> (<year>2011</year>) <volume>29</volume>:<fpage>1595</fpage>&#8211;<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2010.12.083</pub-id><pub-id pub-id-type="pmid">21215343</pub-id></mixed-citation></ref><ref id="B175"><label>175.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de</surname><given-names>Apost&#243;lico JS</given-names></name><name name-style="western"><surname>Lunardelli</surname><given-names>VA</given-names></name><name name-style="western"><surname>Coirada</surname><given-names>FC</given-names></name><name name-style="western"><surname>Boscardin</surname><given-names>SB</given-names></name><name name-style="western"><surname>Rosa</surname><given-names>DS</given-names></name></person-group><article-title>Adjuvants: classification, modus operandi, and licensing</article-title>. <source>J Immunol Res.</source> (<year>2016</year>) <volume>2016</volume>:<fpage>1459394</fpage><pub-id pub-id-type="doi">10.1155/2016/1459394</pub-id><pub-id pub-id-type="pmid">27274998</pub-id><pub-id pub-id-type="pmcid">PMC4870346</pub-id></mixed-citation></ref><ref id="B176"><label>176.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holmgren</surname><given-names>J</given-names></name><name name-style="western"><surname>Adamsson</surname><given-names>J</given-names></name><name name-style="western"><surname>Anju&#232;re</surname><given-names>F</given-names></name><name name-style="western"><surname>Clemens</surname><given-names>J</given-names></name><name name-style="western"><surname>Czerkinsky</surname><given-names>C</given-names></name><name name-style="western"><surname>Eriksson</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA</article-title>. <source>Immunol Lett.</source> (<year>2005</year>) <volume>97</volume>:<fpage>181</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.imlet.2004.11.009</pub-id><pub-id pub-id-type="pmid">15752556</pub-id></mixed-citation></ref><ref id="B177"><label>177.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bromander</surname><given-names>AK</given-names></name><name name-style="western"><surname>Kjerrulf</surname><given-names>M</given-names></name><name name-style="western"><surname>Holmgren</surname><given-names>J</given-names></name><name name-style="western"><surname>Lycke</surname><given-names>N</given-names></name></person-group>. <article-title>Cholera toxin enhances antigen presentation</article-title>. <source>Adv Exp Med Biol.</source> (<year>1995</year>) <volume>371B</volume>:<fpage>1501</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="pmid">7502845</pub-id></mixed-citation></ref><ref id="B178"><label>178.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holmgren</surname><given-names>J</given-names></name><name name-style="western"><surname>Czerkinsky</surname><given-names>C</given-names></name><name name-style="western"><surname>Lycke</surname><given-names>N</given-names></name><name name-style="western"><surname>Svennerholm</surname><given-names>AM</given-names></name></person-group>. <article-title>Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant</article-title>. <source>Am J Trop Med Hyg.</source> (<year>1994</year>) <volume>50</volume>:<fpage>42</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="pmid">8203723</pub-id></mixed-citation></ref><ref id="B179"><label>179.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bromander</surname><given-names>AK</given-names></name><name name-style="western"><surname>Kjerrulf</surname><given-names>M</given-names></name><name name-style="western"><surname>Holmgren</surname><given-names>J</given-names></name><name name-style="western"><surname>Lycke</surname><given-names>N</given-names></name></person-group>. <article-title>Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells</article-title>. <source>Scand J Immunol.</source> (<year>1993</year>) <volume>37</volume>:<fpage>452</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3083.1993.tb03318.x</pub-id><pub-id pub-id-type="pmid">8469928</pub-id></mixed-citation></ref><ref id="B180"><label>180.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holmgren</surname><given-names>J</given-names></name><name name-style="western"><surname>Lycke</surname><given-names>N</given-names></name><name name-style="western"><surname>Czerkinsky</surname><given-names>C</given-names></name></person-group>. <article-title>Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems</article-title>. <source>Vaccine.</source> (<year>1993</year>) <volume>11</volume>:<fpage>1179</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/0264-410X(93)90039-Z</pub-id><pub-id pub-id-type="pmid">8256498</pub-id></mixed-citation></ref><ref id="B181"><label>181.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holmgren</surname><given-names>J</given-names></name><name name-style="western"><surname>Nordqvist</surname><given-names>S</given-names></name><name name-style="western"><surname>Blomquist</surname><given-names>M</given-names></name><name name-style="western"><surname>Jeverstam</surname><given-names>F</given-names></name><name name-style="western"><surname>Lebens</surname><given-names>M</given-names></name><name name-style="western"><surname>Raghavan</surname><given-names>S</given-names></name></person-group>. <article-title>Preclinical immunogenicity and protective efficacy of an oral <italic toggle="yes">Helicobacter pylori</italic> inactivated whole cell vaccine and multiple mutant cholera toxin: a novel and non-toxic mucosal adjuvant</article-title>. <source>Vaccine.</source> (<year>2018</year>) <volume>36</volume>:<fpage>6223</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.07.073</pub-id><pub-id pub-id-type="pmid">30119923</pub-id></mixed-citation></ref><ref id="B182"><label>182.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavelle</surname><given-names>EC</given-names></name><name name-style="western"><surname>Jarnicki</surname><given-names>A</given-names></name><name name-style="western"><surname>McNeela</surname><given-names>E</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>ME</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>SC</given-names></name><name name-style="western"><surname>Leavy</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent</article-title>. <source>J Leukoc Biol.</source> (<year>2004</year>) <volume>75</volume>:<fpage>756</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.1103534</pub-id><pub-id pub-id-type="pmid">14704372</pub-id></mixed-citation></ref><ref id="B183"><label>183.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>MS</given-names></name><name name-style="western"><surname>Yi</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YI</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name><name name-style="western"><surname>Jung</surname><given-names>YS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SR</given-names></name><etal/></person-group>. <article-title>ERdj5 in innate immune cells is a crucial factor for the mucosal adjuvanticity of cholera toxin</article-title>. <source>Front Immunol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>1249</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.01249</pub-id><pub-id pub-id-type="pmid">31275300</pub-id><pub-id pub-id-type="pmcid">PMC6593289</pub-id></mixed-citation></ref><ref id="B184"><label>184.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>JB</given-names></name><name name-style="western"><surname>Holmgren</surname><given-names>J</given-names></name><name name-style="western"><surname>Larena</surname><given-names>M</given-names></name><name name-style="western"><surname>Terrinoni</surname><given-names>M</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bresnick</surname><given-names>AR</given-names></name><etal/></person-group>. <article-title>Deficiency in calcium-binding protein S100A4 impairs the adjuvant action of cholera toxin</article-title>. <source>Front Immunol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>1119</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01119</pub-id><pub-id pub-id-type="pmid">28951732</pub-id><pub-id pub-id-type="pmcid">PMC5600718</pub-id></mixed-citation></ref><ref id="B185"><label>185.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barati</surname><given-names>B</given-names></name><name name-style="western"><surname>Ebrahimi</surname><given-names>F</given-names></name><name name-style="western"><surname>Nazarian</surname><given-names>S</given-names></name></person-group>. <article-title>Production of chicken egg yolk antibody (IgY) against recombinant cholera toxin B subunit and evaluation of its prophylaxis potency in mice</article-title>. <source>Iran J Immunol.</source> (<year>2018</year>) <volume>15</volume>:<fpage>47</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="pmid">29549232</pub-id></mixed-citation></ref><ref id="B186"><label>186.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isaka</surname><given-names>M</given-names></name><name name-style="western"><surname>Komiya</surname><given-names>T</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>M</given-names></name><name name-style="western"><surname>Yasuda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Taniguchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine</article-title>. <source>Vaccine.</source> (<year>2004</year>) <volume>22</volume>:<fpage>3061</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2004.02.019</pub-id><pub-id pub-id-type="pmid">15297056</pub-id></mixed-citation></ref><ref id="B187"><label>187.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SF</given-names></name><name name-style="western"><surname>Halperin</surname><given-names>SA</given-names></name><name name-style="western"><surname>Salloum</surname><given-names>DF</given-names></name><name name-style="western"><surname>MacMillan</surname><given-names>A</given-names></name><name name-style="western"><surname>Morris</surname><given-names>A</given-names></name></person-group>. <article-title>Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein</article-title>. <source>Infect Immun.</source> (<year>2003</year>) <volume>71</volume>:<fpage>2272</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.71.4.2272-2275.2003</pub-id><pub-id pub-id-type="pmid">12654855</pub-id><pub-id pub-id-type="pmcid">PMC152103</pub-id></mixed-citation></ref><ref id="B188"><label>188.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isaka</surname><given-names>M</given-names></name><name name-style="western"><surname>Yasuda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Taniguchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kozuka</surname><given-names>S</given-names></name><name name-style="western"><surname>Matano</surname><given-names>K</given-names></name><name name-style="western"><surname>Maeyama</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant</article-title>. <source>Vaccine.</source> (<year>2003</year>) <volume>21</volume>:<fpage>1165</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/S0264-410X(02)00516-9</pub-id><pub-id pub-id-type="pmid">12559794</pub-id></mixed-citation></ref><ref id="B189"><label>189.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olivera</surname><given-names>N</given-names></name><name name-style="western"><surname>Castuma</surname><given-names>CE</given-names></name><name name-style="western"><surname>Hozbor</surname><given-names>D</given-names></name><name name-style="western"><surname>Gaillard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Rumbo</surname><given-names>M</given-names></name><name name-style="western"><surname>G&#243;mez</surname><given-names>RM</given-names></name></person-group>. <article-title>Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against <italic toggle="yes">Bordetella pertussis</italic> infection</article-title>. <source>Biomed Res Int.</source> (<year>2014</year>) <volume>2014</volume>:<fpage>421486</fpage>. <pub-id pub-id-type="doi">10.1155/2014/421486</pub-id><pub-id pub-id-type="pmid">24982881</pub-id><pub-id pub-id-type="pmcid">PMC4052895</pub-id></mixed-citation></ref><ref id="B190"><label>190.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clements</surname><given-names>JD</given-names></name><name name-style="western"><surname>Norton</surname><given-names>EB</given-names></name></person-group><article-title>The mucosal vaccine adjuvant LT(R192G/L211A) or dmLT</article-title>. <source>mSphere.</source> (<year>2018</year>) <volume>3</volume>:<fpage>e00215</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1128/mSphere.00215-18</pub-id><pub-id pub-id-type="pmid">30045966</pub-id><pub-id pub-id-type="pmcid">PMC6060342</pub-id></mixed-citation></ref><ref id="B191"><label>191.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albert</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Haridas</surname><given-names>S</given-names></name><name name-style="western"><surname>Ebenezer</surname><given-names>M</given-names></name><name name-style="western"><surname>Raghupathy</surname><given-names>R</given-names></name><name name-style="western"><surname>Khan</surname><given-names>I</given-names></name></person-group>. <article-title>Immunization with a double-mutant (R192G/L211A) of the heat-labile enterotoxin of escherichia coli offers partial protection against campylobacter jejuni in an adult mouse intestinal colonization model</article-title>. <source>PLoS ONE.</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0142090</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0142090</pub-id><pub-id pub-id-type="pmid">26540197</pub-id><pub-id pub-id-type="pmcid">PMC4634955</pub-id></mixed-citation></ref><ref id="B192"><label>192.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>PS</given-names></name><name name-style="western"><surname>Chiou</surname><given-names>HY</given-names></name><name name-style="western"><surname>Jeng</surname><given-names>CR</given-names></name><name name-style="western"><surname>Pang</surname><given-names>VF</given-names></name><etal/></person-group>. <article-title>Efficacy of heat-labile enterotoxin B subunit-adjuvanted parenteral porcine epidemic diarrhea virus trimeric spike subunit vaccine in piglets</article-title>. <source>Appl Microbiol Biotechnol.</source> (<year>2018</year>) <volume>102</volume>:<fpage>7499</fpage>&#8211;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-018-9110-6</pub-id><pub-id pub-id-type="pmid">29961099</pub-id></mixed-citation></ref><ref id="B193"><label>193.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brereton</surname><given-names>CF</given-names></name><name name-style="western"><surname>Sutton</surname><given-names>CE</given-names></name><name name-style="western"><surname>Ross</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pizza</surname><given-names>M</given-names></name><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name><etal/></person-group>. <article-title><italic toggle="yes">Escherichia coli</italic> heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production</article-title>. <source>J Immunol.</source> (<year>2011</year>) <volume>186</volume>:<fpage>5896</fpage>&#8211;<lpage>906</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1003789</pub-id><pub-id pub-id-type="pmid">21490151</pub-id></mixed-citation></ref><ref id="B194"><label>194.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>EJ</given-names></name><name name-style="western"><surname>McNeela</surname><given-names>E</given-names></name><name name-style="western"><surname>Pizza</surname><given-names>M</given-names></name><name name-style="western"><surname>Rappuoli</surname><given-names>R</given-names></name><name name-style="western"><surname>O'Neill</surname><given-names>L</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title>Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity</article-title>. <source>J Immunol.</source> (<year>2000</year>) <volume>165</volume>:<fpage>5750</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.165.10.5750</pub-id><pub-id pub-id-type="pmid">11067933</pub-id></mixed-citation></ref><ref id="B195"><label>195.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coleman</surname><given-names>MM</given-names></name><name name-style="western"><surname>Basdeo</surname><given-names>SA</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>AM</given-names></name><name name-style="western"><surname>Cheallaigh</surname><given-names>CN</given-names></name><name name-style="western"><surname>Peral de Castro</surname><given-names>C</given-names></name><name name-style="western"><surname>McLaughlin</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>All-trans retinoic acid augments autophagy during intracellular bacterial infection</article-title>. <source>Am J Respir Cell Mol Biol.</source> (<year>2018</year>) <volume>59</volume>:<fpage>548</fpage>&#8211;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2017-0382OC</pub-id><pub-id pub-id-type="pmid">29852080</pub-id></mixed-citation></ref><ref id="B196"><label>196.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>LM</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>FME</given-names></name><name name-style="western"><surname>Sato</surname><given-names>MN</given-names></name></person-group>. <article-title>Impact of retinoic acid on immune cells and inflammatory diseases</article-title>. <source>Mediators Inflamm.</source> (<year>2018</year>) <volume>2018</volume>:<fpage>3067126</fpage>. <pub-id pub-id-type="doi">10.1155/2018/3067126</pub-id><pub-id pub-id-type="pmid">30158832</pub-id><pub-id pub-id-type="pmcid">PMC6109577</pub-id></mixed-citation></ref><ref id="B197"><label>197.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seo</surname><given-names>GY</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jang</surname><given-names>YS</given-names></name><name name-style="western"><surname>Kang</surname><given-names>SG</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>SI</given-names></name><name name-style="western"><surname>Ko</surname><given-names>HJ</given-names></name><etal/></person-group>. <article-title>Mechanism underlying the suppressor activity of retinoic acid on IL4-induced IgE synthesis and its physiological implication</article-title>. <source>Cell Immunol.</source> (<year>2017</year>) <volume>322</volume>:<fpage>49</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellimm.2017.10.001</pub-id><pub-id pub-id-type="pmid">29042055</pub-id><pub-id pub-id-type="pmcid">PMC5733712</pub-id></mixed-citation></ref><ref id="B198"><label>198.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bezerra</surname><given-names>IPS</given-names></name><name name-style="western"><surname>Costa-Souza</surname><given-names>BLS</given-names></name><name name-style="western"><surname>Carneiro</surname><given-names>G</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>LAM</given-names></name><name name-style="western"><surname>de Matos Guedes</surname><given-names>HL</given-names></name><name name-style="western"><surname>Rossi-Bergmann</surname><given-names>B</given-names></name></person-group>. <article-title>Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for intranasal vaccination against cutaneous leishmaniasis</article-title>. <source>Vaccine.</source> (<year>2019</year>) <volume>37</volume>:<fpage>3660</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.05.043</pub-id><pub-id pub-id-type="pmid">31133469</pub-id></mixed-citation></ref><ref id="B199"><label>199.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mwanza-Lisulo</surname><given-names>M</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>P</given-names></name></person-group>. <article-title>Potential for use of retinoic acid as an oral vaccine adjuvant</article-title>. <source>Philos Trans R Soc Lond B Biol Sci.</source> (<year>2015</year>) <volume>370</volume>:<fpage>20140145</fpage>. <pub-id pub-id-type="doi">10.1098/rstb.2014.0145</pub-id><pub-id pub-id-type="pmid">25964457</pub-id><pub-id pub-id-type="pmcid">PMC4527390</pub-id></mixed-citation></ref><ref id="B200"><label>200.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lisulo</surname><given-names>MM</given-names></name><name name-style="western"><surname>Kapulu</surname><given-names>MC</given-names></name><name name-style="western"><surname>Banda</surname><given-names>R</given-names></name><name name-style="western"><surname>Sinkala</surname><given-names>E</given-names></name><name name-style="western"><surname>Kayamba</surname><given-names>V</given-names></name><name name-style="western"><surname>Sianongo</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Adjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian men</article-title>. <source>Clin Exp Immunol.</source> (<year>2014</year>) <volume>175</volume>:<fpage>468</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1111/cei.12238</pub-id><pub-id pub-id-type="pmid">24237035</pub-id><pub-id pub-id-type="pmcid">PMC3927907</pub-id></mixed-citation></ref><ref id="B201"><label>201.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>X</given-names></name><name name-style="western"><surname>Sande</surname><given-names>JL</given-names></name><name name-style="western"><surname>Pufnock</surname><given-names>JS</given-names></name><name name-style="western"><surname>Blattman</surname><given-names>JN</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>PD</given-names></name></person-group>. <article-title>Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge</article-title>. <source>J Virol.</source> (<year>2011</year>) <volume>85</volume>:<fpage>8316</fpage>&#8211;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00781-11</pub-id><pub-id pub-id-type="pmid">21653670</pub-id><pub-id pub-id-type="pmcid">PMC3147979</pub-id></mixed-citation></ref><ref id="B202"><label>202.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Yan</surname><given-names>C</given-names></name><name name-style="western"><surname>Jin</surname><given-names>H</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>T</given-names></name><name name-style="western"><surname>Yan</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Butyrate and retinoic acid imprint mucosal-like dendritic cell development synergistically from bone marrow cells</article-title>. <source>Clin Exp Immunol.</source> (<year>2017</year>) <volume>189</volume>:<fpage>290</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/cei.12990</pub-id><pub-id pub-id-type="pmid">28542882</pub-id><pub-id pub-id-type="pmcid">PMC5543492</pub-id></mixed-citation></ref><ref id="B203"><label>203.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raverdeau</surname><given-names>M</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title>Modulation of T cell and innate immune responses by retinoic acid</article-title>. <source>J Immunol.</source> (<year>2014</year>) <volume>192</volume>:<fpage>2953</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1303245</pub-id><pub-id pub-id-type="pmid">24659788</pub-id></mixed-citation></ref><ref id="B204"><label>204.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torres-Sangiao</surname><given-names>E</given-names></name><name name-style="western"><surname>Holban</surname><given-names>AM</given-names></name><name name-style="western"><surname>Gestal</surname><given-names>MC</given-names></name></person-group>. <article-title>Advanced nanobiomaterials: vaccines, diagnosis and treatment of infectious diseases</article-title>. <source>Molecules.</source> (<year>2016</year>) <volume>21</volume>:<fpage>E867</fpage>. <pub-id pub-id-type="doi">10.3390/molecules21070867</pub-id><pub-id pub-id-type="pmid">27376260</pub-id><pub-id pub-id-type="pmcid">PMC6273484</pub-id></mixed-citation></ref><ref id="B205"><label>205.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alagpulinsa</surname><given-names>DA</given-names></name><name name-style="western"><surname>Cao</surname><given-names>JJL</given-names></name><name name-style="western"><surname>Driscoll</surname><given-names>RK</given-names></name><name name-style="western"><surname>S&#238;rbulescu</surname><given-names>RF</given-names></name><name name-style="western"><surname>Penson</surname><given-names>MFE</given-names></name><name name-style="western"><surname>Sremac</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Alginate-microencapsulation of human stem cell-derived &#946; cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression</article-title>. <source>Am J Transplant.</source> (<year>2019</year>) <volume>19</volume>:<fpage>1930</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.15308</pub-id><pub-id pub-id-type="pmid">30748094</pub-id></mixed-citation></ref><ref id="B206"><label>206.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibe</surname><given-names>MI</given-names></name><name name-style="western"><surname>Odimegwu</surname><given-names>DC</given-names></name><name name-style="western"><surname>Onuigbo</surname><given-names>EB</given-names></name></person-group>. <article-title>Alginate-coated chitosan microparticles encapsulating an oral plasmid-cured live <italic toggle="yes">Salmonella enterica</italic> serovar Gallinarum vaccine cause a higher expression of interferon-gamma in chickens compared to the parenteral live vaccine</article-title>. <source>Avian Pathol.</source> (<year>2019</year>) <volume>48</volume>:<fpage>423</fpage>&#8211;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1080/03079457.2019.1616673</pub-id><pub-id pub-id-type="pmid">31081347</pub-id></mixed-citation></ref><ref id="B207"><label>207.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minakshi</surname><given-names>P</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>M</given-names></name><name name-style="western"><surname>Brar</surname><given-names>B</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><name name-style="western"><surname>Lambe</surname><given-names>UP</given-names></name><name name-style="western"><surname>Ranjan</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Nano-antimicrobials: a new paradigm for combating mycobacterial resistance</article-title>. <source>Curr Pharm Des.</source> (<year>2019</year>) <volume>25</volume>:<fpage>1554</fpage>&#8211;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.2174/1381612825666190620094041</pub-id><pub-id pub-id-type="pmid">31218956</pub-id></mixed-citation></ref><ref id="B208"><label>208.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaghasiya</surname><given-names>K</given-names></name><name name-style="western"><surname>Eram</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Ray</surname><given-names>E</given-names></name><name name-style="western"><surname>Adlakha</surname><given-names>S</given-names></name><name name-style="western"><surname>Verma</surname><given-names>RK</given-names></name></person-group>. <article-title>Alginate microspheres elicit innate M1-inflammatory response in macrophages leading to bacillary killing</article-title>. <source>AAPS PharmSciTech.</source> (<year>2019</year>) <volume>20</volume>:<fpage>241</fpage>. <pub-id pub-id-type="doi">10.1208/s12249-019-1458-0</pub-id><pub-id pub-id-type="pmid">31250260</pub-id></mixed-citation></ref><ref id="B209"><label>209.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coelho-Rocha</surname><given-names>ND</given-names></name><name name-style="western"><surname>de Castro</surname><given-names>CP</given-names></name><name name-style="western"><surname>de Jesus</surname><given-names>LCL</given-names></name><name name-style="western"><surname>Leclercq</surname><given-names>SY</given-names></name><name name-style="western"><surname>de Cicco Sandes</surname><given-names>SH</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>AC</given-names></name><etal/></person-group>. <article-title>Microencapsulation of lactic acid bacteria improves the gastrointestinal delivery and <italic toggle="yes">in situ</italic> expression of recombinant fluorescent protein</article-title>. <source>Front Microbiol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>2398</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.02398</pub-id><pub-id pub-id-type="pmid">30344518</pub-id><pub-id pub-id-type="pmcid">PMC6182071</pub-id></mixed-citation></ref><ref id="B210"><label>210.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kordbacheh</surname><given-names>E</given-names></name><name name-style="western"><surname>Nazarian</surname><given-names>S</given-names></name><name name-style="western"><surname>Hajizadeh</surname><given-names>A</given-names></name><name name-style="western"><surname>Sadeghi</surname><given-names>D</given-names></name></person-group>. <article-title>Entrapment of LTB protein in alginate nanoparticles protects against Enterotoxigenic <italic toggle="yes">Escherichia coli</italic></article-title>. <source>APMIS.</source> (<year>2018</year>) <volume>126</volume>:<fpage>320</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/apm.12815</pub-id><pub-id pub-id-type="pmid">29460309</pub-id></mixed-citation></ref><ref id="B211"><label>211.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YM</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Cho</surname><given-names>CW</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>JW</given-names></name><name name-style="western"><surname>Park</surname><given-names>JK</given-names></name><etal/></person-group>. <article-title>Nasal delivery of chitosan/alginate nanoparticle encapsulated bee (<italic toggle="yes">Apis mellifera</italic>) venom promotes antibody production and viral clearance during porcine reproductive and respiratory syndrome virus infection by modulating T cell related responses</article-title>. <source>Vet Immunol Immunopathol.</source> (<year>2018</year>) <volume>200</volume>:<fpage>40</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetimm.2018.04.006</pub-id><pub-id pub-id-type="pmid">29776611</pub-id></mixed-citation></ref><ref id="B212"><label>212.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Qin</surname><given-names>X</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Preparation of self-assembled nanoparticles of &#949;-polylysine-sodium alginate: a sustained-release carrier for antigen delivery</article-title>. <source>Colloids Surf B Biointerfaces.</source> (<year>2018</year>) <volume>171</volume>:<fpage>406</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2018.07.058</pub-id><pub-id pub-id-type="pmid">30071482</pub-id></mixed-citation></ref><ref id="B213"><label>213.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><name name-style="western"><surname>Bao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W</given-names></name></person-group>. <article-title>Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines</article-title>. <source>Hum Vaccin Immunother.</source> (<year>2017</year>) <volume>13</volume>:<fpage>1</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1080/21645515.2016.1278098</pub-id><pub-id pub-id-type="pmid">28129034</pub-id><pub-id pub-id-type="pmcid">PMC5489292</pub-id></mixed-citation></ref><ref id="B214"><label>214.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bacon</surname><given-names>A</given-names></name><name name-style="western"><surname>Makin</surname><given-names>J</given-names></name><name name-style="western"><surname>Sizer</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Jabbal-Gill</surname><given-names>I</given-names></name><name name-style="western"><surname>Hinchcliffe</surname><given-names>M</given-names></name><name name-style="western"><surname>Illum</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens</article-title>. <source>Infect Immun.</source> (<year>2000</year>) <volume>68</volume>:<fpage>5764</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.68.10.5764-5770.2000</pub-id><pub-id pub-id-type="pmid">10992483</pub-id><pub-id pub-id-type="pmcid">PMC101535</pub-id></mixed-citation></ref><ref id="B215"><label>215.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bagheripour</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ebrahimi</surname><given-names>F</given-names></name><name name-style="western"><surname>Hajizade</surname><given-names>A</given-names></name><name name-style="western"><surname>Nazarian</surname><given-names>S</given-names></name></person-group>. <article-title>Immunogenicity evaluation of rBoNT/E nanovaccine after mucosal administration</article-title>. <source>Iran J Basic Med Sci.</source> (<year>2019</year>) <volume>22</volume>:<fpage>353</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="pmid">31168338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.22038/ijbms.2019.25333.6258</pub-id><pub-id pub-id-type="pmcid">PMC6535196</pub-id></mixed-citation></ref><ref id="B216"><label>216.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#237;az</surname><given-names>AG</given-names></name><name name-style="western"><surname>Quinteros</surname><given-names>DA</given-names></name><name name-style="western"><surname>Paolicchi</surname><given-names>FA</given-names></name><name name-style="western"><surname>Rivero</surname><given-names>MA</given-names></name><name name-style="western"><surname>Palma</surname><given-names>SD</given-names></name><name name-style="western"><surname>Pardo</surname><given-names>RP</given-names></name><etal/></person-group>. <article-title>Mucosal immunization with polymeric antigen BLSOmp31 using alternative delivery systems against <italic toggle="yes">Brucella ovis</italic> in rams</article-title>. <source>Vet Immunol Immunopathol.</source> (<year>2019</year>) <volume>209</volume>:<fpage>70</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetimm.2019.02.005</pub-id><pub-id pub-id-type="pmid">30885309</pub-id></mixed-citation></ref><ref id="B217"><label>217.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghaffari Marandi</surname><given-names>BH</given-names></name><name name-style="western"><surname>Zolfaghari</surname><given-names>MR</given-names></name><name name-style="western"><surname>Kazemi</surname><given-names>R</given-names></name><name name-style="western"><surname>Motamedi</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Amani</surname><given-names>J</given-names></name></person-group>. <article-title>Immunization against <italic toggle="yes">Vibrio cholerae</italic>, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein</article-title>. <source>Microb Pathog.</source> (<year>2019</year>) <volume>134</volume>:<fpage>103600</fpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2019.103600</pub-id><pub-id pub-id-type="pmid">31202906</pub-id></mixed-citation></ref><ref id="B218"><label>218.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kole</surname><given-names>S</given-names></name><name name-style="western"><surname>Qadiri</surname><given-names>SSN</given-names></name><name name-style="western"><surname>Shin</surname><given-names>SM</given-names></name><name name-style="western"><surname>Kim</surname><given-names>WS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Jung</surname><given-names>SJ</given-names></name></person-group>. <article-title>Nanoencapsulation of inactivated-viral vaccine using chitosan nanoparticles: evaluation of its protective efficacy and immune modulatory effects in olive flounder (<italic toggle="yes">Paralichthys olivaceus</italic>) against viral haemorrhagic septicaemia virus (VHSV) infection</article-title>. <source>Fish Shellfish Immunol.</source> (<year>2019</year>) <volume>91</volume>:<fpage>136</fpage>&#8211;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.fsi.2019.05.017</pub-id><pub-id pub-id-type="pmid">31096061</pub-id></mixed-citation></ref><ref id="B219"><label>219.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korupalli</surname><given-names>C</given-names></name><name name-style="western"><surname>Pan</surname><given-names>WY</given-names></name><name name-style="western"><surname>Yeh</surname><given-names>CY</given-names></name><name name-style="western"><surname>Chen</surname><given-names>PM</given-names></name><name name-style="western"><surname>Mi</surname><given-names>FL</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>HW</given-names></name><etal/></person-group>. <article-title>Single-injecting, bioinspired nanocomposite hydrogel that can recruit host immune cells <italic toggle="yes">in situ</italic> to elicit potent and long-lasting humoral immune responses</article-title>. <source>Biomaterials.</source> (<year>2019</year>) <volume>216</volume>:<fpage>119268</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2019.119268</pub-id><pub-id pub-id-type="pmid">31226570</pub-id></mixed-citation></ref><ref id="B220"><label>220.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muralidharan</surname><given-names>A</given-names></name><name name-style="western"><surname>Russell</surname><given-names>MS</given-names></name><name name-style="western"><surname>Larocque</surname><given-names>L</given-names></name><name name-style="western"><surname>Gravel</surname><given-names>C</given-names></name><name name-style="western"><surname>Sauv&#233;</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice</article-title>. <source>Vaccine.</source> (<year>2019</year>) <volume>37</volume>:<fpage>4031</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.06.003</pub-id><pub-id pub-id-type="pmid">31186190</pub-id></mixed-citation></ref><ref id="B221"><label>221.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Senevirathne</surname><given-names>A</given-names></name><name name-style="western"><surname>Hewawaduge</surname><given-names>C</given-names></name><name name-style="western"><surname>Hajam</surname><given-names>IA</given-names></name><name name-style="western"><surname>Lalsiamthara</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group>. <article-title>Intranasally administered anti-Brucella subunit vaccine formulation induces protective immune responses against nasal Brucella challenge</article-title>. <source>Vet Microbiol.</source> (<year>2019</year>) <volume>228</volume>:<fpage>112</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetmic.2018.11.022</pub-id><pub-id pub-id-type="pmid">30593355</pub-id></mixed-citation></ref><ref id="B222"><label>222.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><name name-style="western"><surname>Nisaa</surname><given-names>K</given-names></name><name name-style="western"><surname>Bhattacharyya</surname><given-names>S</given-names></name><name name-style="western"><surname>Mallick</surname><given-names>AI</given-names></name></person-group>. <article-title>Immunogenicity and protective efficacy of mucosal delivery of recombinant hcp of <italic toggle="yes">Campylobacter jejuni</italic> type VI secretion system (T6SS) in chickens</article-title>. <source>Mol Immunol.</source> (<year>2019</year>) <volume>111</volume>:<fpage>182</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2019.04.016</pub-id><pub-id pub-id-type="pmid">31078054</pub-id></mixed-citation></ref><ref id="B223"><label>223.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soh</surname><given-names>SH</given-names></name><name name-style="western"><surname>Shim</surname><given-names>S</given-names></name><name name-style="western"><surname>Im</surname><given-names>YB</given-names></name><name name-style="western"><surname>Park</surname><given-names>HT</given-names></name><name name-style="western"><surname>Cho</surname><given-names>CS</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>HS</given-names></name></person-group>. <article-title>Induction of Th2-related immune responses and production of systemic IgA in mice intranasally immunized with <italic toggle="yes">Brucella abortus</italic> malate dehydrogenase loaded chitosan nanoparticles</article-title>. <source>Vaccine.</source> (<year>2019</year>) <volume>37</volume>:<fpage>1554</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.02.005</pub-id><pub-id pub-id-type="pmid">30792035</pub-id></mixed-citation></ref><ref id="B224"><label>224.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Chitosan and anisodamine improve the immune efficacy of inactivated infectious spleen and kidney necrosis virus vaccine in Siniperca chuatsi</article-title>. <source>Fish Shellfish Immunol.</source> (<year>2019</year>) <volume>89</volume>:<fpage>52</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.fsi.2019.03.040</pub-id><pub-id pub-id-type="pmid">30904683</pub-id></mixed-citation></ref><ref id="B225"><label>225.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hojatizade</surname><given-names>M</given-names></name><name name-style="western"><surname>Soleymani</surname><given-names>M</given-names></name><name name-style="western"><surname>Tafaghodi</surname><given-names>M</given-names></name><name name-style="western"><surname>Badiee</surname><given-names>A</given-names></name><name name-style="western"><surname>Chavoshian</surname><given-names>O</given-names></name><name name-style="western"><surname>Jaafari</surname><given-names>MR</given-names></name></person-group>. <article-title>Chitosan nanoparticles loaded with whole and soluble leishmania antigens, and evaluation of their immunogenecity in a mouse model of leishmaniasis</article-title>. <source>Iran J Immunol.</source> (<year>2018</year>) <volume>15</volume>:<fpage>281</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.22034/IJI.2018.39397</pub-id><pub-id pub-id-type="pmid">30593742</pub-id></mixed-citation></ref><ref id="B226"><label>226.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Song</surname><given-names>X</given-names></name><name name-style="western"><surname>Jing</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against <italic toggle="yes">Trueperella pyogenes</italic> infection</article-title>. <source>J Nanobiotechnol.</source> (<year>2018</year>) <volume>16</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.1186/s12951-018-0337-2</pub-id><pub-id pub-id-type="pmid">29378591</pub-id><pub-id pub-id-type="pmcid">PMC5787914</pub-id></mixed-citation></ref><ref id="B227"><label>227.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malik</surname><given-names>A</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>M</given-names></name><name name-style="western"><surname>Mani</surname><given-names>R</given-names></name><name name-style="western"><surname>Gogoi</surname><given-names>H</given-names></name><name name-style="western"><surname>Bhatnagar</surname><given-names>R</given-names></name></person-group>. <article-title>Trimethyl chitosan nanoparticles encapsulated protective antigen protects the mice against anthrax</article-title>. <source>Front Immunol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>562</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00562</pub-id><pub-id pub-id-type="pmid">29616046</pub-id><pub-id pub-id-type="pmcid">PMC5870345</pub-id></mixed-citation></ref><ref id="B228"><label>228.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>B</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D</given-names></name><name name-style="western"><surname>Guo</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name></person-group>. <article-title>Polysaccharides as vaccine adjuvants</article-title>. <source>Vaccine.</source> (<year>2018</year>) <volume>36</volume>:<fpage>5226</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.07.040</pub-id><pub-id pub-id-type="pmid">30057282</pub-id></mixed-citation></ref><ref id="B229"><label>229.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lebre</surname><given-names>F</given-names></name><name name-style="western"><surname>Bento</surname><given-names>D</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>J</given-names></name><name name-style="western"><surname>Cola&#231;o</surname><given-names>M</given-names></name><name name-style="western"><surname>Borchard</surname><given-names>G</given-names></name><name name-style="western"><surname>de Lima</surname><given-names>MCP</given-names></name><etal/></person-group>. <article-title>Association of chitosan and aluminium as a new adjuvant strategy for improved vaccination</article-title>. <source>Int J Pharm.</source> (<year>2017</year>) <volume>527</volume>:<fpage>103</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2017.05.028</pub-id><pub-id pub-id-type="pmid">28522427</pub-id></mixed-citation></ref><ref id="B230"><label>230.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spinner</surname><given-names>JL</given-names></name><name name-style="western"><surname>Oberoi</surname><given-names>HS</given-names></name><name name-style="western"><surname>Yorgensen</surname><given-names>YM</given-names></name><name name-style="western"><surname>Poirier</surname><given-names>DS</given-names></name><name name-style="western"><surname>Burkhart</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Plante</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually</article-title>. <source>Vaccine.</source> (<year>2015</year>) <volume>33</volume>:<fpage>5845</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.08.086</pub-id><pub-id pub-id-type="pmid">26392012</pub-id><pub-id pub-id-type="pmcid">PMC4609623</pub-id></mixed-citation></ref><ref id="B231"><label>231.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torlak</surname><given-names>E</given-names></name><name name-style="western"><surname>Sert</surname><given-names>D</given-names></name></person-group>. <article-title>Antibacterial effectiveness of chitosan-propolis coated polypropylene films against foodborne pathogens</article-title>. <source>Int J Biol Macromol.</source> (<year>2013</year>) <volume>60</volume>:<fpage>52</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2013.05.013</pub-id><pub-id pub-id-type="pmid">23707735</pub-id></mixed-citation></ref><ref id="B232"><label>232.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>ML</given-names></name><name name-style="western"><surname>Kang</surname><given-names>SG</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>HL</given-names></name><name name-style="western"><surname>Guo</surname><given-names>DD</given-names></name><name name-style="western"><surname>Lee</surname><given-names>DY</given-names></name><name name-style="western"><surname>Rayamahji</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Chitosan microspheres containing <italic toggle="yes">Bordetella bronchiseptica</italic> antigens as novel vaccine against atrophic rhinitis in pigs</article-title>. <source>J Microbiol Biotechnol.</source> (<year>2008</year>) <volume>18</volume>:<fpage>1179</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="pmid">18600065</pub-id></mixed-citation></ref><ref id="B233"><label>233.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Paula Oliveira Santos</surname><given-names>B</given-names></name><name name-style="western"><surname>Trentini</surname><given-names>MM</given-names></name><name name-style="western"><surname>Machado</surname><given-names>RB</given-names></name><name name-style="western"><surname>R&#250;bia Nunes Celes</surname><given-names>M</given-names></name><name name-style="western"><surname>Kipnis</surname><given-names>A</given-names></name><name name-style="western"><surname>Petrovsky</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of four protective mTB antigens, induces a potent Th1 immune response and protects mice against <italic toggle="yes">Mycobacterium tuberculosis</italic> infection</article-title>. <source>Hum Vaccin Immunother.</source> (<year>2017</year>) <volume>13</volume>:<fpage>2967</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1080/21645515.2017.1368598</pub-id><pub-id pub-id-type="pmid">28937879</pub-id><pub-id pub-id-type="pmcid">PMC5718803</pub-id></mixed-citation></ref><ref id="B234"><label>234.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horst</surname><given-names>G</given-names></name><name name-style="western"><surname>Levine</surname><given-names>R</given-names></name><name name-style="western"><surname>Chick</surname><given-names>R</given-names></name><name name-style="western"><surname>Hofacre</surname><given-names>C</given-names></name></person-group>. <article-title>Effects of beta-1,3-glucan (AletaTM) on vaccination response in broiler chickens</article-title>. <source>Poult Sci.</source> (<year>2019</year>) <volume>98</volume>:<fpage>1643</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3382/ps/pey523</pub-id><pub-id pub-id-type="pmid">30476311</pub-id></mixed-citation></ref><ref id="B235"><label>235.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Tejada</surname><given-names>A</given-names></name><name name-style="western"><surname>Dong</surname><given-names>S</given-names></name></person-group>. <article-title>&#946;-Glucan as an immune activator and a carrier in the construction of a synthetic MUC1 vaccine</article-title>. <source>Chem Commun.</source> (<year>2018</year>) <volume>55</volume>:<fpage>253</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1039/C8CC07691J</pub-id><pub-id pub-id-type="pmid">30534737</pub-id></mixed-citation></ref><ref id="B236"><label>236.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whelan</surname><given-names>AO</given-names></name><name name-style="western"><surname>Flick-Smith</surname><given-names>HC</given-names></name><name name-style="western"><surname>Homan</surname><given-names>J</given-names></name><name name-style="western"><surname>Shen</surname><given-names>ZT</given-names></name><name name-style="western"><surname>Carpenter</surname><given-names>Z</given-names></name><name name-style="western"><surname>Khoshkenar</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles</article-title>. <source>PLoS ONE.</source> (<year>2018</year>) <volume>13</volume>:<fpage>e0200213</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0200213</pub-id><pub-id pub-id-type="pmid">30296254</pub-id><pub-id pub-id-type="pmcid">PMC6175290</pub-id></mixed-citation></ref><ref id="B237"><label>237.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hung</surname><given-names>CY</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Castro-Lopez</surname><given-names>N</given-names></name><name name-style="western"><surname>Ostroff</surname><given-names>GR</given-names></name><name name-style="western"><surname>Khoshlenar</surname><given-names>P</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Glucan-chitin particles enhance Th17 response and improve protective efficacy of a multivalent antigen (rCpa1) against pulmonary <italic toggle="yes">Coccidioides posadasii</italic> infection</article-title>. <source>Infect Immun.</source> (<year>2018</year>) <volume>86</volume>:<fpage>e00070</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00070-18</pub-id><pub-id pub-id-type="pmid">30104216</pub-id><pub-id pub-id-type="pmcid">PMC6204714</pub-id></mixed-citation></ref><ref id="B238"><label>238.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bundle</surname><given-names>DR</given-names></name><name name-style="western"><surname>Paszkiewicz</surname><given-names>E</given-names></name><name name-style="western"><surname>Elsaidi</surname><given-names>HRH</given-names></name><name name-style="western"><surname>Mandal</surname><given-names>SS</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>S</given-names></name></person-group>. <article-title>A three component synthetic vaccine containing a &#946;-mannan T-cell peptide epitope and a &#946;-glucan dendritic cell ligand</article-title>. <source>Molecules.</source> (<year>2018</year>) <volume>23</volume>:<fpage>E1961</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23081961</pub-id><pub-id pub-id-type="pmid">30082627</pub-id><pub-id pub-id-type="pmcid">PMC6222438</pub-id></mixed-citation></ref><ref id="B239"><label>239.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>LG</given-names></name><name name-style="western"><surname>Endrighi</surname><given-names>M</given-names></name><name name-style="western"><surname>Lisenko</surname><given-names>KG</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>MRD</given-names></name><name name-style="western"><surname>Damasceno</surname><given-names>MR</given-names></name><name name-style="western"><surname>Claudino</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>Oat beta-glucan as a dietary supplement for dogs</article-title>. <source>PLoS ONE.</source> (<year>2018</year>) <volume>13</volume>:<fpage>e0201133</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0201133</pub-id><pub-id pub-id-type="pmid">30063762</pub-id><pub-id pub-id-type="pmcid">PMC6067736</pub-id></mixed-citation></ref><ref id="B240"><label>240.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deepe</surname><given-names>GS</given-names></name><name name-style="western"><surname>Buesing</surname><given-names>WR</given-names></name><name name-style="western"><surname>Ostroff</surname><given-names>GR</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>A</given-names></name><name name-style="western"><surname>Specht</surname><given-names>CA</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice</article-title>. <source>Vaccine.</source> (<year>2018</year>) <volume>36</volume>:<fpage>3359</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.04.047</pub-id><pub-id pub-id-type="pmid">29729993</pub-id><pub-id pub-id-type="pmcid">PMC5960637</pub-id></mixed-citation></ref><ref id="B241"><label>241.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name></person-group>. <article-title>&#946;-glucans as potential immunoadjuvants: a review on the adjuvanticity, structure-activity relationship and receptor recognition properties</article-title>. <source>Vaccine.</source> (<year>2018</year>) <volume>36</volume>:<fpage>5235</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.07.038</pub-id><pub-id pub-id-type="pmid">30049632</pub-id></mixed-citation></ref><ref id="B242"><label>242.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Asokanathan</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Khaing</surname><given-names>KK</given-names></name><name name-style="western"><surname>Kmiec</surname><given-names>D</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>PLGA nano/micro particles encapsulated with pertussis toxoid (PTd) enhances Th1/Th17 immune response in a murine model</article-title>. <source>Int J Pharm.</source> (<year>2016</year>) <volume>513</volume>:<fpage>183</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2016.08.059</pub-id><pub-id pub-id-type="pmid">27586408</pub-id></mixed-citation></ref><ref id="B243"><label>243.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>W</given-names></name><name name-style="western"><surname>Kou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name><name name-style="western"><surname>Gao</surname><given-names>F</given-names></name><name name-style="western"><surname>Kong</surname><given-names>W</given-names></name><name name-style="western"><surname>Su</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant</article-title>. <source>Immunol Lett.</source> (<year>2018</year>) <volume>198</volume>:<fpage>26</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.imlet.2018.03.012</pub-id><pub-id pub-id-type="pmid">29601940</pub-id></mixed-citation></ref><ref id="B244"><label>244.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Claesson</surname><given-names>MH</given-names></name></person-group>. <article-title>Immunological links to nonspecific effects of DTwP and BCG vaccines on infant mortality</article-title>. <source>J Trop Med.</source> (<year>2011</year>) <volume>2011</volume>:<fpage>706304</fpage>. <pub-id pub-id-type="doi">10.1155/2011/706304</pub-id><pub-id pub-id-type="pmid">21760811</pub-id><pub-id pub-id-type="pmcid">PMC3134263</pub-id></mixed-citation></ref><ref id="B245"><label>245.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nascimento</surname><given-names>IP</given-names></name><name name-style="western"><surname>Dias</surname><given-names>WO</given-names></name><name name-style="western"><surname>Quintilio</surname><given-names>W</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>T</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>WR</given-names></name><name name-style="western"><surname>Leite</surname><given-names>LC</given-names></name></person-group>. <article-title>Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against <italic toggle="yes">Bordetella pertussis</italic> challenge in neonates</article-title>. <source>Vaccine.</source> (<year>2009</year>) <volume>27</volume>:<fpage>7346</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.09.043</pub-id><pub-id pub-id-type="pmid">19782111</pub-id></mixed-citation></ref><ref id="B246"><label>246.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nascimento</surname><given-names>IP</given-names></name><name name-style="western"><surname>Dias</surname><given-names>WO</given-names></name><name name-style="western"><surname>Quintilio</surname><given-names>W</given-names></name><name name-style="western"><surname>Christ</surname><given-names>AP</given-names></name><name name-style="western"><surname>Moraes</surname><given-names>JF</given-names></name><name name-style="western"><surname>Vancetto</surname><given-names>MD</given-names></name><etal/></person-group>. <article-title>Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against <italic toggle="yes">Bordetella pertussis</italic> intracerebral challenge</article-title>. <source>Microbes Infect.</source> (<year>2008</year>) <volume>10</volume>:<fpage>198</fpage>&#8211;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2007.10.010</pub-id><pub-id pub-id-type="pmid">18248757</pub-id></mixed-citation></ref><ref id="B247"><label>247.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nascimento</surname><given-names>IP</given-names></name><name name-style="western"><surname>Dias</surname><given-names>WO</given-names></name><name name-style="western"><surname>Mazzantini</surname><given-names>RP</given-names></name><name name-style="western"><surname>Miyaji</surname><given-names>EN</given-names></name><name name-style="western"><surname>Gamberini</surname><given-names>M</given-names></name><name name-style="western"><surname>Quintilio</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Recombinant <italic toggle="yes">Mycobacterium bovis</italic> BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live <italic toggle="yes">Bordetella pertussis</italic> in mice</article-title>. <source>Infect Immun.</source> (<year>2000</year>) <volume>68</volume>:<fpage>4877</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.68.9.4877-4883.2000</pub-id><pub-id pub-id-type="pmid">10948100</pub-id><pub-id pub-id-type="pmcid">PMC101688</pub-id></mixed-citation></ref><ref id="B248"><label>248.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cainelli Gebara</surname><given-names>VC</given-names></name><name name-style="western"><surname>Risol&#233;o</surname><given-names>L</given-names></name><name name-style="western"><surname>Lopes</surname><given-names>AP</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>VR</given-names></name><name name-style="western"><surname>Quintilio</surname><given-names>W</given-names></name><name name-style="western"><surname>L&#233;pine</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>Vaccine.</source> (<year>2007</year>) <volume>25</volume>:<fpage>621</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2006.08.033</pub-id><pub-id pub-id-type="pmid">17011680</pub-id></mixed-citation></ref><ref id="B249"><label>249.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliver</surname><given-names>DC</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>RC</given-names></name></person-group>. <article-title>Antibodies to BrkA augment killing of <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>Vaccine.</source> (<year>2001</year>) <volume>20</volume>:<fpage>235</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/S0264-410X(01)00269-9</pub-id><pub-id pub-id-type="pmid">11567769</pub-id></mixed-citation></ref><ref id="B250"><label>250.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marr</surname><given-names>N</given-names></name><name name-style="western"><surname>Shah</surname><given-names>NR</given-names></name><name name-style="western"><surname>Lee</surname><given-names>R</given-names></name><name name-style="western"><surname>Kim</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>RC</given-names></name></person-group>. <article-title><italic toggle="yes">Bordetella pertussis</italic> autotransporter Vag8 binds human C1 esterase inhibitor and confers serum resistance</article-title>. <source>PLoS ONE.</source> (<year>2011</year>) <volume>6</volume>:<fpage>e20585</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0020585</pub-id><pub-id pub-id-type="pmid">21695123</pub-id><pub-id pub-id-type="pmcid">PMC3114845</pub-id></mixed-citation></ref><ref id="B251"><label>251.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finn</surname><given-names>TM</given-names></name><name name-style="western"><surname>Amsbaugh</surname><given-names>DF</given-names></name></person-group>. <article-title>Vag8, a <italic toggle="yes">Bordetella pertussis</italic> bvg-regulated protein</article-title>. <source>Infect Immun.</source> (<year>1998</year>) <volume>66</volume>:<fpage>3985</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="pmid">9673293</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.66.8.3985-3989.1998</pub-id><pub-id pub-id-type="pmcid">PMC108471</pub-id></mixed-citation></ref><ref id="B252"><label>252.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name><name name-style="western"><surname>Shinzawa</surname><given-names>N</given-names></name><name name-style="western"><surname>Ishigaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Abe</surname><given-names>H</given-names></name><name name-style="western"><surname>Fukui-Miyazaki</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Protective effects of <italic toggle="yes">in vivo</italic>-expressed autotransporters against <italic toggle="yes">Bordetella pertussis</italic> infection</article-title>. <source>Microbiol Immunol.</source> (<year>2017</year>) <volume>61</volume>:<fpage>371</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/1348-0421.12504</pub-id><pub-id pub-id-type="pmid">28752940</pub-id></mixed-citation></ref><ref id="B253"><label>253.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boehm</surname><given-names>DT</given-names></name><name name-style="western"><surname>Hall</surname><given-names>JM</given-names></name><name name-style="western"><surname>Wong</surname><given-names>TY</given-names></name><name name-style="western"><surname>DiVenere</surname><given-names>AM</given-names></name><name name-style="western"><surname>Sen-Kilic</surname><given-names>E</given-names></name><name name-style="western"><surname>Bevere</surname><given-names>JR</given-names></name><etal/></person-group>. <article-title>Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines by using a <italic toggle="yes">Bordetella pertussis</italic> challenge model in mice</article-title>. <source>Infect Immun.</source> (<year>2018</year>) <volume>86</volume>:<fpage>e00857</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00857-17</pub-id><pub-id pub-id-type="pmid">30012638</pub-id><pub-id pub-id-type="pmcid">PMC6204743</pub-id></mixed-citation></ref><ref id="B254"><label>254.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Gray</surname><given-names>MC</given-names></name><name name-style="western"><surname>Hewlett</surname><given-names>EL</given-names></name><name name-style="western"><surname>Maynard</surname><given-names>JA</given-names></name></person-group><article-title>The <italic toggle="yes">Bordetella</italic> adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies</article-title>. <source>J Biol Chem.</source> (<year>2015</year>) <volume>290</volume>:<fpage>23025</fpage><pub-id pub-id-type="doi">10.1074/jbc.A114.585281</pub-id><pub-id pub-id-type="pmid">26386047</pub-id><pub-id pub-id-type="pmcid">PMC4645631</pub-id></mixed-citation></ref><ref id="B255"><label>255.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jennings-Gee</surname><given-names>J</given-names></name><name name-style="western"><surname>Quataert</surname><given-names>S</given-names></name><name name-style="western"><surname>Ganguly</surname><given-names>T</given-names></name><name name-style="western"><surname>D'Agostino</surname><given-names>R</given-names></name><name name-style="western"><surname>Deora</surname><given-names>R</given-names></name><name name-style="western"><surname>Dubey</surname><given-names>P</given-names></name></person-group>. <article-title>The adjuvant <italic toggle="yes">Bordetella</italic> colonization factor A attenuates alum-induced Th2 responses and enhances <italic toggle="yes">Bordetella pertussis</italic> clearance from mouse lungs</article-title>. <source>Infect Immun.</source> (<year>2018</year>) <volume>86</volume>:<fpage>e00935</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00935-17</pub-id><pub-id pub-id-type="pmid">29531137</pub-id><pub-id pub-id-type="pmcid">PMC5964531</pub-id></mixed-citation></ref><ref id="B256"><label>256.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scanlon</surname><given-names>KM</given-names></name><name name-style="western"><surname>Skerry</surname><given-names>C</given-names></name><name name-style="western"><surname>Carbonetti</surname><given-names>NH</given-names></name></person-group>. <article-title>Novel therapies for the treatment of pertussis disease</article-title>. <source>Pathog Dis.</source> (<year>2015</year>) <volume>73</volume>:<fpage>ftv074</fpage>. <pub-id pub-id-type="doi">10.1093/femspd/ftv074</pub-id><pub-id pub-id-type="pmid">26394802</pub-id><pub-id pub-id-type="pmcid">PMC4626598</pub-id></mixed-citation></ref><ref id="B257"><label>257.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skerry</surname><given-names>CM</given-names></name><name name-style="western"><surname>Mahon</surname><given-names>BP</given-names></name></person-group>. <article-title>A live, attenuated <italic toggle="yes">Bordetella pertussis</italic> vaccine provides long-term protection against virulent challenge in a murine model</article-title>. <source>Clin Vaccine Immunol.</source> (<year>2011</year>) <volume>18</volume>:<fpage>187</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1128/CVI.00371-10</pub-id><pub-id pub-id-type="pmid">21147936</pub-id><pub-id pub-id-type="pmcid">PMC3067348</pub-id></mixed-citation></ref><ref id="B258"><label>258.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skerry</surname><given-names>CM</given-names></name><name name-style="western"><surname>Cassidy</surname><given-names>JP</given-names></name><name name-style="western"><surname>English</surname><given-names>K</given-names></name><name name-style="western"><surname>Feunou-Feunou</surname><given-names>P</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name><name name-style="western"><surname>Mahon</surname><given-names>BP</given-names></name></person-group><article-title>A live attenuated <italic toggle="yes">Bordetella pertussis</italic> candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice</article-title>. <source>Clin Vaccine Immunol.</source> (<year>2009</year>) <volume>16</volume>:<fpage>1344</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1128/CVI.00082-09</pub-id><pub-id pub-id-type="pmid">19625486</pub-id><pub-id pub-id-type="pmcid">PMC2745004</pub-id></mixed-citation></ref><ref id="B259"><label>259.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brennan</surname><given-names>MJ</given-names></name></person-group>. <article-title>A new whooping cough vaccine that may prevent colonization and transmission</article-title>. <source>Vaccines.</source> (<year>2017</year>) <volume>5</volume>:<fpage>E43</fpage>. <pub-id pub-id-type="doi">10.3390/vaccines5040043</pub-id><pub-id pub-id-type="pmid">29125532</pub-id><pub-id pub-id-type="pmcid">PMC5748610</pub-id></mixed-citation></ref><ref id="B260"><label>260.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name><name name-style="western"><surname>Papin</surname><given-names>JF</given-names></name><name name-style="western"><surname>Lecher</surname><given-names>S</given-names></name><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>Thalen</surname><given-names>M</given-names></name><name name-style="western"><surname>Solovay</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Live attenuated pertussis vaccine BPZE1 protects baboons against <italic toggle="yes">Bordetella pertussis</italic> disease and infection</article-title>. <source>J Infect Dis.</source> (<year>2017</year>) <volume>216</volume>:<fpage>117</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jix254</pub-id><pub-id pub-id-type="pmid">28535276</pub-id><pub-id pub-id-type="pmcid">PMC5853371</pub-id></mixed-citation></ref><ref id="B261"><label>261.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name></person-group>. <article-title>Live pertussis vaccines will they protect against carriage and spread of pertussis?</article-title><source>Clin Microbiol Infect.</source> (<year>2016</year>) <volume>22</volume>(<issue>Suppl. 5</issue>):<fpage>S96</fpage>&#8211;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmi.2016.05.029</pub-id><pub-id pub-id-type="pmid">28341014</pub-id></mixed-citation></ref><ref id="B262"><label>262.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name></person-group>. <article-title>Pertussis: where did we go wrong and what can we do about it?</article-title><source>J Infect.</source> (<year>2016</year>) <volume>72</volume>(<issue>Suppl.</issue>): <fpage>S34</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2016.04.020</pub-id><pub-id pub-id-type="pmid">27161992</pub-id></mixed-citation></ref><ref id="B263"><label>263.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feunou</surname><given-names>PF</given-names></name><name name-style="western"><surname>Kammoun</surname><given-names>H</given-names></name><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name></person-group>. <article-title>Heterologous prime-boost immunization with live attenuated <italic toggle="yes">B. pertussis</italic> BPZE1 followed by acellular pertussis vaccine in mice</article-title>. <source>Vaccine.</source> (<year>2014</year>) <volume>32</volume>:<fpage>4281</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.06.019</pub-id><pub-id pub-id-type="pmid">24950361</pub-id></mixed-citation></ref><ref id="B264"><label>264.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jahnmatz</surname><given-names>M</given-names></name><name name-style="western"><surname>Amu</surname><given-names>S</given-names></name><name name-style="western"><surname>Ljungman</surname><given-names>M</given-names></name><name name-style="western"><surname>Wehlin</surname><given-names>L</given-names></name><name name-style="western"><surname>Chiodi</surname><given-names>F</given-names></name><name name-style="western"><surname>Mielcarek</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>B-cell responses after intranasal vaccination with the novel attenuated <italic toggle="yes">Bordetella pertussis</italic> vaccine strain BPZE1 in a randomized phase I clinical trial</article-title>. <source>Vaccine.</source> (<year>2014</year>) <volume>32</volume>:<fpage>3350</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.04.048</pub-id><pub-id pub-id-type="pmid">24793938</pub-id></mixed-citation></ref><ref id="B265"><label>265.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>A</given-names></name><name name-style="western"><surname>Ng</surname><given-names>JK</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>S</given-names></name></person-group>. <article-title>Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate</article-title>. <source>Microbes Infect.</source> (<year>2014</year>) <volume>16</volume>:<fpage>51</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2013.10.002</pub-id><pub-id pub-id-type="pmid">24140230</pub-id></mixed-citation></ref><ref id="B266"><label>266.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schiavoni</surname><given-names>I</given-names></name><name name-style="western"><surname>Fedele</surname><given-names>G</given-names></name><name name-style="western"><surname>Quattrini</surname><given-names>A</given-names></name><name name-style="western"><surname>Bianco</surname><given-names>M</given-names></name><name name-style="western"><surname>Schnoeller</surname><given-names>C</given-names></name><name name-style="western"><surname>Openshaw</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>Live attenuated <italic toggle="yes">B. pertussis</italic> BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responses</article-title>. <source>PLoS ONE.</source> (<year>2014</year>) <volume>9</volume>:<fpage>e100166</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0100166</pub-id><pub-id pub-id-type="pmid">24967823</pub-id><pub-id pub-id-type="pmcid">PMC4072631</pub-id></mixed-citation></ref><ref id="B267"><label>267.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schnoeller</surname><given-names>C</given-names></name><name name-style="western"><surname>Roux</surname><given-names>X</given-names></name><name name-style="western"><surname>Sawant</surname><given-names>D</given-names></name><name name-style="western"><surname>Raze</surname><given-names>D</given-names></name><name name-style="western"><surname>Olszewska</surname><given-names>W</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Attenuated <italic toggle="yes">Bordetella pertussis</italic> vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism</article-title>. <source>Am J Respir Crit Care Med.</source> (<year>2014</year>) <volume>189</volume>:<fpage>194</fpage>&#8211;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201307-1227OC</pub-id><pub-id pub-id-type="pmid">24261996</pub-id><pub-id pub-id-type="pmcid">PMC3983892</pub-id></mixed-citation></ref><ref id="B268"><label>268.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thorstensson</surname><given-names>R</given-names></name><name name-style="western"><surname>Trollfors</surname><given-names>B</given-names></name><name name-style="western"><surname>Al-Tawil</surname><given-names>N</given-names></name><name name-style="western"><surname>Jahnmatz</surname><given-names>M</given-names></name><name name-style="western"><surname>Bergstr&#246;m</surname><given-names>J</given-names></name><name name-style="western"><surname>Ljungman</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>A phase I clinical study of a live attenuated <italic toggle="yes">Bordetella pertussis</italic> vaccine&#8211;BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers</article-title>. <source>PLoS ONE.</source> (<year>2014</year>) <volume>9</volume>:<fpage>e83449</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0083449</pub-id><pub-id pub-id-type="pmid">24421886</pub-id><pub-id pub-id-type="pmcid">PMC3885431</pub-id></mixed-citation></ref><ref id="B269"><label>269.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kammoun</surname><given-names>H</given-names></name><name name-style="western"><surname>Roux</surname><given-names>X</given-names></name><name name-style="western"><surname>Raze</surname><given-names>D</given-names></name><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>De Filette</surname><given-names>M</given-names></name><name name-style="western"><surname>Ysenbaert</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Immunogenicity of live attenuated <italic toggle="yes">B. pertussis</italic> BPZE1 producing the universal influenza vaccine candidate M2e</article-title>. <source>PLoS ONE.</source> (<year>2013</year>) <volume>8</volume>:<fpage>e59198</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0059198</pub-id><pub-id pub-id-type="pmid">23555631</pub-id><pub-id pub-id-type="pmcid">PMC3602086</pub-id></mixed-citation></ref><ref id="B270"><label>270.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kammoun</surname><given-names>H</given-names></name><name name-style="western"><surname>Feunou</surname><given-names>PF</given-names></name><name name-style="western"><surname>Foligne</surname><given-names>B</given-names></name><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>Raze</surname><given-names>D</given-names></name><name name-style="western"><surname>Mielcarek</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Dual mechanism of protection by live attenuated <italic toggle="yes">Bordetella pertussis</italic> BPZE1 against <italic toggle="yes">Bordetella bronchiseptica</italic> in mice</article-title>. <source>Vaccine.</source> (<year>2012</year>) <volume>30</volume>:<fpage>5864</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2012.07.005</pub-id><pub-id pub-id-type="pmid">22814407</pub-id></mixed-citation></ref><ref id="B271"><label>271.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>C</given-names></name><name name-style="western"><surname>Chong</surname><given-names>SZ</given-names></name><name name-style="western"><surname>Lim</surname><given-names>AR</given-names></name><name name-style="western"><surname>Goh</surname><given-names>YF</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Attenuated <italic toggle="yes">Bordetella pertussis</italic> BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models</article-title>. <source>Allergy.</source> (<year>2012</year>) <volume>67</volume>:<fpage>1250</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1398-9995.2012.02884.x</pub-id><pub-id pub-id-type="pmid">22909095</pub-id></mixed-citation></ref><ref id="B272"><label>272.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fedele</surname><given-names>G</given-names></name><name name-style="western"><surname>Bianco</surname><given-names>M</given-names></name><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name><name name-style="western"><surname>Ausiello</surname><given-names>CM</given-names></name></person-group>. <article-title>Attenuated <italic toggle="yes">Bordetella pertussis</italic> vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response</article-title>. <source>J Immunol.</source> (<year>2011</year>) <volume>186</volume>:<fpage>5388</fpage>&#8211;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1003765</pub-id><pub-id pub-id-type="pmid">21430219</pub-id></mixed-citation></ref><ref id="B273"><label>273.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Lim</surname><given-names>A</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>S</given-names></name></person-group>. <article-title>Attenuated <italic toggle="yes">Bordetella pertussis</italic> BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route</article-title>. <source>Bioeng Bugs.</source> (<year>2011</year>) <volume>2</volume>:<fpage>315</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4161/bbug.2.6.18167</pub-id><pub-id pub-id-type="pmid">22067832</pub-id></mixed-citation></ref><ref id="B274"><label>274.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Lim</surname><given-names>A</given-names></name><name name-style="western"><surname>Ow</surname><given-names>ST</given-names></name><name name-style="western"><surname>Phoon</surname><given-names>MC</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name><name name-style="western"><surname>Chow</surname><given-names>VT</given-names></name><etal/></person-group>. <article-title>Development of live attenuated <italic toggle="yes">Bordetella pertussis</italic> strains expressing the universal influenza vaccine candidate M2e</article-title>. <source>Vaccine.</source> (<year>2011</year>) <volume>29</volume>:<fpage>5502</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.05.052</pub-id><pub-id pub-id-type="pmid">21624415</pub-id></mixed-citation></ref><ref id="B275"><label>275.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feunou</surname><given-names>PF</given-names></name><name name-style="western"><surname>Bertout</surname><given-names>J</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name></person-group>. <article-title>T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis</article-title>. <source>PLoS ONE.</source> (<year>2010</year>) <volume>5</volume>:<fpage>e10178</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0010178</pub-id><pub-id pub-id-type="pmid">20419113</pub-id><pub-id pub-id-type="pmcid">PMC2855369</pub-id></mixed-citation></ref><ref id="B276"><label>276.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feunou</surname><given-names>PF</given-names></name><name name-style="western"><surname>Kammoun</surname><given-names>H</given-names></name><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>Mielcarek</surname><given-names>N</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name></person-group>. <article-title>Long-term immunity against pertussis induced by a single nasal administration of live attenuated <italic toggle="yes">B. pertussis</italic> BPZE1</article-title>. <source>Vaccine.</source> (<year>2010</year>) <volume>28</volume>:<fpage>7047</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2010.08.017</pub-id><pub-id pub-id-type="pmid">20708998</pub-id></mixed-citation></ref><ref id="B277"><label>277.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kavanagh</surname><given-names>H</given-names></name><name name-style="western"><surname>Noone</surname><given-names>C</given-names></name><name name-style="western"><surname>Cahill</surname><given-names>E</given-names></name><name name-style="western"><surname>English</surname><given-names>K</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name><name name-style="western"><surname>Mahon</surname><given-names>BP</given-names></name></person-group>. <article-title>Attenuated <italic toggle="yes">Bordetella pertussis</italic> vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model</article-title>. <source>Clin Exp Allergy.</source> (<year>2010</year>) <volume>40</volume>:<fpage>933</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2222.2010.03459.x</pub-id><pub-id pub-id-type="pmid">20184606</pub-id></mixed-citation></ref><ref id="B278"><label>278.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Lim</surname><given-names>A</given-names></name><name name-style="western"><surname>Phoon</surname><given-names>MC</given-names></name><name name-style="western"><surname>Narasaraju</surname><given-names>T</given-names></name><name name-style="western"><surname>Ng</surname><given-names>JK</given-names></name><name name-style="western"><surname>Poh</surname><given-names>WP</given-names></name><etal/></person-group>. <article-title>Attenuated <italic toggle="yes">Bordetella pertussis</italic> protects against highly pathogenic influenza A viruses by dampening the cytokine storm</article-title>. <source>J Virol.</source> (<year>2010</year>) <volume>84</volume>:<fpage>7105</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02542-09</pub-id><pub-id pub-id-type="pmid">20444902</pub-id><pub-id pub-id-type="pmcid">PMC2898226</pub-id></mixed-citation></ref><ref id="B279"><label>279.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mielcarek</surname><given-names>N</given-names></name><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>Mahieux</surname><given-names>S</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name></person-group>. <article-title>Dose response of attenuated <italic toggle="yes">Bordetella pertussis</italic> BPZE1-induced protection in mice</article-title>. <source>Clin Vaccine Immunol.</source> (<year>2010</year>) <volume>17</volume>:<fpage>317</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1128/CVI.00322-09</pub-id><pub-id pub-id-type="pmid">20107007</pub-id><pub-id pub-id-type="pmcid">PMC2837960</pub-id></mixed-citation></ref><ref id="B280"><label>280.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feunou</surname><given-names>PF</given-names></name><name name-style="western"><surname>Ismaili</surname><given-names>J</given-names></name><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>Huot</surname><given-names>L</given-names></name><name name-style="western"><surname>Hot</surname><given-names>D</given-names></name><name name-style="western"><surname>Raze</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Genetic stability of the live attenuated <italic toggle="yes">Bordetella pertussis</italic> vaccine candidate BPZE1</article-title>. <source>Vaccine.</source> (<year>2008</year>) <volume>26</volume>:<fpage>5722</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2008.08.018</pub-id><pub-id pub-id-type="pmid">18762220</pub-id></mixed-citation></ref><ref id="B281"><label>281.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>SY</given-names></name><name name-style="western"><surname>Chua</surname><given-names>SQ</given-names></name><name name-style="western"><surname>Foo</surname><given-names>DG</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name><name name-style="western"><surname>Chow</surname><given-names>VT</given-names></name><name name-style="western"><surname>Poh</surname><given-names>CL</given-names></name><etal/></person-group>. <article-title>Highly attenuated <italic toggle="yes">Bordetella pertussis</italic> strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates</article-title>. <source>Infect Immun.</source> (<year>2008</year>) <volume>76</volume>:<fpage>111</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00795-07</pub-id><pub-id pub-id-type="pmid">17954727</pub-id><pub-id pub-id-type="pmcid">PMC2223651</pub-id></mixed-citation></ref><ref id="B282"><label>282.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mielcarek</surname><given-names>N</given-names></name><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>Raze</surname><given-names>D</given-names></name><name name-style="western"><surname>Bertout</surname><given-names>J</given-names></name><name name-style="western"><surname>Rouanet</surname><given-names>C</given-names></name><name name-style="western"><surname>Younes</surname><given-names>AB</given-names></name><etal/></person-group>. <article-title>Live attenuated B. <italic toggle="yes">pertussis</italic> as a single-dose nasal vaccine against whooping cough</article-title>. <source>PLoS Pathog.</source> (<year>2006</year>) <volume>2</volume>:<fpage>e65</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.0020065</pub-id><pub-id pub-id-type="pmid">16839199</pub-id><pub-id pub-id-type="pmcid">PMC1487175</pub-id></mixed-citation></ref><ref id="B283"><label>283.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>Coutte</surname><given-names>L</given-names></name><name name-style="western"><surname>Raze</surname><given-names>D</given-names></name><name name-style="western"><surname>Mooi</surname><given-names>F</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>F</given-names></name><name name-style="western"><surname>Gorringe</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Construction and evaluation of <italic toggle="yes">Bordetella pertussis</italic> live attenuated vaccine strain BPZE1 producing Fim3</article-title>. <source>Vaccine.</source> (<year>2018</year>) <volume>36</volume>:<fpage>1345</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.02.017</pub-id><pub-id pub-id-type="pmid">29433898</pub-id></mixed-citation></ref><ref id="B284"><label>284.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solans</surname><given-names>L</given-names></name><name name-style="western"><surname>Debrie</surname><given-names>AS</given-names></name><name name-style="western"><surname>Borkner</surname><given-names>L</given-names></name><name name-style="western"><surname>Aguil&#243;</surname><given-names>N</given-names></name><name name-style="western"><surname>Thiriard</surname><given-names>A</given-names></name><name name-style="western"><surname>Coutte</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>IL-17-dependent SIgA-mediated protection against nasal <italic toggle="yes">Bordetella pertussis</italic> infection by live attenuated BPZE1 vaccine</article-title>. <source>Mucosal Immunol.</source> (<year>2018</year>) <volume>11</volume>:<fpage>1753</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/s41385-018-0073-9</pub-id><pub-id pub-id-type="pmid">30115992</pub-id></mixed-citation></ref><ref id="B285"><label>285.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gasperini</surname><given-names>G</given-names></name><name name-style="western"><surname>Biagini</surname><given-names>M</given-names></name><name name-style="western"><surname>Arato</surname><given-names>V</given-names></name><name name-style="western"><surname>Gianfaldoni</surname><given-names>C</given-names></name><name name-style="western"><surname>Vadi</surname><given-names>A</given-names></name><name name-style="western"><surname>Norais</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Outer Membrane Vesicles (OMV)-based and proteomics-driven antigen selection identifies novel factors contributing to epithelial cells</article-title>. <source>Mol Cell Proteomics.</source> (<year>2018</year>) <volume>17</volume>:<fpage>205</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.RA117.000045</pub-id><pub-id pub-id-type="pmid">29203497</pub-id><pub-id pub-id-type="pmcid">PMC5795387</pub-id></mixed-citation></ref><ref id="B286"><label>286.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gasperini</surname><given-names>G</given-names></name><name name-style="western"><surname>Biagini</surname><given-names>M</given-names></name><name name-style="western"><surname>Arato</surname><given-names>V</given-names></name><name name-style="western"><surname>Gianfaldoni</surname><given-names>C</given-names></name><name name-style="western"><surname>Vadi</surname><given-names>A</given-names></name><name name-style="western"><surname>Norais</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Outer Membrane Vesicles (OMV)-based and proteomics-driven antigen selection identifies novel factors contributing to <italic toggle="yes">Bordetella pertussis</italic> adhesion to epithelial cells</article-title>. <source>Mol Cell Proteomics.</source> (<year>2017</year>) <volume>17</volume>:<fpage>205</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="pmid">29203497</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/mcp.RA117.000045</pub-id><pub-id pub-id-type="pmcid">PMC5795387</pub-id></mixed-citation></ref><ref id="B287"><label>287.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saito</surname><given-names>M</given-names></name><name name-style="western"><surname>Odanaka</surname><given-names>K</given-names></name><name name-style="western"><surname>Otsuka</surname><given-names>N</given-names></name><name name-style="western"><surname>Kamachi</surname><given-names>K</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>M</given-names></name></person-group>. <article-title>Development of vaccines against pertussis caused by <italic toggle="yes">Bordetella holmesii</italic> using a mouse intranasal challenge model</article-title>. <source>Microbiol Immunol.</source> (<year>2016</year>) <volume>60</volume>:<fpage>599</fpage>&#8211;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1111/1348-0421.12409</pub-id><pub-id pub-id-type="pmid">27515393</pub-id></mixed-citation></ref><ref id="B288"><label>288.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bottero</surname><given-names>D</given-names></name><name name-style="western"><surname>Zurita</surname><given-names>ME</given-names></name><name name-style="western"><surname>Gaillard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Bartel</surname><given-names>E</given-names></name><name name-style="western"><surname>Vercellini</surname><given-names>C</given-names></name><name name-style="western"><surname>Hozbor</surname><given-names>D</given-names></name></person-group>. <article-title>Membrane vesicles derived from <italic toggle="yes">Bordetella bronchiseptica</italic>: active constituent of a new vaccine against infections caused by this pathogen</article-title>. <source>Appl Environ Microbiol.</source> (<year>2018</year>) <volume>84</volume>:<fpage>e01877</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01877-17</pub-id><pub-id pub-id-type="pmid">29180369</pub-id><pub-id pub-id-type="pmcid">PMC5795063</pub-id></mixed-citation></ref><ref id="B289"><label>289.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bottero</surname><given-names>D</given-names></name><name name-style="western"><surname>Zurita</surname><given-names>ME</given-names></name><name name-style="western"><surname>Gaillard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Bartel</surname><given-names>E</given-names></name><name name-style="western"><surname>Vercellini</surname><given-names>C</given-names></name><name name-style="western"><surname>Hozbor</surname><given-names>D</given-names></name></person-group>. <article-title>Membrane vesicles derived from <italic toggle="yes">Bordetella bronchiseptica</italic>: active constituent of a new vaccine against infections caused by this pathogen</article-title>. <source>Appl Environ Microbiol</source>. (<year>2017</year>) <volume>84</volume>:<fpage>e01877</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="pmid">29180369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AEM.01877-17</pub-id><pub-id pub-id-type="pmcid">PMC5795063</pub-id></mixed-citation></ref><ref id="B290"><label>290.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bottero</surname><given-names>D</given-names></name><name name-style="western"><surname>Gaillard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Zurita</surname><given-names>E</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>G</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>DS</given-names></name><name name-style="western"><surname>Bartel</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Characterization of the immune response induced by pertussis OMVs-based vaccine</article-title>. <source>Vaccine.</source> (<year>2016</year>) <volume>34</volume>:<fpage>3303</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.04.079</pub-id><pub-id pub-id-type="pmid">27151884</pub-id></mixed-citation></ref><ref id="B291"><label>291.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaillard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Bottero</surname><given-names>D</given-names></name><name name-style="western"><surname>Errea</surname><given-names>A</given-names></name><name name-style="western"><surname>Ormaz&#225;bal</surname><given-names>M</given-names></name><name name-style="western"><surname>Zurita</surname><given-names>ME</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes</article-title>. <source>Vaccine.</source> (<year>2014</year>) <volume>32</volume>:<fpage>931</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.12.048</pub-id><pub-id pub-id-type="pmid">24397896</pub-id></mixed-citation></ref><ref id="B292"><label>292.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ormaz&#225;bal</surname><given-names>M</given-names></name><name name-style="western"><surname>Bartel</surname><given-names>E</given-names></name><name name-style="western"><surname>Gaillard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Bottero</surname><given-names>D</given-names></name><name name-style="western"><surname>Errea</surname><given-names>A</given-names></name><name name-style="western"><surname>Zurita</surname><given-names>ME</given-names></name><etal/></person-group>. <article-title>Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles</article-title>. <source>Vaccine.</source> (<year>2014</year>) <volume>32</volume>:<fpage>6084</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2014.08.084</pub-id><pub-id pub-id-type="pmid">25240753</pub-id></mixed-citation></ref><ref id="B293"><label>293.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bottero</surname><given-names>D</given-names></name><name name-style="western"><surname>Gaillard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Errea</surname><given-names>A</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>G</given-names></name><name name-style="western"><surname>Zurita</surname><given-names>E</given-names></name><name name-style="western"><surname>Pianciola</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Outer membrane vesicles derived from <italic toggle="yes">Bordetella parapertussis</italic> as an acellular vaccine against <italic toggle="yes">Bordetella parapertussis</italic> and <italic toggle="yes">Bordetella pertussis</italic> infection</article-title>. <source>Vaccine.</source> (<year>2013</year>) <volume>31</volume>:<fpage>5262</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.08.059</pub-id><pub-id pub-id-type="pmid">24012570</pub-id></mixed-citation></ref><ref id="B294"><label>294.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaillard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Bottero</surname><given-names>D</given-names></name><name name-style="western"><surname>Castuma</surname><given-names>CE</given-names></name><name name-style="western"><surname>Basile</surname><given-names>LA</given-names></name><name name-style="western"><surname>Hozbor</surname><given-names>D</given-names></name></person-group>. <article-title>Laboratory adaptation of <italic toggle="yes">Bordetella pertussis</italic> is associated with the loss of type three secretion system functionality</article-title>. <source>Infect Immun.</source> (<year>2011</year>) <volume>79</volume>:<fpage>3677</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00136-11</pub-id><pub-id pub-id-type="pmid">21730086</pub-id><pub-id pub-id-type="pmcid">PMC3165473</pub-id></mixed-citation></ref><ref id="B295"><label>295.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>R</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>G</given-names></name><name name-style="western"><surname>Bottero</surname><given-names>D</given-names></name><name name-style="western"><surname>Gaillard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Fingermann</surname><given-names>M</given-names></name><name name-style="western"><surname>Graieb</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Outer membrane vesicles as acellular vaccine against pertussis</article-title>. <source>Vaccine.</source> (<year>2008</year>) <volume>26</volume>:<fpage>4639</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2008.07.004</pub-id><pub-id pub-id-type="pmid">18640169</pub-id></mixed-citation></ref><ref id="B296"><label>296.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raeven</surname><given-names>RH</given-names></name><name name-style="western"><surname>Brummelman</surname><given-names>J</given-names></name><name name-style="western"><surname>Pennings</surname><given-names>JLA</given-names></name><name name-style="western"><surname>van der Maas</surname><given-names>L</given-names></name><name name-style="western"><surname>Helm</surname><given-names>K</given-names></name><name name-style="western"><surname>Tilstra</surname><given-names>WA</given-names></name><etal/></person-group><article-title>Molecular and cellular signatures underlying superior immunity against <italic toggle="yes">Bordetella pertussis</italic> upon pulmonary vaccination</article-title>. <source>Mucosal Immunol.</source> (<year>2018</year>) <volume>11</volume>:<fpage>979</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2017.81</pub-id><pub-id pub-id-type="pmid">28930286</pub-id></mixed-citation></ref><ref id="B297"><label>297.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raeven</surname><given-names>RH</given-names></name><name name-style="western"><surname>van der Maas</surname><given-names>L</given-names></name><name name-style="western"><surname>Tilstra</surname><given-names>W</given-names></name><name name-style="western"><surname>Uittenbogaard</surname><given-names>JP</given-names></name><name name-style="western"><surname>Bindels</surname><given-names>TH</given-names></name><name name-style="western"><surname>Kuipers</surname><given-names>BA</given-names></name><etal/></person-group>. <article-title>Immunoproteomic profiling of <italic toggle="yes">Bordetella pertussis</italic> outer membrane vesicle vaccine reveals broad and balanced humoral immunogenicity</article-title>. <source>J Proteome Res.</source> (<year>2015</year>) <volume>14</volume>:<fpage>2929</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.5b00258</pub-id><pub-id pub-id-type="pmid">25988566</pub-id></mixed-citation></ref><ref id="B298"><label>298.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raeven</surname><given-names>RH</given-names></name><name name-style="western"><surname>Brummelman</surname><given-names>J</given-names></name><name name-style="western"><surname>Pennings</surname><given-names>JL</given-names></name><name name-style="western"><surname>van der Maas</surname><given-names>L</given-names></name><name name-style="western"><surname>Tilstra</surname><given-names>W</given-names></name><name name-style="western"><surname>Helm</surname><given-names>K</given-names></name><etal/></person-group>. <article-title><italic toggle="yes">Bordetella pertussis</italic> outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>38240</fpage>. <pub-id pub-id-type="doi">10.1038/srep38240</pub-id><pub-id pub-id-type="pmid">27905535</pub-id><pub-id pub-id-type="pmcid">PMC5131296</pub-id></mixed-citation></ref><ref id="B299"><label>299.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raeven</surname><given-names>RHM</given-names></name><name name-style="western"><surname>Brummelman</surname><given-names>J</given-names></name><name name-style="western"><surname>Pennings</surname><given-names>JLA</given-names></name><name name-style="western"><surname>van der Maas</surname><given-names>L</given-names></name><name name-style="western"><surname>Helm</surname><given-names>K</given-names></name><name name-style="western"><surname>Tilstra</surname><given-names>WA</given-names></name><etal/></person-group><article-title>Molecular and cellular signatures underlying superior immunity against <italic toggle="yes">Bordetella pertussis</italic> upon pulmonary vaccination</article-title>. <source>Mucosal Immunol.</source> (<year>2018</year>) <volume>11</volume>:<fpage>979</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2017.110</pub-id><pub-id pub-id-type="pmid">28930286</pub-id></mixed-citation></ref><ref id="B300"><label>300.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanojia</surname><given-names>G</given-names></name><name name-style="western"><surname>Raeven</surname><given-names>RHM</given-names></name><name name-style="western"><surname>van der Maas</surname><given-names>L</given-names></name><name name-style="western"><surname>Bindels</surname><given-names>THE</given-names></name><name name-style="western"><surname>van Riet</surname><given-names>E</given-names></name><name name-style="western"><surname>Metz</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization</article-title>. <source>J Control Release.</source> (<year>2018</year>) <volume>286</volume>:<fpage>167</fpage>&#8211;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2018.07.035</pub-id><pub-id pub-id-type="pmid">30048656</pub-id></mixed-citation></ref><ref id="B301"><label>301.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>AA</given-names></name><name name-style="western"><surname>Patton</surname><given-names>AK</given-names></name><name name-style="western"><surname>Millen</surname><given-names>SH</given-names></name><name name-style="western"><surname>Chang</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Ward</surname><given-names>JI</given-names></name><name name-style="western"><surname>Bernstein</surname><given-names>DI</given-names></name></person-group>. <article-title>Acellular pertussis vaccines and complement killing of <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>Infect Immun.</source> (<year>2004</year>) <volume>72</volume>:<fpage>7346</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.72.12.7346-7351.2004</pub-id><pub-id pub-id-type="pmid">15557666</pub-id><pub-id pub-id-type="pmcid">PMC529164</pub-id></mixed-citation></ref><ref id="B302"><label>302.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coutte</surname><given-names>L</given-names></name><name name-style="western"><surname>Locht</surname><given-names>C</given-names></name></person-group>. <article-title>Investigating pertussis toxin and its impact on vaccination</article-title>. <source>Future Microbiol.</source> (<year>2015</year>) <volume>10</volume>:<fpage>241</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.2217/fmb.14.123</pub-id><pub-id pub-id-type="pmid">25689536</pub-id></mixed-citation></ref><ref id="B303"><label>303.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isbrucker</surname><given-names>RA</given-names></name><name name-style="western"><surname>Bliu</surname><given-names>A</given-names></name><name name-style="western"><surname>Prior</surname><given-names>F</given-names></name></person-group>. <article-title>Modified binding assay for improved sensitivity and specificity in the detection of residual pertussis toxin in vaccine preparations</article-title>. <source>Vaccine.</source> (<year>2010</year>) <volume>28</volume>:<fpage>2687</fpage>&#8211;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2010.01.040</pub-id><pub-id pub-id-type="pmid">20123053</pub-id></mixed-citation></ref><ref id="B304"><label>304.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quentin-Millet</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Arminjon</surname><given-names>F</given-names></name><name name-style="western"><surname>Danve</surname><given-names>B</given-names></name><name name-style="western"><surname>Cadoz</surname><given-names>M</given-names></name><name name-style="western"><surname>Armand</surname><given-names>J</given-names></name></person-group>. <article-title>Acellular pertussis vaccines: evaluation of reversion in a nude mouse model</article-title>. <source>J Biol Stand.</source> (<year>1988</year>) <volume>16</volume>:<fpage>99</fpage>&#8211;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/0092-1157(88)90037-6</pub-id><pub-id pub-id-type="pmid">3259580</pub-id></mixed-citation></ref><ref id="B305"><label>305.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kil&#225;r</surname><given-names>A</given-names></name><name name-style="western"><surname>D&#246;rnyei</surname><given-names>&#193;</given-names></name><name name-style="western"><surname>Kocsis</surname><given-names>B</given-names></name></person-group>. <article-title>Structural characterization of bacterial lipopolysaccharides with mass spectrometry and on- and off-line separation techniques</article-title>. <source>Mass Spectrom Rev.</source> (<year>2013</year>) <volume>32</volume>:<fpage>90</fpage>&#8211;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1002/mas.21352</pub-id><pub-id pub-id-type="pmid">23165926</pub-id></mixed-citation></ref><ref id="B306"><label>306.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higgs</surname><given-names>R</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>SC</given-names></name><name name-style="western"><surname>Ross</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title>Immunity to the respiratory pathogen <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>Mucosal Immunol.</source> (<year>2012</year>) <volume>5</volume>:<fpage>485</fpage>&#8211;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2012.54</pub-id><pub-id pub-id-type="pmid">22718262</pub-id></mixed-citation></ref><ref id="B307"><label>307.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahon</surname><given-names>BP</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>MS</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>F</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name></person-group>. <article-title>Interleukin-12 is produced by macrophages in response to live or killed <italic toggle="yes">Bordetella pertussis</italic> and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells</article-title>. <source>Infect Immun.</source> (<year>1996</year>) <volume>64</volume>:<fpage>5295</fpage>&#8211;<lpage>301</lpage>. <pub-id pub-id-type="pmid">8945580</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.64.12.5295-5301.1996</pub-id><pub-id pub-id-type="pmcid">PMC174522</pub-id></mixed-citation></ref><ref id="B308"><label>308.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kubler-Kielb</surname><given-names>J</given-names></name><name name-style="western"><surname>Vinogradov</surname><given-names>E</given-names></name><name name-style="western"><surname>Lagerg&#229;rd</surname><given-names>T</given-names></name><name name-style="western"><surname>Ginzberg</surname><given-names>A</given-names></name><name name-style="western"><surname>King</surname><given-names>JD</given-names></name><name name-style="western"><surname>Preston</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Oligosaccharide conjugates of <italic toggle="yes">Bordetella pertussis</italic> and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2011</year>) <volume>108</volume>:<fpage>4087</fpage>&#8211;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1100782108</pub-id><pub-id pub-id-type="pmid">21367691</pub-id><pub-id pub-id-type="pmcid">PMC3054038</pub-id></mixed-citation></ref><ref id="B309"><label>309.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niedziela</surname><given-names>T</given-names></name><name name-style="western"><surname>Letowska</surname><given-names>I</given-names></name><name name-style="western"><surname>Lukasiewicz</surname><given-names>J</given-names></name><name name-style="western"><surname>Kaszowska</surname><given-names>M</given-names></name><name name-style="western"><surname>Czarnecka</surname><given-names>A</given-names></name><name name-style="western"><surname>Kenne</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Epitope of the vaccine-type <italic toggle="yes">Bordetella pertussis</italic> strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate</article-title>. <source>Infect Immun.</source> (<year>2005</year>) <volume>73</volume>:<fpage>7381</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.73.11.7381-7389.2005</pub-id><pub-id pub-id-type="pmid">16239537</pub-id><pub-id pub-id-type="pmcid">PMC1273879</pub-id></mixed-citation></ref><ref id="B310"><label>310.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koj</surname><given-names>S</given-names></name><name name-style="western"><surname>&#321;ugowski</surname><given-names>C</given-names></name><name name-style="western"><surname>Niedziela</surname><given-names>T</given-names></name></person-group>. <article-title>[<italic toggle="yes">Bordetella pertussis</italic> lipooligosaccharide-derived neoglycoconjugates - new components of pertussis vaccine]</article-title>. <source>Postepy Hig Med Dosw (Online)</source> (<year>2015</year>) <volume>69</volume>:<fpage>1013</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="pmid">26400888</pub-id></mixed-citation></ref><ref id="B311"><label>311.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ernst</surname><given-names>K</given-names></name><name name-style="western"><surname>Eberhardt</surname><given-names>N</given-names></name><name name-style="western"><surname>Mittler</surname><given-names>AK</given-names></name><name name-style="western"><surname>Sonnabend</surname><given-names>M</given-names></name><name name-style="western"><surname>Anastasia</surname><given-names>A</given-names></name><name name-style="western"><surname>Freisinger</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Pharmacological cyclophilin inhibitors prevent intoxication of mammalian cells with <italic toggle="yes">Bordetella pertussis</italic> toxin</article-title>. <source>Toxins.</source> (<year>2018</year>) <volume>10</volume>:<fpage>E181</fpage>. <pub-id pub-id-type="doi">10.3390/toxins10050181</pub-id><pub-id pub-id-type="pmid">29723951</pub-id><pub-id pub-id-type="pmcid">PMC5983237</pub-id></mixed-citation></ref><ref id="B312"><label>312.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaiser</surname><given-names>E</given-names></name><name name-style="western"><surname>Pust</surname><given-names>S</given-names></name><name name-style="western"><surname>Kroll</surname><given-names>C</given-names></name><name name-style="western"><surname>Barth</surname><given-names>H</given-names></name></person-group>. <article-title>Cyclophilin A facilitates translocation of the <italic toggle="yes">Clostridium botulinum</italic> C2 toxin across membranes of acidified endosomes into the cytosol of mammalian cells</article-title>. <source>Cell Microbiol.</source> (<year>2009</year>) <volume>11</volume>:<fpage>780</fpage>&#8211;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-5822.2009.01291.x</pub-id><pub-id pub-id-type="pmid">19159389</pub-id></mixed-citation></ref><ref id="B313"><label>313.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>AE</given-names></name><name name-style="western"><surname>Ernst</surname><given-names>K</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><name name-style="western"><surname>Papatheodorou</surname><given-names>P</given-names></name><name name-style="western"><surname>Schwan</surname><given-names>C</given-names></name><name name-style="western"><surname>Barth</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>The chaperone Hsp90 and PPIases of the cyclophilin and FKBP families facilitate membrane translocation of <italic toggle="yes">Photorhabdus luminescens</italic> ADP-ribosyltransferases</article-title>. <source>Cell Microbiol.</source> (<year>2014</year>) <volume>16</volume>:<fpage>490</fpage>&#8211;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1111/cmi.12228</pub-id><pub-id pub-id-type="pmid">24138221</pub-id></mixed-citation></ref><ref id="B314"><label>314.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shitara</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Nagamatsu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wada</surname><given-names>S</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Horie</surname><given-names>T</given-names></name></person-group><article-title>Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake</article-title>. <source>Drug Metab Pharmacokinet.</source> (<year>2012</year>) <volume>27</volume>:<fpage>368</fpage>&#8211;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.2133/dmpk.DMPK-11-RG-096</pub-id><pub-id pub-id-type="pmid">22240838</pub-id></mixed-citation></ref><ref id="B315"><label>315.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fabre</surname><given-names>I</given-names></name><name name-style="western"><surname>Fabre</surname><given-names>G</given-names></name><name name-style="western"><surname>Lena</surname><given-names>N</given-names></name><name name-style="western"><surname>Cano</surname><given-names>JP</given-names></name></person-group>. <article-title>Kinetics of uptake and intracellular binding of Cyclosporine A in RAJI cells, <italic toggle="yes">in vitro</italic></article-title>. <source>Biochem Pharmacol.</source> (<year>1986</year>) <volume>35</volume>:<fpage>4261</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(86)90704-5</pub-id><pub-id pub-id-type="pmid">3790152</pub-id></mixed-citation></ref><ref id="B316"><label>316.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bertault-P&#233;r&#232;s</surname><given-names>P</given-names></name><name name-style="western"><surname>Maraninchi</surname><given-names>D</given-names></name><name name-style="western"><surname>Carcassonne</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cano</surname><given-names>JP</given-names></name><name name-style="western"><surname>Barbet</surname><given-names>J</given-names></name></person-group>. <article-title>Clinical pharmacokinetics of ciclosporin A in bone marrow transplantation patients</article-title>. <source>Cancer Chemother Pharmacol.</source> (<year>1985</year>) <volume>15</volume>:<fpage>76</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1007/BF00257300</pub-id><pub-id pub-id-type="pmid">3891122</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>